Set Analyses:
Advanced Search

Advanced Search

 
Search By
Section (entire)
for


 



MAOA Gene

protein-coding   GIFtS: 72
GCID: GC0XP043515

Monoamine Oxidase A

  See related diseases
at  

(According to 1HGNC, 2Entrez Gene,
3UniProtKB/Swiss-Prot, 4UniProtKB/TrEMBL, 5OMIM, 6GeneLoc, 7Ensembl, 8DME, 9miRBase, 10fRNAdb, 12H-InvDB, 13NCBI, 14NONCODE, and/or 15RNAdb)
About This Section

TryGeneCards Plus

Aliases
Monoamine Oxidase A1 2
Monoamine Oxidase Type A2 3
MAO-A2 3
EC 1.4.3.43 8
Amine Oxidase [Flavin-Containing] A2
EC 1.4.38

External Ids:    HGNC: 68331   Entrez Gene: 41282   Ensembl: ENSG000001892217   OMIM: 3098505   UniProtKB: P213973   

Export aliases for MAOA gene to outside databases

Previous GC identifers: GC0XP041545 GC0XP041794 GC0XP042360 GC0XP042636 GC0XP043271 GC0XP043400 GC0XP041246


(According to Entrez Gene, GeneCards, Tocris Bioscience, Wikipedia's Gene Wiki, PharmGKB,
UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL)
About This Section

TryGeneCards Plus

Entrez Gene summary for MAOA Gene:
This gene is one of two neighboring gene family members that encode mitochondrial enzymes which catalyze the
oxidative deamination of amines, such as dopamine, norepinephrine, and serotonin. Mutation of this gene results
in Brunner syndrome. This gene has also been associated with a variety of other psychiatric disorders, including
antisocial behavior. Alternatively spliced transcript variants encoding multiple isoforms have been observed.
(provided by RefSeq, Jul 2012)

GeneCards Summary for MAOA Gene:
MAOA (monoamine oxidase A) is a protein-coding gene. Diseases associated with MAOA include antisocial personality disorder, and avoidant personality disorder. GO annotations related to this gene include primary amine oxidase activity. An important paralog of this gene is MAOB.

UniProtKB/Swiss-Prot: AOFA_HUMAN, P21397
Function: Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the
metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues. MAOA
preferentially oxidizes biogenic amines such as 5-hydroxytryptamine (5-HT), norepinephrine and epinephrine

summary for MAOA Gene:
Monoamine Oxidases (MAO) catalyze the oxidation of monoamines such as dopamine, serotonin and adrenalin.
They are found bound to the outer membrane of mitochondria in most cell types in the body. Two subtypes of
monoamine oxidase have been identified: MAO-A and MAO-B. Both are found in neurons and astroglia, with MAO-A
also found in the liver, gastrointestinal tract and placenta and MAO-B in blood platelets. Abnormal
regulation of MAOs in the body has been associated with depression, substance abuse, attention deficit
disorder, and irregular sexual maturation.

Gene Wiki entry for MAOA (Monoamine oxidase A) Gene


(According to GeneLoc and/or HGNC, and/or
Entrez Gene (NCBI build 37),
and/or miRBase,
Genomic Views according to UCSC (hg19) and Ensembl (release 75), Regulatory elements and Epigenetics data according to QIAGEN, and/or SwitchGear Genomics)
About This Section

TryGeneCards Plus
RefSeq DNA sequence:
NC_000023.11  NC_018934.2  NT_079573.5  
Regulatory elements:
   Regulatory transcription factor binding sites in the MAOA gene promoter:
         MEF-2A   c-Fos   AP-1   ATF-2   c-Jun   
         Other transcription factors

SwitchGear Promoter luciferase reporter plasmidMAOA promoter sequence
   Search Chromatin IP Primers for MAOA

Epigenetics:
DNA Methylation CpG Assay Predesigned for Pyrosequencing in human, mouse, rat MAOA


Genomic Location:
Genomic View: UCSC Golden Path with GeneCards custom track

Entrez Gene cytogenetic band: Xp11.3   Ensembl cytogenetic band:  Xp11.3   HGNC cytogenetic band: Xp11.4-p11.3

MAOA Gene in genomic location: bands according to Ensembl, locations according to (and/or Entrez Gene and/or Ensembl if different)
MAOA gene location

GeneLoc information about chromosome X         GeneLoc Exon Structure

GeneLoc location for GC0XP043515:  view genomic region     (about GC identifiers)

Start:
43,515,409 bp from pter      End:
43,606,068 bp from pter
Size:
90,660 bases      Orientation:
plus strand

(According to 1UniProtKB, HORDE, 2neXtProt, Ensembl, and/or Reactome, Modification sites according to PhosphoSitePlus, Specific Peptides from DME, RefSeq according to NCBI, PDB rendering according to OCA and/or Proteopedia, Recombinant Proteins from EMD Millipore, R&D Systems, GenScript, Enzo Life Sciences, OriGene, Novus Biologicals, Sino Biological, ProSpec, and/or Cloud-Clone Corp.,
Biochemical Assays by EMD Millipore, R&D Systems, OriGene, GenScript, Cell Signaling Technology, Enzo Life Sciences, and/or Cloud-Clone Corp., Antibodies by EMD Millipore, R&D Systems, Cell Signaling Technology, OriGene, Novus Biologicals, Thermo Fisher Scientific, LSBio, Abcam, Cloud-Clone Corp, and/or others.)
About This Section

TryGeneCards Plus

UniProtKB/Swiss-Prot: AOFA_HUMAN, P21397 (See protein sequence)
Recommended Name: Amine oxidase [flavin-containing] A  
Size: 527 amino acids; 59682 Da
Cofactor: FAD
Subunit: Monomer, homo- or heterodimer (containing two subunits of similar size). Each subunit contains a
covalently bound flavin. Enzymatically active as monomer
Mass spectrometry: Mass=60512; Mass_error=6; Method=Electrospray; Range=1-527; Source=PubMed:11812236;
5 PDB 3D structures from and Proteopedia for MAOA:
1H8Q (3D)        2BXR (3D)        2BXS (3D)        2Z5X (3D)        2Z5Y (3D)    
Secondary accessions: B4DF46 Q16426
Alternative splicing: 2 isoforms:  P21397-1   P21397-2   

Explore the universe of human proteins at neXtProt for MAOA: NX_P21397

Explore proteomics data for MAOA at MOPED

Post-translational modifications: 

  • Ubiquitination2 at Lys469
  • Modification sites at PhosphoSitePlus
  • Selected DME Specific Peptides for MAOA (P21397) (see all 22)
     RQPVGRI  DYNNLWR  ERNLPSV  FPPVWNP 


    See MAOA Protein Expression from SPIRE MOPED, PaxDB, and MaxQB

    REFSEQ proteins (2 alternative transcripts): 
    NP_000231.1  NP_001257387.1  

    ENSEMBL proteins: 
     ENSP00000340684   ENSP00000440846  
    Reactome Protein details: P21397

    MAOA Human Recombinant Protein Products:

    Browse Purified and Recombinant Proteins at EMD Millipore
    Browse R&D Systems for human recombinant proteins
    Browse recombinant and purified proteins available from Enzo Life Sciences
    Browse OriGene full length recombinant human proteins expressed in human HEK293 cells
    OriGene Protein Over-expression Lysate for MAOA
    OriGene Custom MassSpec
    OriGene Custom Protein Services for MAOA
    GenScript Custom Purified and Recombinant Proteins Services for MAOA
    Novus Biologicals MAOA Protein
    Novus Biologicals MAOA Lysates
    Sino Biological Recombinant Protein for MAOA
    Browse Sino Biological Cell Lysates
    Browse ProSpec Recombinant Proteins
    Cloud-Clone Corp. Proteins for MAOA

    MAOA Antibody Products:

    EMD Millipore Mono- and Polyclonal Antibodies for the study of MAOA
    Browse R&D Systems for Antibodies
    OriGene Antibodies for MAOA
    OriGene Custom Antibody Services for MAOA
    Novus Biologicals MAOA Antibodies
    Abcam antibodies for MAOA (P21397, P27338)
    Cloud-Clone Corp. Antibodies for MAOA
    ThermoFisher Antibodies for MAOA
    LSBio Antibodies in human, mouse, rat for MAOA

    MAOA Assay Products:

    Browse Kits and Assays available from EMD Millipore
    OriGene Custom Assay Services for MAOA
    Browse R&D Systems for biochemical assays
    GenScript Custom Assay Services for MAOA
    Browse Enzo Life Sciences for kits & assays
    Cloud-Clone Corp. ELISAs for MAOA
    Cloud-Clone Corp. CLIAs for MAOA


    (According to HGNC, IUPHAR, InterPro, ProtoNet, UniProtKB, and/or BLOCKS, Sets of similar genes according to GeneDecks)
    About This Section

    TryGeneCards Plus
    2 InterPro protein domains:
     IPR001613 Flavin_amine_oxidase
     IPR002937 Amino_oxidase

    Graphical View of Domain Structure for InterPro Entry P21397

    ProtoNet protein and cluster: P21397

    1 Blocks protein domain: IPB001613 Flavin-containing amine oxidase signature

    UniProtKB/Swiss-Prot: AOFA_HUMAN, P21397
    Similarity: Belongs to the flavin monoamine oxidase family


    MAOA for domains           About GeneDecksing


    (According to 1UniProtKB, Genatlas, LifeMap Discovery™, IUBMB, and/or 2DME, Human phenotypes from GenomeRNAi, Animal models from MGI Mar 06 2013, inGenious Targeting Laboratory, genOway,
    transcription factor targeting from QIAGEN and/or HOMER, miRNA Gene Targets from miRTarBase, shRNA from OriGene, siRNAs from OriGene, QIAGEN, microRNA from QIAGEN, SwitchGear Genomics, Gene Editing from DNA2.0, Clones from OriGene, GenScript, Sino Biological, DNA2.0, and Vector BioLabs, Cell Lines from GenScript, ESI BIO, In Situ Hybridization Assays from Advanced Cell Diagnostics, Ontologies according to Gene Ontology Consortium 01 Apr 2014 via Entrez Gene.)
    About This Section

    TryGeneCards Plus

    Molecular Function:

         UniProtKB/Swiss-Prot Summary: AOFA_HUMAN, P21397
    Function: Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the
    metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues. MAOA
    preferentially oxidizes biogenic amines such as 5-hydroxytryptamine (5-HT), norepinephrine and epinephrine
    Catalytic activity: RCH(2)NHR' + H(2)O + O(2) = RCHO + R'NH(2) + H(2)O(2)

         Genatlas biochemistry entry for MAOA:
    monoamine oxidase A,overexpressed in female panic disorders

         Enzyme Numbers (IUBMB): EC 1.4.3.41 2 EC 1.4.32

         Gene Ontology (GO): 3 molecular function terms:    About this table

    GO IDQualified GO termEvidencePubMed IDs
    GO:0008131primary amine oxidase activity TAS--
    GO:0016491oxidoreductase activity ----
    GO:0050660flavin adenine dinucleotide binding ----
         
    MAOA for ontologies           About GeneDecksing


    Phenotypes:
         1 GenomeRNAi human phenotype for MAOA:
     Decreased viability 

         4 MGI mutant phenotypes (inferred from 2 alleles(MGI details for Maoa):
     behavior/neurological  cardiovascular system  homeostasis/metabolism  nervous system 

    MAOA for phenotypes           About GeneDecksing

    Animal Models:
         MGI mouse knock-out Maoatm1Shih for MAOA

       inGenious Targeting Laboratory: Let us create your new Knockout/Knockin mouse model for MAOA
       inGenious Targeting Laboratory: Contact us about creating complex and humanized mouse models for MAOA

       genOway customized KO model: permanent, tissue-specific or time-controlled inactivation for MAOA
       genOway customized Knockin model: humanization, point mutation, expression monitoring, etc. for MAOA

    miRNA
    Products:
        
    miRTarBase miRNAs that target MAOA:
    hsa-mir-22-3p (MIRT005902)

    Block miRNA regulation of human, mouse, rat MAOA using miScript Target Protectors
    Selected qRT-PCR Assays for microRNAs that regulate MAOA (see all 13):
    hsa-miR-3163 hsa-miR-495 hsa-miR-767-3p hsa-miR-7-2* hsa-miR-1324 hsa-miR-3065-5p hsa-miR-624* hsa-miR-29b-1*
    SwitchGear 3'UTR luciferase reporter plasmidMAOA 3' UTR sequence
    Inhib. RNA
    Products:
        
    OriGene RNAi products in human, mouse, rat for MAOA
    Predesigned siRNA for gene silencing in human, mouse, rat MAOA

    Gene Editing
    Products:
    DNA2.0 Custom Protein Engineering Service for MAOA

    Clone
    Products:
         
    OriGene clones in human, mouse for MAOA (see all 7)
    OriGene ORF clones in mouse, rat for MAOA
    OriGene custom cloning services - gene synthesis, subcloning, mutagenesis, variant library, vector shuttling
    GenScript: all cDNA clones in your preferred vector: MAOA (NM_000240)
    Sino Biological Human cDNA Clone for MAOA
    DNA2.0 Custom Codon Optimized Gene Synthesis Service for MAOA
    Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat MAOA

    Cell Line
    Products:
         
    GenScript Custom overexpressing Cell Line Services for MAOA
    Browse ESI BIO Cell Lines and PureStem Progenitors for MAOA 
    In Situ Assay
    Products:
       

     
    Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for MAOA


    (According to UniProtKB, COMPARTMENTS Subcellular localization database, Ontologies according to Gene Ontology Consortium 01 Apr 2014 via Entrez Gene.)
    About This Section

    TryGeneCards Plus

    Subcellular locations from UniProtKB/Swiss-Prot
    AOFA_HUMAN, P21397: Mitochondrion outer membrane; Single-pass type IV membrane protein; Cytoplasmic side
    Subcellular locations from COMPARTMENTS: 

    CompartmentConfidence
    mitochondrion5
    cytosol2
    extracellular2
    nucleus2
    peroxisome1
    plasma membrane1

    Gene Ontology (GO): 3 cellular component terms:    About this table

    GO IDQualified GO termEvidencePubMed IDs
    GO:0005739mitochondrion IDA--
    GO:0005741mitochondrial outer membrane TAS--
    GO:0016021integral component of membrane IEA--

    MAOA for ontologies           About GeneDecksing


    (SuperPaths according to PathCards, Pathways according to R&D Systems, Cell Signaling Technology, KEGG, PharmGKB, BioSystems, Sino Biological, Reactome, Tocris Bioscience, GeneGo (Thomson Reuters), QIAGEN, and/or UniProtKB, Sets of similar genes according to GeneDecks, Interaction Networks according to QIAGEN, and/or STRING, Interactions according to 1UniProtKB, 2MINT, 3I2D, and/or 4STRING, with links to IntAct and Ensembl, Ontologies according to Gene Ontology Consortium 01 Apr 2014 via Entrez Gene).
    About This Section

    TryGeneCards Plus

    SuperPaths for MAOA About   (see all 25)  
    See pathways by source

    SuperPathContained pathways About
    1Serotonin clearance from the synaptic cleft
    Enzymatic degradation of dopamine by COMT0.33
    Enzymatic degradation of Dopamine by monoamine oxidase0.00
    Serotonin clearance from the synaptic cleft0.33
    Metabolism of serotonin0.00
    melatonin degradation II0.00
    2Phenylalanine metabolism
    Phenylalanine metabolism0.36
    noradrenaline and adrenaline degradation0.31
    Tyrosine metabolism0.36
    phenylalanine degradation IV0.00
    phenylalanine utilization0.33
    3Metabolism
    Metabolism0.38
    Metabolic pathways0.38
    4Transmission across Chemical Synapses
    Transmission across Chemical Synapses0.72
    Neurotransmitter Clearance In The Synaptic Cleft0.00
    Neuronal System0.68
    Dopamine clearance from the synaptic cleft0.00
    5tryptophan utilization II
    tryptophan utilization II0.71
    superpathway of melatonin degradation0.00
    tryptophan utilization I0.71
    serotonin degradation0.00

    Pathways by source                                                                                                                                                                 See SuperPaths
    Show all pathways


    1 GeneGo (Thomson Reuters) Pathway for MAOA
        Tyrosine metabolism p.1 (dopamine)

    Selected BioSystems Pathways for MAOA (see all 15)
        Biogenic Amine Synthesis
    SIDS Susceptibility Pathways
    Oxidative Stress
    dopamine degradation
    serotonin degradation


    5 Reactome Pathways for MAOA
        Enzymatic degradation of dopamine by COMT
    Metabolism of serotonin
    Enzymatic degradation of Dopamine by monoamine oxidase
    Norepinephrine Neurotransmitter Release Cycle
    Monoamines are oxidized to aldehydes by MAOA and MAOB, producing NH3 and H2O2

    1 PharmGKB Pathway for MAOA
        Selective Serotonin Reuptake Inhibitor Pathway, Pharmacodynamics

    Selected Kegg Pathways  (Kegg details for MAOA) (see all 13):
        Glycine, serine and threonine metabolism
    Arginine and proline metabolism
    Histidine metabolism
    Tyrosine metabolism
    Phenylalanine metabolism


    MAOA for pathways           About GeneDecksing

        Pathway & Disease-focused RT2 Profiler PCR Arrays including MAOA: 
              Amino Acid Metabolism II in human mouse rat
              Drug Metabolism: Phase I Enzymes in human mouse rat
              Molecular Toxicology PathwayFinder 384HT in human mouse rat

    Interactions:

        GeneGlobe Interaction Network for MAOA

    STRING Interaction Network Preview (showing 5 interactants - click image to see 25)

    Selected Interacting proteins for MAOA (P213972, 3 ENSP000003406844) via UniProtKB, MINT, STRING, and/or I2D (see all 94)
    InteractantInteraction Details
    GeneCardExternal ID(s)
    UBCP0CG483, ENSP000003448184I2D: score=1 STRING: ENSP00000344818
    NDRG1Q925973, ENSP000003199774I2D: score=3 STRING: ENSP00000319977
    ATP6V1B2P212812, ENSP000002763904MINT-4054731 STRING: ENSP00000276390
    YWHABP319463I2D: score=1 
    A2MP010232MINT-4054731
    About this table

    Gene Ontology (GO): Selected biological process terms (see all 10):    About this table

    GO IDQualified GO termEvidencePubMed IDs
    GO:0006576cellular biogenic amine metabolic process TAS8211186
    GO:0006805xenobiotic metabolic process TAS--
    GO:0007268synaptic transmission TAS--
    GO:0007269neurotransmitter secretion TAS--
    GO:0007610behavior ----

    MAOA for ontologies           About GeneDecksing



    (Chemical Compounds according to UniProtKB, Enzo Life Sciences, EMD Millipore, Tocris Bioscience, ApexBio, HMDB, BitterDB, and/or Novoseek, Ligands according to IUPHAR, and Drugs according to DrugBank, Enzo Life Sciences, and/or PharmGKB)
    About This Section

    TryGeneCards Plus
    Browse Small Molecules at EMD Millipore
       Browse drugs & compounds from Enzo Life Sciences
      Browse compounds at ApexBio 

    Compounds for MAOA available from Tocris Bioscience    About this table
    CompoundAction CAS #
    Rasagiline mesylate Selective, irreversible MAO-B inhibitor [161735-79-1]
    (R)-(-)-Deprenyl hydrochlorideMAO-B inhibitor[14611-52-0]
    MoclobemideReversible MAO-A inhibitor[71320-77-9]
    Lazabemide hydrochlorideSelective MAO-B inhibitor[103878-83-7]
    Bifemelane hydrochlorideMAO-A and MAO-B inhibitor[90293-01-9]

    Selected HMDB Compounds for MAOA (see all 43)    About this table
    CompoundSynonyms CAS #PubMed Ids
    1-Methylhistamine1-Methyl-1H-imidazole-4-ethanamine (see all 21)501-75-7--
    1-Phenylethylaminea-phenylethylamine (see all 17)98-84-0--
    3,4-Dihydroxymandelaldehyde3,4-Dihydroxyphenylglycolaldehyde (see all 4)13023-73-9--
    3,4-DihydroxyphenylacetaldehydeProtocatechuatealdehyde (see all 2)5707-55-1--
    3-Methoxy-4-hydroxyphenylglycolaldehydea,4-dihydroxy-3-methoxy-Benzeneacetaldehyde (see all 4)17592-23-3--
    3-Methoxytyramine3-Methoxy-4-hydroxyphenylethyl amine (see all 7)554-52-9--
    4,6-Dihydroxyquinoline4,6-Quinolinediol (see all 2)3517-61-1--
    5-Hydroxyindoleacetaldehyde(5-hydroxy-1H-indol-3-yl)acetaldehyde (see all 6)1892-21-3--
    5-Hydroxykynurenamine5-Hydroxykynuramine (see all 3)708-23-6--
    5-Methoxytryptamine2-(5-Methoxy-1H-indol-3-yl)ethanamine (see all 10)608-07-1--

    Selected DrugBank Compounds for MAOA (see all 37)    About this table
    CompoundSynonyms CAS #TypeActionsPubMed Ids
    Tranylcypromine-- 155-09-9targetinhibitor12504917 8749840 15351283 15276688 10548268 14574774 11752352 20655983 16495723 10027835 15049511 10494892 9829163
    Phenelzine-- 51-71-8targetantagonist17768678 17912044 14574774 11752352 7092487 19201819 16370964 18700056 9829163
    enzymesubstrate17768678 17912044 14574774 11752352 7092487 19201819 16370964 18700056 9829163 17768678
    PargylineBenzyl-methyl-2-propinylamin (see all 12)555-57-7targetinhibitor19300583 17823646 9564606 477738 16641841 17715422
    Phentermine-- 122-09-8targetantagonist11911838 11673765 10799660 10231134
    enzymeinhibitor11911838 11673765 10799660 10231134 11911838 10799660
    Moclobemide4-Chlor-N-(2-morpholinoethyl)benzamid (see all 11)71320-77-9targetinhibitor1705137 8875133 11752352
    enzymeinhibitor1705137 8875133 11752352 11752352
    SelegilineL-Deprenalin (see all 4)14611-51-9targetinhibitor19300583 17823646 16641841 17715422
    Almotriptan-- 181183-52-8enzymesubstrate12353056 12642466 15762767
    DopamineDopamin (see all 6)51-61-6enzymesubstrate15817751 18652859 20869994
    Flavin-Adenine Dinucleotide-- 146-14-5target--17139284 17016423 10592235
    FurazolidoneNitrofurazolidone (see all 3)67-45-8enzymeinhibitor12623758 2032659 10543364

    Selected Novoseek inferred chemical compound relationships for MAOA gene (see all 133)    About this table
    Compound   -log (P-Val)   Hits   PubMed IDs for Articles with Shared Sentences (# sentences)
    maoa 98.5 1084 17692293 (10), 19224413 (8), 11927135 (8), 15936529 (8) (see all 99)
    moclobemide 94.9 153 1546132 (5), 8612391 (3), 9663810 (3), 9174681 (3) (see all 99)
    clorgyline 91.8 98 1741773 (4), 9564606 (3), 1893487 (3), 8243537 (2) (see all 54)
    brofaromine 90.8 33 8430214 (4), 1967018 (2), 8313400 (2), 8313393 (2) (see all 22)
    befloxatone 90.4 36 8613928 (8), 12729662 (3), 7665725 (2), 9728902 (2) (see all 15)
    kynuramine 89.7 14 20504539 (1), 8990278 (1), 16139309 (1), 8443155 (1) (see all 12)
    toloxatone 88.5 10 1546145 (2), 1705137 (2), 1424410 (2), 8713690 (1) (see all 6)
    tyramine 85.5 68 17561096 (4), 8255365 (3), 8695909 (2), 7665725 (2) (see all 37)
    pirlindole 83.5 16 8953568 (3), 9564636 (2), 12781338 (2), 9272198 (2) (see all 7)
    1-phenylcyclopropylamine 81.4 3 15755651 (1), 15848762 (1)



    MAOA for compounds           About GeneDecksing



    (Secondary structures according to fRNAdb,
    GenBank/EMBL/DDBJ Accessions according to
    Unigene (Build 236 Homo sapiens; Apr 25 2013) or GenBank,
    RefSeq according to Entrez Gene,
    DOTS (version 10), and/or AceView, transcript ids from Ensembl with links to UCSC,
    exon structure from GeneLoc, alternative splicing isoforms according to ASD and/or ECgene,
    siRNAs from OriGene, QIAGEN, shRNA from OriGene, microRNA from QIAGEN, SwitchGear Genomics,
    Tagged/untagged cDNA clones from OriGene, GenScript, DNA2.0, Vector BioLabs, Primers from OriGene, and/or QIAGEN )
    About This Section

    TryGeneCards Plus

    REFSEQ mRNAs for MAOA gene (2 alternative transcripts): 
    NM_000240.3  NM_001270458.1  

    Unigene Cluster for MAOA:

    Monoamine oxidase A
    Hs.183109  [show with all ESTs]
    Unigene Representative Sequence: NM_001270458
    4 Ensembl transcripts including schematic representations, and UCSC links where relevant:
    ENST00000338702(uc004dfy.3 uc011mkw.2) ENST00000497485 ENST00000490604
    ENST00000542639
    miRNA
    Products:
         
    Block miRNA regulation of human, mouse, rat MAOA using miScript Target Protectors
    Selected qRT-PCR Assays for microRNAs that regulate MAOA (see all 13):
    hsa-miR-3163 hsa-miR-495 hsa-miR-767-3p hsa-miR-7-2* hsa-miR-1324 hsa-miR-3065-5p hsa-miR-624* hsa-miR-29b-1*
    SwitchGear 3'UTR luciferase reporter plasmidMAOA 3' UTR sequence
    Inhib. RNA
    Products:
         
    OriGene RNAi products in human, mouse, rat for MAOA
    Predesigned siRNA for gene silencing in human, mouse, rat MAOA
    Clone
    Products:
         
    OriGene clones in human, mouse for MAOA (see all 7)
    OriGene ORF clones in mouse, rat for MAOA
    OriGene custom cloning services - gene synthesis, subcloning, mutagenesis, variant library, vector shuttling
    GenScript: all cDNA clones in your preferred vector: MAOA (NM_000240)
    DNA2.0 Custom Codon Optimized Gene Synthesis Service for MAOA
    Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat MAOA
    Primer
    Products:
        
    OriGene qPCR primer pairs and template standards for MAOA
    OriGene qSTAR qPCR primer pairs in human, mouse for MAOA
    Pre-validated RT2 qPCR Primer Assay in human, mouse, rat MAOA
      QuantiTect SYBR Green Assays in human, mouse, rat MAOA
      QuantiFast Probe-based Assays in human, mouse, rat MAOA

    Additional mRNA sequence: 

    AK123241.1 AK223499.1 AK291769.1 AK293926.1 BC008064.2 BC044787.1 BT006651.1 M68840.1 
    X17192.1 

    11 DOTS entries:

    DT.95120451  DT.87015236  DT.101981844  DT.100025285  DT.100825058  DT.121278195  DT.100708824  DT.121278204 
    DT.95120454  DT.100718004  DT.70102839 

    Selected AceView cDNA sequences (see all 267):

    AI674356 AW511315 BU684121 R97085 CA444528 AA865791 BM923944 AA995668 
    F02245 AI076531 BQ717463 N29331 AW873998 BQ716421 AI890731 NM_000240 
    AW627528 BG534382 BF448960 N30236 H82430 CK818786 R86250 AI335934 

    GeneLoc Exon Structure


    (RNA expression data according to H-InvDB, NONCODE, miRBase, and RNAdb, Expression images according to data from BioGPS, Illumina Human BodyMap, and CGAP SAGE, Sets of similar genes according to GeneDecks, in vivo and in vitro expression data from LifeMap Discovery™, Protein expression images according to data from SPIRE 1MOPED, 2PaxDb, and 3MaxQB, plus additional links to SOURCE, and/or BioGPS, and/or UniProtKB,
    PCR Arrays from QIAGEN, Primers from OriGene, and/or QIAGEN, In Situ Hybridization Assays from Advanced Cell Diagnostics)
    About This Section

    TryGeneCards Plus

    MAOA expression in normal human tissues (normalized intensities)
    See probesets specificity/sensitivity at GeneAnnot
    About this imageBioGPS <intensity>2/3
    CGAP TAG: TCTGAAGTTT
    MAOA Expression
    About this image


    MAOA expression in embryonic tissues and stem cells    About this table
    Data from LifeMap, the Embryonic Development and Stem Cells Database
     selected tissues (see all 13) fully expand
     
     Bone (Muscoskeletal System)    fully expand to see all 4 entries
             TGFbeta3+BMP7-induced chondrocytes
     
     Cartilage (Muscoskeletal System)    fully expand to see all 4 entries
             TGFbeta3+BMP7-induced chondrocytes
     
     Adipose (Muscoskeletal System)    fully expand to see all 3 entries
             White adipocyte-like cells
     
     Brain (Nervous System)    fully expand to see all 3 entries
             Cerebral Cortex
     
     Lung (Respiratory System)    fully expand to see all 2 entries
             Stem Bronchi
             Alveolar type II cells
    MAOA Protein expression data from MOPED1, PaxDb2 and MaxQB3    About this image

    MAOA Protein Expression

    SOURCE GeneReport for Unigene cluster: Hs.183109

    UniProtKB/Swiss-Prot: AOFA_HUMAN, P21397
    Tissue specificity: Heart, liver, duodenum, blood vessels and kidney

        Pathway & Disease-focused RT2 Profiler PCR Arrays including MAOA: 
              Amino Acid Metabolism II in human mouse rat
              Drug Metabolism: Phase I Enzymes in human mouse rat
              Molecular Toxicology PathwayFinder 384HT in human mouse rat

    Primer
    Products:
    OriGene qPCR primer pairs and template standards for MAOA
    OriGene qSTAR qPCR primer pairs in human, mouse for MAOA
    Pre-validated RT2 qPCR Primer Assay in human, mouse, rat MAOA
    QuantiTect SYBR Green Assays in human, mouse, rat MAOA
    QuantiFast Probe-based Assays in human, mouse, rat MAOA
    In Situ
    Assay Products:
     

     
    Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for MAOA

    (Orthologs according to 1,2HomoloGene (2older version, for species not in 1newer version), 3euGenes, 4SGD , 5MGI Mar 06 2013, with possible further links to Flybase and/or WormBase, and/or 6Ensembl pan taxonomic compara , Gene Trees according to Ensembl and TreeFam)
    About This Section

    TryGeneCards Plus

    This gene was present in the common ancestor of chordates.

    Orthologs for MAOA gene from Selected species (see all 11)    About this table
    Organism Taxonomic
    classification
    Gene Description Human
    Similarity
    Orthology
    Type
    Details
    mouse
    (Mus musculus)
    Mammalia Maoa1 , 5 monoamine oxidase A1, 5 85.19(n)1
    88.12(a)1
      X (11.78 cM)5
    171611  NM_173740.31  NP_776101.31 
     166196985 
    chicken
    (Gallus gallus)
    Aves MAOA6
    Gallus gallus monoamine oxidase A (MAOA), nuclear ...
    72(a)
    1 ↔ 1
    1(110613430-110658911)
    lizard
    (Anolis carolinensis)
    Reptilia MAOA6
    monoamine oxidase A
    72(a)
    1 ↔ 1
    3(135069134-135125415)
    tropical clawed frog
    (Xenopus tropicalis)
    Amphibia LOC1004951981 amine oxidase [flavin-containing] A-like 68.62(n)
    70.76(a)
      100495198  XM_002932798.2  XP_002932844.2 
    zebrafish
    (Danio rerio)
    Actinopterygii mao6
    monoamine oxidase
    69(a)
    1 → many
    9(34618751-34683759) ENSDARG00000023712


    ENSEMBL Gene Tree for MAOA (if available)
    TreeFam Gene Tree for MAOA (if available)

    (Paralogs according to 1HomoloGene,
    2Ensembl, and 3SIMAP, Pseudogenes according to 4Pseudogene.org Build 68)
    About This Section

    TryGeneCards Plus
    Paralogs for MAOA gene
    MAOB2  
    1 SIMAP similar gene for MAOA using alignment to 7 protein entries:     AOFA_HUMAN (see all proteins):
    MAOB

    MAOA for paralogs           About GeneDecksing



    (SNPs/Variants according to the 1NCBI SNP Database, 2Ensembl, 3PupaSUITE, 4UniProtKB, and DNA2.0, Linkage Disequilibrium by HapMap, Structural Variations(CNVs/InDels/Inversions) from the Database of Genomic Variants, Mutations from the Human Gene Mutation Database (HGMD), the Human Cytochrome P450 Allele Nomenclature Database, and the Locus Specific Mutation Databases (LSDB), Blood group antigen gene mutations by BGMUT, Resequencing Primers, Cancer Mutation PCR Arrays and Assays, and Copy Number PCR Arrays from QIAGEN)
    About This Section

    TryGeneCards Plus

    Polymorphic Variants from UniProtKB/Swiss-Prot
    AOFA_HUMAN, P21397: A polymorphism 1.2 kb upstream of the MAOA coding sequences consists of a 30-bp repeated sequence
    present in 3, 3.5, 4, or 5 copies. The polymorphism affect transcriptional activity of the MAOA gene promoter.
    Alleles with 3.5 or 4 copies of the repeat sequence are transcribed 2 to 10 times more efficiently than those
    with 3 or 5 copies of the repeat


    Selected SNPs for MAOA (see all 1109)    About this table    
    Genomic DataTranscription Related DataAllele Frequencies
    SNP IDValidClinical
    significance
    Chr X posSequence#AA
    Chg
    TypeMore#Allele
    freq
    PopTotal
    sample
    More
    ----------
    VAR_0365454
    A breast cancer sample4--see VAR_0365452 D E mis40--------
    rs725546321,2
    Cpathogenic143591031(+) TAATTC/TAGCGG 4 Q * stg10--------
    rs1923952121,2
    --43512260(+) AGGATC/TGAGGC 2 -- us2k10--------
    rs66518041,2
    C,F--43512290(+) caGTCA/GGCCTC 2 -- us2k12Minor allele frequency- G:0.00WA CSA 3
    rs66518051,2
    C,F--43512293(+) TCGGCT/CTCAGC 2 -- us2k12Minor allele frequency- C:0.00WA CSA 3
    rs48246571,2
    C,F,A,H--43512302(+) GCAGCC/GTTGTC 2 -- us2k110Minor allele frequency- G:0.32NA WA CSA 19
    rs1904159451,2
    --43512369(+) TTTTTC/TCTACC 2 -- us2k10--------
    rs1118209341,2
    C,F--43512512(+) ACATTC/TGTCAG 2 -- us2k11Minor allele frequency- T:0.00CSA 1
    rs1816096531,2
    --43512744(+) GATTTC/TTTCAT 2 -- us2k10--------
    rs1843172791,2
    --43512882(+) CATATG/TTCTTT 2 -- us2k10--------

    HapMap Linkage Disequilibrium report for MAOA (43515409 - 43606068 bp)

    Structural Variations
         Database of Genomic Variants (DGV) 2 variations for MAOA:    About this table    
    Variant IDTypeSubtypePubMed ID
    esv21483CNV Gain19812545
    nsv517873CNV Gain19592680

    Human Gene Mutation Database (HGMD): MAOA
    Locus Specific Mutation Databases (LSDB): MAOA

    Site Specific Mutation Identification with PCR Assays
    SeqTarget long-range PCR primers for resequencing MAOA
    DNA2.0 Custom Variant and Variant Library Synthesis for MAOA

    (in which this Gene is Involved, According to MalaCards, OMIM, UniProtKB, the University of Copenhagen DISEASES database, Novoseek, Genatlas, GeneTests, GAD, HuGE Navigator, and/or TGDB.)
    About This Section

    TryGeneCards Plus
    OMIM gene information: 309850   
    OMIM disorders: 300615  
    UniProtKB/Swiss-Prot: AOFA_HUMAN, P21397
  • Brunner syndrome (BRUNS) [MIM:300615]: A form of X-linked non-dysmorphic mild mental retardation. Male
    patients are affected by borderline mental retardation and exhibit abnormal behavior, including disturbed
    regulation of impulsive aggression. Obligate female carriers have normal intelligence and behavior. Note=The
    disease is caused by mutations affecting the gene represented in this entry

  • Selected diseases for MAOA (see all 114):    
    About MalaCards
    antisocial personality disorder    avoidant personality disorder    maoa-related behavior disorders    monoamine oxidase a deficiency
    social phobia    brunner syndrome    personality disorder    paranoid schizophrenia
    substance abuse    serotonin syndrome    anxiety disorder    conduct disorder
    exhibitionism    melancholia    borderline personality disorder    postpartum depression
    hepatic encephalopathy    specific phobia    norrie disease    agoraphobia

    13 diseases from the University of Copenhagen DISEASES database for MAOA:
    Parkinson's disease     Anxiety disorder     Antisocial personality disorder     Conduct disorder
    Attention deficit hyperactivity disorder     Endogenous depression     Schizophrenia     Toxic encephalopathy
    Melancholia     Alcohol dependence     Avoidant personality disorder     Borderline personality disorder
    Migraine

    MAOA for disorders           About GeneDecksing

    Selected Novoseek inferred disease relationships for MAOA gene (see all 76)    About this table

    Disease   -log (P-Val)   Hits   PubMed IDs for Articles with Shared Sentences (# sentences)
    antisocial behavior 75.8 57 17008143 (4), 18023041 (3), 19120058 (3), 10359483 (2) (see all 20)
    borderline mental retardation 74.5 3 8776592 (1), 9326944 (1), 8613523 (1)
    antisocial personality disorder 65.4 32 12824808 (5), 17007976 (3), 10049583 (2), 20175604 (2) (see all 10)
    major depression 64.7 65 18337637 (4), 10564737 (4), 17884271 (4), 9179504 (3) (see all 28)
    aggressive behavior 63 36 15817751 (3), 15211623 (2), 18996506 (2), 17657171 (2) (see all 22)
    crisis hypertensive 59.4 7 17554106 (1), 9829163 (1), 14697896 (1), 19527191 (1)
    attention-deficit hyperactivity disorder 55.8 15 17230031 (2), 8862874 (1), 12140786 (1), 19309535 (1) (see all 13)
    bipolar disorder 53.7 47 10402508 (4), 8776592 (3), 9342194 (3), 16958037 (3) (see all 21)
    phobia social 53.6 8 8313403 (2), 10361959 (1), 8619339 (1), 9534836 (1) (see all 5)
    parkinson disease 52.5 32 7593732 (3), 17044053 (2), 8358501 (2), 9579294 (2) (see all 22)

    Genetic Association Database (GAD): MAOA
    Human Genome Epidemiology (HuGE) Navigator: MAOA (290 documents)

    Export disorders for MAOA gene to outside databases

    (in PubMed. Associations of this gene to articles via 1Entrez Gene, 2UniProtKB/Swiss-Prot, 3HGNC, 4GAD, 5PharmGKB, 6HMDB, 7DrugBank, 8UniProtKB/TrEMBL, 9 Novoseek, and/or 10fRNAdb)
    About This Section

    TryGeneCards Plus

    PubMed articles for MAOA gene, integrated from 10 sources (see all 1107) (see top 10):
    (articles sorted by number of sources associating them with MAOA)
        Utopia: connect your pdf to the dynamic
    world of online information

    1. A non-additive interaction of a functional MAO-A VNTR and testosterone predicts antisocial behavior. (PubMed id 17429405)1, 4, 7, 9 SjAPberg R.L....Goldman D. (Neuropsychopharmacology 2008)
    2. Early trauma and increased risk for physical aggression during adulthood: the moderating role of MAOA genotype. (PubMed id 17534436)1, 4, 9 Frazzetto G....Troisi A. (PLoS ONE 2007)
    3. A promoter polymorphism in the monoamine oxidase A gene is associated with the pineal MAOA activity in Alzheimer's disease patients. (PubMed id 17692293)1, 4, 9 Wu Y.H....Swaab D.F. (Brain Res. 2007)
    4. [Association study of the polymorphisms of monoamine oxidase A genes with schizophrenia]. (PubMed id 17680543)1, 4, 9 Shi Y.Z....Lou B.Y. (Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2007)
    5. Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B. (PubMed id 16129825)1, 2, 9 De Colibus L.... Mattevi A. (Proc. Natl. Acad. Sci. U.S.A. 2005)
    6. Analysis of monoamine oxidase A (MAOA) promoter polymorphism in Finnish male alcoholics. (PubMed id 11927135)1, 4, 9 Saito T....Tiihonen J. (Psychiatry Res 2002)
    7. Structure of human monoamine oxidase A at 2.2-A resolution: the control of opening the entry for substrates/inhibitors. (PubMed id 18391214)1, 2, 9 Son S.-Y.... Tsukihara T. (Proc. Natl. Acad. Sci. U.S.A. 2008)
    8. Effects of MAOA-genotype, alcohol consumption, and aging on violent behavior. (PubMed id 19120058)1, 4, 9 Tikkanen R....Virkkunen M. (Alcohol. Clin. Exp. Res. 2009)
    9. The development of peripartum depressive symptoms is associated with gene polymorphisms of MAOA, 5-HTT and COMT. (PubMed id 19625011)1, 4, 9 Doornbos B....Korf J. (amp 2009)
    10. MAOA gene polymorphisms and response to mirtazapine in major depression. (PubMed id 19382113)1, 4, 9 Tzeng D.S....Yang C.Y. (Hum Psychopharmacol 2009)
    11. Monoamine oxidase A genotype predicts human serotonin 1A receptor availability in vivo. (PubMed id 18971477)1, 4, 9 Mickey B.J....Zubieta J.K. (J. Neurosci. 2008)
    12. MAOA, maltreatment, and gene-environment interaction predicting children's mental health: new evidence and a meta-analysis. (PubMed id 16801953)1, 4, 9 Kim-Cohen J....Moffitt T.E. (Mol. Psychiatry 2006)
    13. MAOA promoter polymorphism and attention deficit hyperactivity disorder (ADHD) in indian children. (PubMed id 16856146)1, 4, 9 Das M....Mukhopadhyay K. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006)
    14. Cluster B personality disorders are associated with allelic variation of monoamine oxidase A activity. (PubMed id 15870836)1, 4, 9 Jacob C.P....Lesch K.P. (Neuropsychopharmacology 2005)
    15. Telomeric length varies with age and polymorphisms of the MAOA gene promoter in peripheral blood cells obtained from a community in Taiwan. (PubMed id 15722955)1, 4, 9 Lung F.W....Shu B.C. (Psychiatr. Genet. 2005)
    16. Gene-gene interaction between MAOA and COMT in suicidal behavior. (PubMed id 15936529)1, 4, 9 De Luca V....Kennedy J.L. (Neurosci. Lett. 2005)
    17. Association of variations in monoamine oxidases A and B with Parkinson's disease subgroups. (PubMed id 14962671)1, 4, 9 Parsian A....Perlmutter J.S. (Genomics 2004)
    18. Analysis of monoamine oxidase A (MAO-A) promoter polymorphism in male heroin-dependent subjects: behavioural and personality correlates. (PubMed id 15088154)1, 4, 9 Gerra G....Donnini C. (J Neural Transm 2004)
    19. A regulatory monoamine oxidase a promoter polymorphism and personality traits. (PubMed id 12566936)1, 4, 9 Garpenstrand H....JAPnsson E.G. (Neuropsychobiology 2002)
    20. No association of the MAOA gene with alcoholism among Han Chinese males in Taiwan. (PubMed id 11999895)1, 4, 9 Lu R.B....Shih J.C. (amp 2002)
    21. Promoter organization and activity of human monoamine oxidase (MAO) A and B genes. (PubMed id 1432104)1, 2, 9 Zhu Q.S.... Shih J.C. (J. Neurosci. 1992)
    22. Structure of the human gene for monoamine oxidase type A. (PubMed id 1886775)1, 2, 9 Chen Z.-Y.... Hsu Y.-P.P. (Nucleic Acids Res. 1991)
    23. Monoamine oxidase A and childhood adversity as risk factors for conduct disorder in females. (PubMed id 18752729)1, 4, 9 Prom-Wormley E.C....Silberg J.L. (Psychol Med 2009)
    24. Association analysis of monoamine oxidase A gene and bipolar affective disorder in Han Chinese. (PubMed id 18501009)1, 4, 9 Lin Y.M....Sun H.S. (Behav Brain Funct 2008)
    25. Possible interaction between MAOA and DRD2 genes associated with antisocial alcoholism among Han Chinese men in Taiwan. (PubMed id 17007976)1, 4, 9 Wang T.J....Lu R.B. (amp 2007)
    26. The monoamine oxidase A (MAO-A) gene, family function and maltreatment as predictors of destructive behaviour during male adolescent alcohol consumption. (PubMed id 17298646)1, 4, 9 Nilsson K.W....Oreland L. (Addiction 2007)
    27. MAOA and the &quot;cycle of violence:&quot; childhood abuse and neglect, MAOA genotype, and risk for violent and antisocial behavior. (PubMed id 16814261)1, 4, 9 Widom C.S. and Brzustowicz L.M. (Biol. Psychiatry 2006)
    28. A functional polymorphism in the MAOA gene promoter (MAOA-LPR) predicts central dopamine function and body mass index. (PubMed id 16770335)1, 4, 9 Ducci F....Goldman D. (Mol. Psychiatry 2006)
    29. Monoamine oxidase A (MAOA) and antisocial behaviors in the presence of childhood and adolescent maltreatment. (PubMed id 15806601)1, 4, 9 Haberstick B.C....Hewitt J.K. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005)
    30. Association analysis of monoamine oxidase A and attention deficit hyperactivity disorder. (PubMed id 12497620)1, 4, 9 Lawson D.C....Thapar A. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003)
    31. Meta-analysis of the association between the monoamine oxidase-A gene and mood disorders. (PubMed id 20010318)1, 4, 9 Fan M....Zhang J. (Psychiatr. Genet. 2010)
    32. Association of VNTR polymorphisms in the MAOA promoter and DRD4 exon 3 with heroin dependence in male Chinese addicts. (PubMed id 20218801)1, 4, 9 Chien C.C....Lung F.W. (World J. Biol. Psychiatry 2010)
    33. Monoamine oxidase A gene (MAOA) predicts behavioral aggression following provocation. (PubMed id 19168625)1, 4, 9 McDermott R....Johnson D.D. (Proc. Natl. Acad. Sci. U.S.A. 2009)
    34. Association between monoamine oxidase (MAO)-A gene variants and schizophrenia in a Chinese population. (PubMed id 19573521)1, 4, 9 Qiu H.T....Zhang X.Y. (Brain Res. 2009)
    35. Neither single-marker nor haplotype analyses support an association between monoamine oxidase A gene and bipolar disorder. (PubMed id 18437281)1, 4, 9 Huang S.Y....Lu R.B. (Eur Arch Psychiatry Clin Neurosci 2008)
    36. Differential association between MAOA, ADHD and neuropsychological functioning in boys and girls. (PubMed id 18726986)1, 4, 9 Rommelse N.N....Franke B. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008)
    37. Interaction between a functional MAOA locus and childhood sexual abuse predicts alcoholism and antisocial personality disorder in adult women. (PubMed id 17592478)1, 4, 9 Ducci F....Goldman D. (Mol. Psychiatry 2008)
    38. Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: a preliminary study. (PubMed id 18937309)1, 4, 9 Biederman J....Faraone S.V. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008)
    39. Association of MAO-A variant with complicated grief in major depression. (PubMed id 18337637)1, 4, 9 Kersting A....Domschke K. (Neuropsychobiology 2007)
    40. Convergent genetic modulation of the endocrine stress response involves polymorphic variations of 5-HTT, COMT and MAOA. (PubMed id 17453062)1, 4, 9 Jabbi M....den Boer J.A. (Mol. Psychiatry 2007)
    41. The MAOA promoter polymorphism, disruptive behavior disorders, and early onset substance use disorder: gene-environment interaction. (PubMed id 18075472)1, 4, 9 Vanyukov M.M....Ferrell R.E. (Psychiatr. Genet. 2007)
    42. Childhood maltreatment, subsequent antisocial behavior, and the role of monoamine oxidase A genotype. (PubMed id 17008143)1, 4, 9 Huizinga D....Hewitt J.K. (Biol. Psychiatry 2006)
    43. No allele variation of the MAOA gene promoter in male Chinese subjects with attention deficit hyperactivity disorder. (PubMed id 17230031)1, 4, 9 Lung F.W....Kao W.T. (Neuropsychobiology 2006)
    44. [Association of functional genes polymorphisms of key enzymes in the metabolism of biogenic amines with paranoid schizophrenia susceptibility and the influence of these polymorphisms on PANSS results in antipsychotic treatment]. (PubMed id 17217235)1, 4, 9 Tybura P....Samochowiec J. (Psychiatr. Pol. 2006)
    45. Monoamine oxidases A and B gene polymorphisms in migraine patients. (PubMed id 15694196)1, 4, 9 Filic V....Jernej B. (J. Neurol. Sci. 2005)
    46. No association between monoamine oxidase A promoter polymorphism and personality traits in Japanese females. (PubMed id 16139427)1, 4, 9 Hakamata Y....Inada T. (Neurosci. Lett. 2005)
    47. Polymorphisms in the MAOA, MAOB, and COMT genes and aggressive behavior in schizophrenia. (PubMed id 15211623)1, 4, 9 Zammit S....Owen M.J. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004)
    48. Neither antisocial personality disorder nor antisocial alcoholism is associated with the MAO-A gene in Han Chinese males. (PubMed id 12824808)1, 4, 9 Lu R.B....Shih J.C. (Alcohol. Clin. Exp. Res. 2003)
    49. Association analysis of MAOA and COMT with neuroticism assessed by peers. (PubMed id 12815746)1, 4, 9 Eley T.C....Craig I. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003)
    50. Human monoamine oxidase A and B genes exhibit identical exon-intron organization. (PubMed id 2023912)1, 2, 9 Grimsby J.... Shih J.C. (Proc. Natl. Acad. Sci. U.S.A. 1991)
    51. MAOA is associated with methylphenidate improvement of oppositional symptoms in boys with attention deficit hyperactivity disorder. (PubMed id 19309535)1, 4, 9 GuimarALes A.P....Hutz M.H. (Int. J. Neuropsychopharmacol. 2009)
    52. Reduced amygdala-prefrontal coupling in major depression: association with MAOA genotype and illness severity. (PubMed id 18544183)1, 4, 9 Dannlowski U....Suslow T. (Int. J. Neuropsychopharmacol. 2009)
    53. Negative emotionality: monoamine oxidase B gene variants modulate personality traits in healthy humans. (PubMed id 19657584)1, 4, 9 Dlugos A.M....de Wit H. (J Neural Transm 2009)
    54. Further evidence of MAO-A gene variants associated with bipolar disorder. (PubMed id 16958037)1, 4, 9 MA1ller D.J....Kennedy J.L. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007)
    55. Monoamine oxidase-A polymorphisms might modify the association between the dopamine D2 receptor gene and alcohol dependence. (PubMed id 17476365)1, 4, 9 Huang S.Y....Lu R.B. (amp 2007)
    56. Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia. (PubMed id 15261699)1, 4, 9 Matsumoto C....Nakamura J. (Psychiatry Res 2004)
    57. Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression. (PubMed id 12555227)1, 4, 9 Tadic A....Dahmen N. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003)
    58. Functional variation in promoter region of monoamine oxidase A and subtypes of alcoholism: haplotype analysis. (PubMed id 12555234)1, 4, 9 Parsian A....Zhang Z.H. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003)
    59. No evidence of an association between a functional monoamine oxidase a gene polymorphism and completed suicides. (PubMed id 11920860)1, 4, 9 Ono H....Maeda K. (Am. J. Med. Genet. 2002)
    60. MAO-A and COMT polymorphisms and gene effects in narcolepsy. (PubMed id 11443519)1, 4, 9 Dauvilliers Y....Tafti M. (Mol. Psychiatry 2001)
    61. Serotonin genes and gene-gene interactions in borderline personality disorder in a matched case-control study. (PubMed id 19032968)1, 4, 9 Ni X....Kennedy J.L. (amp 2009)
    62. Psychopathy trait scores in adolescents with childhood ADHD: the contribution of genotypes affecting MAOA, 5HTT and COMT activity. (PubMed id 19829167)1, 4, 9 Fowler T....Thapar A. (Psychiatr. Genet. 2009)
    63. Serotonin transporter (5-HTTLPR) and monoamine oxidase (MAOA) promoter polymorphisms in women with severe alcoholism. (PubMed id 18827956)1, 4, 9 Gokturk C....Hallman J. (Arch Womens Ment Health 2008)
    64. The MAO-A gene, platelet MAO-B activity and psychosocial environment in adolescent female alcohol-related problem behaviour. (PubMed id 18029114)1, 4, 9 Nilsson K.W....Oreland L. (Drug Alcohol Depend 2008)
    65. A community-based study of cigarette smoking behavior in relation to variation in three genes involved in dopamine metabolism: Catechol-O-methyltransferase (COMT), dopamine beta-hydroxylase (DBH) and monoamine oxidase-A (MAO-A). (PubMed id 18486967)1, 4, 9 Shiels M.S....Alberg A.J. (Prev Med 2008)
    66. Meta-study on association between the monoamine oxidase A gene (MAOA) and schizophrenia. (PubMed id 17894408)1, 4, 9 Li D. and He L. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008)
    67. Gene-gene interaction analysis of personality traits in a Japanese population using an electrochemical DNA array chip analysis. (PubMed id 17208375)1, 4, 9 Urata T....Inada T. (Neurosci. Lett. 2007)
    68. Combined analysis of association between personality traits and three functional polymorphisms in the tyrosine hydroxylase, monoamine oxidase A, and catechol-O-methyltransferase genes. (PubMed id 16360899)1, 4, 9 Tochigi M....Sasaki T. (Neurosci. Res. 2006)
    69. Obesity is associated with genetic variants that alter dopamine availability. (PubMed id 16674552)1, 4, 9 Need A.C....Goldstein D.B. (Ann. Hum. Genet. 2006)
    70. Family-based case-control study of MAOA and MAOB polymorphisms in Parkinson disease. (PubMed id 17044053)1, 4, 9 Kang S.J....Martin E.R. (Mov. Disord. 2006)
    71. Association between monoamine oxidase gene polymorphisms and smoking behaviour in Chinese males. (PubMed id 16207390)1, 4, 9 Jin Y....Li L. (Int. J. Neuropsychopharmacol. 2006)
    72. Serotonin transporter, tryptophan hydroxylase, and monoamine oxidase A gene polymorphisms in premenstrual dysphoric disorder. (PubMed id 17026953)1, 4, 9 Magnay J.L....O'Brien S. (Am. J. Obstet. Gynecol. 2006)
    73. Association of MAO A polymorphism and alcoholism in Brazilian females. (PubMed id 15900229)1, 4, 9 Guindalini C....Zatz M. (Psychiatr. Genet. 2005)
    74. Association analysis between a functional polymorphism in the monoamine oxidase A gene promoter and severe mood disorders. (PubMed id 15564894)1, 4, 9 GutiAcrrez B....FaA+anA!s L. (Psychiatr. Genet. 2004)
    75. MAO-A gene polymorphisms are associated with major depression and sleep disturbance in males. (PubMed id 15486489)1, 4, 9 Du L....Hrdina P.D. (Neuroreport 2004)
    76. Pharmacogenetics of lithium prophylaxis in mood disorders: analysis of COMT, MAO-A, and Gbeta3 variants. (PubMed id 11992559)1, 4, 9 Serretti A....Smeraldi E. (Am. J. Med. Genet. 2002)
    77. Additional evidence that genetic variation of MAO-A gene supports a gender subtype in obsessive-compulsive disorder. (PubMed id 11353450)1, 4, 9 Camarena B....Nicolini H. (Am. J. Med. Genet. 2001)
    78. Polymorphic MAO-A and 5-HT-transporter genes: analysis of interactions in panic disorder. (PubMed id 12607224)1, 4, 9 Sand P....Deckert J. (World J. Biol. Psychiatry 2000)
    79. Association study of the serotoninergic system in migraine in the Spanish population. (PubMed id 19455600)1, 4, 9 Corominas R....Cormand B. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010)
    80. Gene-gene interaction between COMT and MAOA potentially predicts the intelligence of attention-deficit hyperactivity disorder boys in China. (PubMed id 19941049)1, 4, 9 Qian Q.J....Faraone S.V. (Behav. Genet. 2010)
    81. Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine. (PubMed id 20213484)1, 4, 9 Gentile G....Martelletti P. (J Headache Pain 2010)
    82. Associations between polymorphisms in dopamine neurotransmitter pathway genes and pain response in healthy humans. (PubMed id 19796878)1, 4, 9 Treister R....Eisenberg E. (Pain 2009)
    83. No evidence for association between an MAOA functional polymorphism and susceptibility to Parkinson's disease. (PubMed id 19267171)1, 4, 9 Williams-Gray C....Barker R.A. (J. Neurol. 2009)
    84. [Association study of intelligence of attention deficit hyperactivity disorder children in China]. (PubMed id 19727210)1, 4, 9 Qian Q.J....Liu L. (Beijing Da Xue Xue Bao 2009)
    85. Sex-specific interaction between MAOA promoter polymorphism and Apo epsilon 2 allele in major depressive disorder in the Chinese population. (PubMed id 19859025)1, 4, 9 Lin C.H....Lung F.W. (Psychiatr. Genet. 2009)
    86. Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response. (PubMed id 19077664)1, 4, 9 Peters E.J....Hamilton S.P. (Pharmacogenet. Genomics 2009)
    87. The genetics of Alzheimer's disease in Brazil: 10 years of analysis in a unique population. (PubMed id 18607773)1, 4, 9 Oliveira J.R....Zatz M. (J. Mol. Neurosci. 2009)
    88. Single nucleotide polymorphisms in obesity-related genes and all-cause and cause-specific mortality: a prospective cohort study. (PubMed id 19818126)1, 4, 9 Gallicchio L....Helzlsouer K.J. (BMC Med. Genet. 2009)
    89. MAOA-uVNTR polymorphism may modify the protective effect of ALDH2 gene against alcohol dependence in antisocial personality disorder. (PubMed id 19302089)1, 4, 9 Lee S.Y....Lu R.B. (Alcohol. Clin. Exp. Res. 2009)
    90. A polymorphism of the MAOA gene is associated with emotional brain markers and personality traits on an antisocial index. (PubMed id 19194374)1, 4, 9 Williams L.M....Gordon E. (Neuropsychopharmacology 2009)
    91. Candidate gene studies of ADHD: a meta-analytic review. (PubMed id 19506906)1, 4, 9 Gizer I.R....Waldman I.D. (Hum. Genet. 2009)
    92. Association of MAOA gene functional promoter polymorphism with CSF dopamine turnover and atypical depression. (PubMed id 19214141)1, 4, 9 Aklillu E....Agren H. (Pharmacogenet. Genomics 2009)
    93. The interleukin-6, serotonin transporter, and monoamine oxidase A genes and endurance performance during the South African Ironman Triathlon. (PubMed id 19935847)1, 4, 9 de Milander L....Collins M. (Appl Physiol Nutr Metab 2009)
    94. Association of dopamine transporter and monoamine oxidase molecular polymorphisms with sudden infant death syndrome and stillbirth: new insights into the serotonin hypothesis. (PubMed id 18810510)1, 4, 9 Filonzi L....Marzano F.N. (Neurogenetics 2009)
    95. Interactions between genotype and depressive symptoms on obesity. (PubMed id 19337825)1, 4, 9 Fuemmeler B.F....Ashley-Koch A.E. (Behav. Genet. 2009)
    96. MAO-A and COMT genotypes as possible regulators of perinatal serotonergic symptoms after in utero exposure to SSRIs. (PubMed id 19223155)1, 4, 9 Hilli J....Laine K. (Eur Neuropsychopharmacol 2009)
    97. A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms. (PubMed id 19506579)1, 4, 9 GassA^ P....Lafuente A. (Pharmacogenomics J. 2009)
    98. Brief report: aggression and stereotypic behavior in males with fragile X syndrome--moderating secondary genes in a &quot;single gene&quot; disorder. (PubMed id 17340199)1, 4, 9 Hessl D....Hagerman R.J. (J Autism Dev Disord 2008)
    99. Hyperserotonemia in autism: the potential role of 5HT-related gene variants. (PubMed id 18405062)1, 4, 9 HraniloviA8 D....Jernej B. (Coll Antropol 2008)
    100. Alcohol dependence and polymorphisms of serotonin-related genes: association studies. (PubMed id 18405071)1, 4, 9 MokroviA8 G....Cicin-Sain L. (Coll Antropol 2008)
    101. Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase A gene. (PubMed id 18361446)1, 4, 9 Davis L.K....Wassink T.H. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008)
    102. Interactions between genotype and retrospective ADHD symptoms predict lifetime smoking risk in a sample of young adults. (PubMed id 18188752)1, 4, 9 McClernon F.J....Ashley-Koch A.E. (amp 2008)
    103. Lipid levels are associated with a regulatory polymorphism of the monoamine oxidase-A gene promoter (MAOA-uVNTR). (PubMed id 18227761)1, 4, 9 Brummett B.H....Williams R.B. (Med. Sci. Monit. 2008)
    104. HPA axis function in male caregivers: effect of the monoamine oxidase-A gene promoter (MAOA-uVNTR). (PubMed id 18639608)1, 4, 9 Brummett B.H....Williams R.B. (Biol Psychol 2008)
    105. 5-HT2C receptor and MAO-A interaction analysis: no association with suicidal behaviour in bipolar patients. (PubMed id 18504633)1, 4, 9 De Luca V....Kennedy J.L. (Eur Arch Psychiatry Clin Neurosci 2008)
    106. Monoamine oxidase A-uVNTR genotype affects limbic brain activity in response to affective facial stimuli. (PubMed id 18388730)1, 4, 9 Lee B.T. and Ham B.J. (Neuroreport 2008)
    107. ADHD and Disruptive Behavior scores - associations with MAO-A and 5-HTT genes and with platelet MAO-B activity in adolescents. (PubMed id 18430257)1, 4, 9 Malmberg K....Larsson J.O. (BMC Psychiatry 2008)
    108. Association study of MAO-A and DRD4 genes in schizophrenic patients with aggressive behavior. (PubMed id 17657171)1, 4, 9 Fresan A....Nicolini H. (Neuropsychobiology 2007)
    109. Monoamine oxidase a gene is associated with borderline personality disorder. (PubMed id 17417058)1, 4, 9 Ni X....Kennedy J.L. (Psychiatr. Genet. 2007)
    110. Gene-lifecourse interaction for alcohol consumption in adolescence and young adulthood: five monoamine genes. (PubMed id 17440951)1, 4, 9 Guo G....Hamilton N. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007)
    111. The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression. (PubMed id 17192957)1, 4, 9 TadiA8 A....Szegedi A. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007)
    112. Association study between the monoamine oxidase A gene and attention deficit hyperactivity disorder in Taiwanese samples. (PubMed id 17328795)1, 4, 9 Xu X....Asherson P. (BMC Psychiatry 2007)
    113. Gene-environment interactions in parkinsonism and Parkinson's disease: the Geoparkinson study. (PubMed id 17449559)1, 4, 9 Dick F.D....Felice A. (Occup Environ Med 2007)
    114. Association analysis of 15 polymorphisms within 10 candidate genes for antisocial behavioural traits. (PubMed id 17728669)1, 4, 9 Prichard Z.M....Easteal S. (Psychiatr. Genet. 2007)
    115. A linkage and family-based association analysis of a potential neurocognitive endophenotype of bipolar disorder. (PubMed id 17627031)1, 4, 9 Savitz J....Ramesar R. (Neuromolecular Med. 2007)
    116. Association study between clinical response to rizatriptan and some candidate genes. (PubMed id 17563839)1, 4, 9 Asuni C....Stochino M.E. (J Headache Pain 2007)
    117. Associations of a regulatory polymorphism of monoamine oxidase-A gene promoter (MAOA-uVNTR) with symptoms of depression and sleep quality. (PubMed id 17585061)1, 4, 9 Brummett B.H....Williams R.B. (Psychosom Med 2007)
    118. Genetically increased risk of sleep disruption in Alzheimer's disease. (PubMed id 16944667)1, 4, 9 Craig D....Passmore A.P. (Sleep 2006)
    119. An association study of catechol-O-methyltransferase and monoamine oxidase A polymorphisms and personality traits in Koreans. (PubMed id 16584839)1, 4, 9 Kim S.J....Kim C.H. (Neurosci. Lett. 2006)
    120. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. (PubMed id 16894395)1, 4, 9 Brookes K....Asherson P. (Mol. Psychiatry 2006)
    121. A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse. (PubMed id 16930369)1, 4, 9 Cevoli S....Montagna P. (Eur. J. Neurol. 2006)
    122. Genetic polymorphisms in monoamine neurotransmitter systems show only weak association with acute post-surgical pain in humans. (PubMed id 16848906)1, 4, 9 Kim H....Dionne R.A. (Mol Pain 2006)
    123. Monoamine oxidase A gene promoter polymorphism affects novelty seeking and reward dependence in healthy study participants. (PubMed id 16538181)1, 4, 9 Shiraishi H....Otani K. (Psychiatr. Genet. 2006)
    124. Gene-gene interaction between MAOA and COMT in suicidal behavior: analysis in schizophrenia. (PubMed id 16725119)1, 4, 9 De Luca V....Kennedy J.L. (Brain Res. 2006)
    125. Temperament and character in mood disorders: influence of DRD4, SERTPR, TPH and MAO-A polymorphisms. (PubMed id 16319504)1, 4, 9 Serretti A....Cloninger C.R. (Neuropsychobiology 2006)
    126. The association of DNA sequence variation at the MAOA genetic locus with quantitative behavioural traits in normal males. (PubMed id 16896926)1, 4, 9 Rosenberg S....Skorecki K. (Hum. Genet. 2006)
    127. Polymorphisms in genes regulating the HPA axis associated with empirically delineated classes of unexplained chronic fatigue. (PubMed id 16610949)1, 4, 9 Smith A.K....Rajeevan M.S. (Pharmacogenomics 2006)
    128. Interaction between MAO-A genotype and maltreatment in the risk for conduct disorder: failure to confirm in adolescent patients. (PubMed id 16741202)1, 4, 9 Young S.E....Crowley T.J. (Am J Psychiatry 2006)
    129. Monoamine oxidase-a genetic variations influence brain activity associated with inhibitory control: new insight into the neural correlates of impulsivity. (PubMed id 16202396)1, 4, 9 Passamonti L....Quattrone A. (Biol. Psychiatry 2006)
    130. Associations between serotonin-related gene polymorphisms and panic disorder. (PubMed id 15670397)1, 4, 9 Maron E....Shlik J. (Int. J. Neuropsychopharmacol. 2005)
    131. Relationship of MAO-A promoter (u-VNTR) and COMT (V158M) gene polymorphisms to CSF monoamine metabolites levels in a psychiatric sample of caucasians: A preliminary report. (PubMed id 15457497)1, 4, 9 Zalsman G....Mann J.J. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005)
    132. Association study of a monoamine oxidase a gene promoter polymorphism with major depressive disorder and antidepressant response. (PubMed id 15956990)1, 4, 9 Yu Y.W....Yang C.W. (Neuropsychopharmacology 2005)
    133. MAOA haplotypes associated with thrombocyte-MAO activity. (PubMed id 16174289)1, 4, 9 Jansson M....Pedersen N.L. (BMC Genet. 2005)
    134. Monoamine oxidase a polymorphism in Brazilian patients: risk factor for late-onset Alzheimer's disease? (PubMed id 16186632)1, 4, 9 Nishimura A.L....Zatz M. (J. Mol. Neurosci. 2005)
    135. Association study of a functional MAOA-uVNTR gene polymorphism and personality traits in Chinese young females. (PubMed id 16110245)1, 4, 9 Yu Y.W....Chen T.J. (Neuropsychobiology 2005)
    136. Association study of a functional MAOA-uVNTR gene polymorphism and cognitive function in healthy females. (PubMed id 15990460)1, 4, 9 Yu Y.W....Chen T.J. (Neuropsychobiology 2005)
    137. Association analysis of the functional monoamine oxidase A gene promotor polymorphism in migraine. (PubMed id 15088153)1, 4, 9 Marziniak M....Sommer C. (J Neural Transm 2004)
    138. Association between serotonin-related genetic polymorphisms and CCK-4-induced panic attacks with or without 5-hydroxytryptophan pretreatment in healthy volunteers. (PubMed id 15346539)1, 4, 9 Maron E....Shlik J. (World J. Biol. Psychiatry 2004)
    139. Gene-environment interaction analysis of serotonin system markers with adolescent depression. (PubMed id 15241435)1, 4, 9 Eley T.C....Craig I.W. (Mol. Psychiatry 2004)
    140. Investigation of serotonin-related genes in antidepressant response. (PubMed id 15052272)1, 4, 9 Peters E.J....Hamilton S.P. (Mol. Psychiatry 2004)
    141. Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum. (PubMed id 15450911)1, 4, 9 Samochowiec J....Kucharska-Mazur J. (Psychiatry Res 2004)
    142. An association between a functional polymorphism in the monoamine oxidase a gene promoter, impulsive traits and early abuse experiences. (PubMed id 15150530)1, 4, 9 Huang Y.Y....Mann J.J. (Neuropsychopharmacology 2004)
    143. Association analysis for MAOA gene polymorphism with long-latency auditory evoked potentials in healthy females. (PubMed id 15539858)1, 4, 9 Yu Y.W....Yang C.W. (Neuropsychobiology 2004)
    144. [Polymorphism of the serotonin system genes in some Finno-Ugric populations]. (PubMed id 15341275)1, 4, 9 Andreenkov O.V....Popova N.K. (Genetika 2004)
    145. Tourette syndrome and dopaminergic genes: a family-based association study in the French Canadian founder population. (PubMed id 15094788)1, 4, 9 DA-az-AnzaldA_a A....Rouleau G.A. (Mol. Psychiatry 2004)
    146. Family-based association study between the monoamine oxidase A gene and obesity: implications for psychopharmacogenetic studies. (PubMed id 15034227)1, 4, 9 Camarena B....Nicolini H. (Neuropsychobiology 2004)
    147. Catechol-O-methyltransferase and monoamine oxidase A genotypes and drug response to conventional neuroleptics in schizophrenia. (PubMed id 14520117)1, 4, 9 Illi A....Leinonen E. (J Clin Psychopharmacol 2003)
    148. Serotonin-related gene polymorphisms and central nervous system serotonin function. (PubMed id 12629534)1, 4, 9 Williams R.B....Siegler I.C. (Neuropsychopharmacology 2003)
    149. Deliberate self-harm is associated with allelic variation in the tryptophan hydroxylase gene (TPH A779C), but not with polymorphisms in five other serotonergic genes. (PubMed id 12877392)1, 4, 9 Pooley E.C....Harrison P.J. (Psychol Med 2003)
    150. Monoamine oxidase A gene polymorphism, 5-HT 2A receptor gene polymorphism and incidence of nausea induced by fluvoxamine. (PubMed id 12886034)1, 4, 9 Yoshida K....Ohkubo T. (Neuropsychobiology 2003)
    151. No association between a polymorphism in the promoter region of the MAOA gene with antisocial personality traits in alcoholics. (PubMed id 12554604)1, 4, 9 Koller G....Soyka M. (Alcohol Alcohol. 2003)
    152. Association between a promoter variant in the monoamine oxidase A gene and schizophrenia. (PubMed id 12648733)1, 4, 9 JAPnsson E.G....Sedvall G.C. (Schizophr. Res. 2003)
    153. Investigating the role of dopaminergic and serotonergic candidate genes in obsessive-compulsive disorder. (PubMed id 12650952)1, 4, 9 Hemmings S.M....Stein D.J. (Eur Neuropsychopharmacol 2003)
    154. Relation of shyness in grade school children to the genotype for the long form of the serotonin transporter promoter region polymorphism. (PubMed id 12668354)1, 4, 9 Arbelle S....Ebstein R.P. (Am J Psychiatry 2003)
    155. High-level expression of human liver monoamine oxidase A in Pichia pastoris: comparison with the enzyme expressed in Saccharomyces cerevisiae. (PubMed id 11812236)1, 2, 9 Li M.... Edmondson D.E. (Protein Expr. Purif. 2002)
    156. Family-based association study of 5-HTTLPR, TPH, MAO-A, and DRD4 polymorphisms in mood disorders. (PubMed id 11992558)1, 4, 9 Serretti A....Smeraldi E. (Am. J. Med. Genet. 2002)
    157. Association study of MAO-A, COMT, 5-HT2A, DRD2, and DRD4 polymorphisms with illness time course in mood disorders. (PubMed id 11992560)1, 4, 9 Cusin C....Smeraldi E. (Am. J. Med. Genet. 2002)
    158. Genotype frequencies of 50 polymorphisms for 241 Japanese non-cancer patients. (PubMed id 12164325)1, 4, 9 Hamajima N....Tajima K. (J Epidemiol 2002)
    159. Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotype in Parkinson's disease. (PubMed id 12428723)1, 4, 9 Kelada S.N....Checkoway H. (Neurotoxicology 2002)
    160. Family-based and association studies of monoamine oxidase A and attention deficit hyperactivity disorder (ADHD): preferential transmission of the long promoter-region repeat and its association with impaired performance on a continuous performance test (TOVA). (PubMed id 12140786)1, 4, 9 Manor I....Ebstein R.P. (Mol. Psychiatry 2002)
    161. Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder. (PubMed id 12502014)1, 4, 9 Yoshida K....Otani K. (amp 2002)
    162. [The EcoR V polymorphism of human monoamine oxidase A is not associated with idiopathic Parkinson's disease in a Shanghai Han population]. (PubMed id 12170473)1, 4, 9 Xie H....Ren D. (Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2002)
    163. Association analysis of the functional monoamine oxidase A gene promoter polymorphism in psychiatric disorders. (PubMed id 11304831)1, 4, 9 Syagailo Y.V....Lesch K.P. (Am. J. Med. Genet. 2001)
    164. Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder. (PubMed id 11121185)1, 4, 9 Schulze T.G....Rietschel M. (Am. J. Med. Genet. 2000)
    165. The promoter of the human monoamine oxidase A gene. (PubMed id 8584674)1, 2, 9 Denney R.M. (Prog. Brain Res. 1995)
    166. A new look at the promoter of the human monoamine oxidase A gene: mapping transcription initiation sites and capacity to drive luciferase expression. (PubMed id 7519662)1, 2, 9 Denney R.M.... Waguespack A. (J. Neurochem. 1994)
    167. Catechol-o-methyltransferase genotype and childhood trauma may interact to impact schizotypal personality traits. (PubMed id 20033274)1, 4 Savitz J....Ramesar R. (Behav. Genet. 2010)
    168. A case-control study of Parkinson's disease and tobacco use: gene-tobacco interactions. (PubMed id 20461808)1, 4 De Palma G....Mutti A. (Mov. Disord. 2010)
    169. A cis-phase interaction study of genetic variants within the MAOA gene in major depressive disorder. (PubMed id 20691428)1, 4 Zhang J....Xu Q. (Biol. Psychiatry 2010)
    170. MAOA alters the effects of heavy drinking and childhood physical abuse on risk for severe impulsive acts of violence among alcoholic violent offenders. (PubMed id 20201935)1, 4 Tikkanen R....Virkkunen M. (Alcohol. Clin. Exp. Res. 2010)
    171. A population-based association study of candidate genes for depression and sleep disturbance. (PubMed id 19548263)1, 4 Utge S....Paunio T. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010)
    172. Questionable association between a monoamine oxidase A promoter polymorphism and sudden infant death syndrome. (PubMed id 20354746)1, 4 Klintschar M. and Heimbold C. (Neurogenetics 2010)
    173. Lack of association between antipsychotic-induced extrapyramidal symptoms and polymorphisms in dopamine metabolism and transport genes. (PubMed id 19892410)1, 4 GassA^ P....Lafuente A. (Psychiatry Res 2010)
    174. MAOA-uVNTR and early physical discipline interact to influence delinquent behavior. (PubMed id 19951362)1, 4 Edwards A.C....Dick D.M. (J Child Psychol Psychiatry 2010)
    175. Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study. (PubMed id 20628086)1, 4 Bailey S.D....Anand S. (Diabetes Care 2010)
    176. Monoamine oxidase A gene polymorphisms and enzyme activity associated with risk of gout in Taiwan aborigines. (PubMed id 19915868)1, 4 Tu H.P....Ko Y.C. (Hum. Genet. 2010)
    177. Epilepsy and serotonin (5HT): variations of 5HT-related genes in temporal lobe epilepsy. (PubMed id 20435093)1, 4 Stefulj J....Jernej B. (Neurosci. Lett. 2010)
    178. Interaction of prenatal exposure to cigarettes and MAOA genotype in pathways to youth antisocial behavior. (PubMed id 19255579)1, 4 Wakschlag L.S....Cook E.H. (Mol. Psychiatry 2010)
    179. The intersection of genes and neuropsychological deficits in the prediction of adolescent delinquency and low self-control. (PubMed id 18955512)1, 4 Beaver K.M....Wright J.P. (Int J Offender Ther Comp Criminol 2010)
    180. Association study between antipsychotic-induced restless legs syndrome and polymorphisms of monoamine oxidase genes in schizophrenia. (PubMed id 20589923)1, 4 Kang S.G....Kim L. (Hum Psychopharmacol 2010)
    181. Lack of association between schizophrenia and polymorphisms in dopamine metabolism and transport genes. (PubMed id 20041956)1, 4 Alvarez S....Lafuente A. (amp 2010)
    182. Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine. (PubMed id 20652353)1, 4 Gentile G....Martelletti P. (J Headache Pain 2010)
    183. [Functional polymorphism of genes inactivating catecholamines and emotional deficits in paranoid schizophrenia]. (PubMed id 20677440)1, 4 Tylec A....Stryjecka-Zimmer M. (Psychiatr. Pol. 2010)
    184. Genetic susceptibility to distinct bladder cancer subphenotypes. (PubMed id 19692168)1, 4 Guey L.T....Malats N. (Eur. Urol. 2010)
    185. Association study of 182 candidate genes in anorexia nervosa. (PubMed id 20468064)1, 4 Pinheiro A.P....Woodside D.B. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010)
    186. Central nervous system serotonin and clustering of hostility, psychosocial, metabolic, and cardiovascular endophenotypes in men. (PubMed id 20595415)1, 4 Williams R.B....Kuhn C.M. (Psychosom Med 2010)
    187. A large-scale candidate gene association study of age at menarche and age at natural menopause. (PubMed id 20734064)1, 4 He C....Hunter D.J. (Hum. Genet. 2010)
    188. Gene-environment interaction of child temperament. (PubMed id 20729761)1, 4 Ivorra J.L....Molto M.D. (J Dev Behav Pediatr 2010)
    189. Genome-wide and candidate gene association study of cigarette smoking behaviors. (PubMed id 19247474)1, 4 Caporaso N....Bergen A.W. (PLoS ONE 2009)
    190. Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. (PubMed id 19156168)1, 4 Need A.C....Goldstein D.B. (Eur. J. Hum. Genet. 2009)
    191. Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder. (PubMed id 19593178)1, 4 Leuchter A.F....Alpert J.E. (J Clin Psychopharmacol 2009)
    192. Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China. (PubMed id 19170196)1, 4 Shen M....Lan Q. (Environ. Mol. Mutagen. 2009)
    193. Neural mechanisms of anger regulation as a function of genetic risk for violence. (PubMed id 19485616)1, 4 Alia-Klein N....Volkow N.D. (Emotion 2009)
    194. A common variant in DRD3 receptor is associated with autism spectrum disorder. (PubMed id 19058789)1, 4 de Krom M....van Ree J.M. (Biol. Psychiatry 2009)
    195. Gene-gene interactions of CYP2A6 and MAOA polymorphisms on smoking behavior in Chinese male population. (PubMed id 19415821)1, 4 Tang X....Chen D. (Pharmacogenet. Genomics 2009)
    196. Monoamine oxidase a promoter gene associated with problem behavior in adults with intellectual/developmental disabilities. (PubMed id 19642709)1, 4 May M.E....Kennedy C.H. (Am J Intellect Dev Disabil 2009)
    197. Association of a monoamine oxidase-a gene promoter polymorphism with ADHD and anxiety in boys with autism spectrum disorder. (PubMed id 18566880)1, 4 Roohi J....Gadow K.D. (J Autism Dev Disord 2009)
    198. Family- and population-based association studies of monoamine oxidase A and autism spectrum disorders in Korean. (PubMed id 19100789)1, 4 Yoo H.J....Kim S.A. (Neurosci. Res. 2009)
    199. High-activity variants of the uMAOA polymorphism increase the risk for depression in a large primary care sample. (PubMed id 18626920)1, 4 Rivera M....Cervilla J.A. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009)
    200. Parental care moderates the influence of MAOA-uVNTR genotype and childhood stressors on trait impulsivity and aggression in adult women. (PubMed id 19357553)1, 4 Kinnally E.L....Mann J.J. (Psychiatr. Genet. 2009)
    201. An association study of monoamine oxidase A (MAOA) gene polymorphism in methamphetamine psychosis. (PubMed id 19368859)1, 4 Nakamura K....Mori N. (Neurosci. Lett. 2009)
    202. Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment. (PubMed id 19086053)1, 4 GratacA^s M....Carracedo A. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009)
    203. Genetical genomic determinants of alcohol consumption in rats and humans. (PubMed id 19874574)1, 4 Tabakoff B....Hoffman P.L. (BMC Biol. 2009)
    204. Financial and psychological risk attitudes associated with two single nucleotide polymorphisms in the nicotine receptor (CHRNA4) gene. (PubMed id 19693267)1, 4 Roe B.E....Papp A.C. (PLoS ONE 2009)
    205. Prolactin levels in olanzapine treatment correlate with positive symptoms of schizophrenia: results from an open-label, flexible-dose study. (PubMed id 19333405)1, 4 Chen Y.L....Lung F.W. (Prim Care Companion J Clin Psychiatry 2009)
    206. MAO A VNTR polymorphism and variation in human morphology: a VBM study. (PubMed id 18596609)1, 4 Cerasa A....Quattrone A. (Neuroreport 2008)
    207. The functional MAOA-uVNTR promoter polymorphism in patients with frontotemporal dementia. (PubMed id 18474080)1, 4 Reif A....Galimberti D. (Eur. J. Neurol. 2008)
    208. Genes regulating the serotonin metabolic pathway in the brain stem and their role in the etiopathogenesis of the sudden infant death syndrome. (PubMed id 18387780)1, 4 Nonnis Marzano F....Matturri L. (Genomics 2008)
    209. Polymorphisms in mitochondrial genes and prostate cancer risk. (PubMed id 19064571)1, 4 Wang L....Thibodeau S.N. (amp 2008)
    210. Genes implicated in serotonergic and dopaminergic functioning predict BMI categories. (PubMed id 18239643)1, 4 Fuemmeler B.F....Ashley-Koch A.E. (Obesity (Silver Spring) 2008)
    211. Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteers. (PubMed id 18832011)1, 4 Maron E....Shlik J. (Neurosci. Lett. 2008)
    212. Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway. (PubMed id 18676680)1, 4 Hosgood H.D....Lan Q. (Carcinogenesis 2008)
    213. Worldwide genetic variation in dopamine and serotonin pathway genes: implications for association studies. (PubMed id 18270970)1, 4 Gardner M....Comas D. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008)
    214. Genetic evaluation of the serotonergic system in chronic fatigue syndrome. (PubMed id 18079067)1, 4 Smith A.K....Rajeevan M.S. (Psychoneuroendocrinology 2008)
    215. Relationship of genetic variability and depressive symptoms to adverse events after coronary artery bypass graft surgery. (PubMed id 19005081)1, 4 Phillips-Bute B....Newman M.F. (Psychosom Med 2008)
    216. Monoamine oxidases: activities, genotypes and the shaping of behaviour. (PubMed id 17426915)1, 4 Oreland L....Hallman J. (J Neural Transm 2007)
    217. Candidate gene polymorphisms in the serotonergic pathway: influence on depression symptomatology in an elderly population. (PubMed id 16806099)1, 4 Christiansen L....Christensen K. (Biol. Psychiatry 2007)
    218. The association between fibromyalgia and polymorphism of monoamine oxidase A and interleukin-4. (PubMed id 16547693)1, 4 Su S.Y....Tsai F.J. (Clin. Rheumatol. 2007)
    219. Monoamine oxidase A gene polymorphism predicts adolescent outcome of attention-deficit/hyperactivity disorder. (PubMed id 17427196)1, 4 Li J....Faraone S.V. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007)
    220. The influence of four serotonin-related genes on decision-making in suicide attempters. (PubMed id 17221847)1, 4 Jollant F....Courtet P. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007)
    221. Adolescent girls and criminal activity: role of MAOA-LPR genotype and psychosocial factors. (PubMed id 17034017)1, 4 SjAPberg R.L....Oreland L. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007)
    222. MAOA-uVNTR polymorphism in a Brazilian sample: further support for the association with impulsive behaviors and alcohol dependence. (PubMed id 16526025)1, 4 Contini V....Bau C.H. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006)
    223. Role of monoamine oxidase A genotype and psychosocial factors in male adolescent criminal activity. (PubMed id 16125147)1, 4 Nilsson K.W....Oreland L. (Biol. Psychiatry 2006)
    224. A functional polymorphism in the promoter region of the monoamine oxidase A gene is associated with the cigarette smoking quantity in alcohol-dependent heavy smokers. (PubMed id 16763378)1, 4 Wiesbeck G.A....Boening J. (Neuropsychobiology 2006)
    225. Interaction of serotonergic and noradrenergic gene variants in panic disorder. (PubMed id 16538182)1, 4 Freitag C.M....Deckert J. (Psychiatr. Genet. 2006)
    226. CYP2A6, MAOA, DBH, DRD4, and 5HT2A genotypes, smoking behaviour and cotinine levels in 1518 UK adolescents. (PubMed id 16272956)1, 4 Huang S....Day I.N. (Pharmacogenet. Genomics 2005)
    227. Serotonin transporter promoter polymorphism and monoamine oxidase type A VNTR allelic variants together influence alcohol binge drinking risk in young women. (PubMed id 15635592)1, 4 Herman A.I....DePetrillo P.B. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005)
    228. The monoamine oxidase A gene may influence the means used in suicide attempts. (PubMed id 16094253)1, 4 Courtet P....Malafosse A. (Psychiatr. Genet. 2005)
    229. Polymorphisms in the serotonin transporter and monoamine oxidase A genes and their relationship to personality traits measured by the Temperament and Character Inventory and NEO Five-Factor Inventory in healthy volunteers. (PubMed id 15292674)1, 4 Samochowiec J....Kucharska-Mazur J. (Neuropsychobiology 2004)
    230. [Association between the functional monoamine oxidase A gene polymorphism and aggressively driving behavior]. (PubMed id 15498245)1, 4 Li F.Z....Jin H. (Zhonghua Yu Fang Yi Xue Za Zhi 2004)
    231. The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). (PubMed id 15489334)1, 2 Gerhard D.S.... Malek J. (Genome Res. 2004)
    232. Early-onset schizophrenia and dopamine-related gene polymorphism. (PubMed id 12497608)1, 4 Iwata Y....Mori N. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003)
    233. [Relationship between the Fnu4HI site polymorphism of monoamine oxidase A gene and Parkinson's disease]. (PubMed id 12778446)1, 4 Jiang X.H....Chen B. (Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2003)
    234. Monoamine oxidase polymorphisms and smoking behaviour in Japanese. (PubMed id 12563176)1, 4 Ito H....Tajima K. (Pharmacogenetics 2003)
    235. Association of autism severity with a monoamine oxidase A functional polymorphism. (PubMed id 12919132)1, 4 Cohen I.L....Holden J.J. (Clin. Genet. 2003)
    236. Polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers: seeking confirmation of the association in a follow-up study. (PubMed id 12360111)1, 4 Johnstone E.C....Walton R.T. (Pharmacogenetics 2002)
    237. [Investigation of monoamine oxidase gene restriction polymorphism in male populations of the Volga-Ural region]. (PubMed id 11963571)1, 4 Gorbunova E.V....Khusnutdinova E.K. (Genetika 2002)
    238. Association of monoamine oxidase A gene polymorphism with Alzheimer's disease and Lewy body variant. (PubMed id 12098640)1, 4 Takehashi M....Ueda K. (Neurosci. Lett. 2002)
    239. Concurrent positive association between pathological gambling and functional DNA polymorphisms at the MAO-A and the 5-HT transporter genes. (PubMed id 12399942)1, 4 PAcrez de Castro I....FernA!ndez-Piqueras J. (Mol. Psychiatry 2002)
    240. Role of genotype in the cycle of violence in maltreated children. (PubMed id 12161658)1, 4 Caspi A....Poulton R. (Science 2002)
    241. High activity-related allele of MAO-A gene associated with depressed suicide in males. (PubMed id 12151768)1, 4 Du L....Hrdina P.D. (Neuroreport 2002)
    242. Evidence for a genetic association between monoamine oxidase A and restless legs syndrome. (PubMed id 12136060)1, 4 Desautels A....Rouleau G.A. (Neurology 2002)
    243. Schizophrenia and functional polymorphisms in the MAOA and COMT genes: no evidence for association or epistasis. (PubMed id 12116182)1, 4 Norton N....Owen M.J. (Am. J. Med. Genet. 2002)
    244. A multivariate analysis of 59 candidate genes in personality traits: the temperament and character inventory. (PubMed id 11140838)1, 4 Comings D.E....MacMurray J.P. (Clin. Genet. 2000)
    245. Site-directed mutagenesis of monoamine oxidase A and B: role of cysteines. (PubMed id 8316221)1, 2 Wu H.F.... Shih J.C. (Mol. Pharmacol. 1993)
    246. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. (PubMed id 8211186)1, 2 Brunner H.G.... van Oost B.A. (Science 1993)
    247. Monoamine oxidase A from human placenta and monoamine oxidase B from bovine liver both have one FAD per subunit. (PubMed id 2764901)1, 2 Weyler W. (Biochem. J. 1989)
    248. cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. (PubMed id 3387449)1, 2 Bach A.W.J.... Shih J.C. (Proc. Natl. Acad. Sci. U.S.A. 1988)
    249. Structural features of human monoamine oxidase A elucidated from cDNA and peptide sequences. (PubMed id 3418353)1, 2 Hsu Y.-P.P.... Breakefield X.O. (J. Neurochem. 1988)
    250. Partial amino acid sequence analysis of human placenta monoamine oxidase A and bovine liver monoamine oxidase B. (PubMed id 3178846)1, 2 Chen S.-Y. and Weyler W. (Biochem. Biophys. Res. Commun. 1988)
    251. Calcium alters monoamine oxidase-A parameters in human cerebellar and rat glial C6 cell extracts: possible influence by distinct signalling pathways. (PubMed id 19539632)1, 9 Cao X....Mousseau D.D. (Life Sci. 2009)
    252. Evidence that brain MAO A activity does not correspond to MAO A genotype in healthy male subjects. (PubMed id 17141746)1, 9 Fowler J.S....Wang G.J. (Biol. Psychiatry 2007)
    253. Brain monoamine oxidase A activity predicts trait aggression. (PubMed id 18463263)1, 9 Alia-Klein N....Fowler J.S. (J. Neurosci. 2008)
    254. Association between monoamine oxidase A activity in human male skin fibroblasts and genotype of the MAOA promoter-associated variable number tandem repeat. (PubMed id 10647887)1, 9 Denney R.M....Craig I.W. (Hum. Genet. 1999)
    255. Monoamine oxidase A genotype is associated with gang membership and weapon use. (PubMed id 20152292)1, 9 Beaver K.M....Barnes J.C. (Compr Psychiatry 2010)
    256. Association of monoamine oxidase A (MAOA) polymorphisms and clinical subgroups of major depressive disorders in the Han Chinese population. (PubMed id 19224413)1, 9 Huang S.Y....Lu R.B. (World J. Biol. Psychiatry 2009)
    257. Inhibition of monoamine oxidase A promotes secretory differentiation in basal prostatic epithelial cells. (PubMed id 18248494)1, 9 Zhao H....Peehl D.M. ( research in biological diversity 2008)
    258. Deficient expression of monoamine oxidase A in the endometrium is associated with implantation failure in women participating as recipients in oocyte donation. (PubMed id 17020906)1, 9 Henriquez S....Velasquez L. (Mol. Hum. Reprod. 2006)
    259. Analysis of conserved active site residues in monoamine oxidase A and B and their three-dimensional molecular modeling. (PubMed id 11861643)1, 9 Geha R.M....Shih J.C. (J. Biol. Chem. 2002)
    260. Monoamine oxidase expression and activity in human placentae from pre-eclamptic and normotensive pregnancies. (PubMed id 11945082)1, 9 Sivasubramaniam S.D....Billett E.E. (Placenta 2002)
    261. Analysis of the monoamine oxidase A (MAOA) gene in bipolar affective disorder by association studies, meta-analyses, and sequencing of the promoter. (PubMed id 10402508)4, 9 Furlong R.A....Rubinsztein D.C. (Am. J. Med. Genet. 1999)
    262. Epistatic interaction between the monoamine oxidase A and serotonin transporter genes in anorexia nervosa. (PubMed id 15523490)1, 9 Urwin R.E. and Nunn K.P. (Eur. J. Hum. Genet. 2005)
    263. Structural comparison of human monoamine oxidases A and B: mass spectrometry monitoring of cysteine reactivities. (PubMed id 12777388)1, 9 Hubalek F....Edmondson D.E. (J. Biol. Chem. 2003)
    264. Inhibition of monoamine oxidase type A, but not type B, is an effective means of inducing anticonvulsant activity in the kindling model of epilepsy. (PubMed id 10027835)7, 9 LAPscher W....Gross G. (J. Pharmacol. Exp. Ther. 1999)
    265. A functional polymorphism in the monoamine oxidase A gene promoter. (PubMed id 9799080)2, 9 Sabol S.Z.... Hamer D. (Hum. Genet. 1998)
    266. Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline). (PubMed id 9564606)7, 9 Murphy D.L....Sunderland T. (J. Neural Transm. Suppl. 1998)
    267. Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain. (PubMed id 1578281)1, 9 Saura J....Richards J.G. (J. Neurosci. 1992)
    268. Mode of action and characteristics of monoamine oxidase-A inhibition by moclobemide. (PubMed id 1546132)1, 9 Cesura A.M....Da Prada M. (Psychopharmacology (Berl.) 1992)
    269. High activity of monoamine oxidase A is associated with externalizing behaviour in maltreated and nonmaltreated adoptees. (PubMed id 19398936)1, 9 van der Vegt E.J....Tiemeier H. (Psychiatr. Genet. 2009)
    270. Mutagenic probes of the role of Ser209 on the cavity shaping loop of human monoamine oxidase A. (PubMed id 19645722)1, 9 Wang J....Edmondson D.E. (FEBS J. 2009)
    271. Monoamine oxidase-A modulates apoptotic cell death induced by staurosporine in human neuroblastoma cells. (PubMed id 17883400)1, 9 Fitzgerald J.C....Billett E.E. (J. Neurochem. 2007)
    272. Association of MAOA, 5-HTT, and NET promoter polymorphisms with gene expression and protein activity in human placentas. (PubMed id 20332182)1, 9 Zhang H....Holden J.J. (Physiol. Genomics 2010)
    273. No evidence for interaction between MAOA and childhood adversity for antisocial behavior. (PubMed id 18023041)1, 9 Prichard Z....Easteal S. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008)
    274. Genetically dependent modulation of serotonergic inactivation in the human prefrontal cortex. (PubMed id 18261931)1, 9 Passamonti L....Fera F. (Neuroimage 2008)
    275. Interactions of child maltreatment and serotonin transporter and monoamine oxidase A polymorphisms: depressive symptomatology among adolescents from low socioeconomic status backgrounds. (PubMed id 17931441)1, 9 Cicchetti D....Sturge-Apple M.L. (Dev. Psychopathol. 2007)
    276. Glucocorticoid and androgen activation of monoamine oxidase A is regulated differently by R1 and Sp1. (PubMed id 16728402)1, 9 Ou X.-M.... Shih J.C. (J. Biol. Chem. 2006)
    277. Phentermine inhibition of recombinant human liver monoamine oxidases A and B. (PubMed id 11911838)7, 9 Nandigama R.K....Edmondson D.E. (Biochem. Pharmacol. 2002)
    278. Evidence for a genetic association between alleles of monoamine oxidase A gene and bipolar affective disorder. (PubMed id 7485270)4, 9 Lim L.C....Gill M. (Am. J. Med. Genet. 1995)
    279. Role of monoamine oxidases in the exaggerated 5-hydroxytryptamine-induced tension development of human isolated preeclamptic umbilical artery. (PubMed id 19248248)1, 9 Seto S.W....Kwan Y.W. (Eur. J. Pharmacol. 2009)
    280. The VNTR 2 repeat in MAOA and delinquent behavior in adolescence and young adulthood: associations and MAOA promoter activity. (PubMed id 18212819)1, 9 Guo G....Shih J.C. (Eur. J. Hum. Genet. 2008)
    281. No association between Parkinson's disease and monoamine oxidase A and B gene polymorphisms. (PubMed id 8929994)4, 9 Nanko S....Hattori M. (Neurosci. Lett. 1996)
    282. Genetic association between monoamine oxidase A microsatellite and RFLP alleles and bipolar affective disorder: analysis and meta-analysis. (PubMed id 8776592)4, 9 Rubinsztein D.C....Paykel E.S. (Hum. Mol. Genet. 1996)
    283. Preliminary evidence for an association of a dinucleotide repeat polymorphism at the MAOA gene with early onset alcoholism/substance abuse. (PubMed id 7485245)4, 9 Vanyukov M.M....Deka R. (Am. J. Med. Genet. 1995)
    284. Child maltreatment moderates the association of MAOA with symptoms of depression and antisocial personality disorder. (PubMed id 20175604)1, 9 Beach S.R....Philibert R.A. (J Fam Psychol 2010)
    285. [Association between monoamine oxidase A gene and major depression in Chinese Han population]. (PubMed id 20078943)1, 9 Zhang J.X....Shen Y. (Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2009)
    286. An interaction between the norepinephrine transporter and monoamine oxidase A polymorphisms, and novelty-seeking personality traits in Korean females. (PubMed id 17920180)1, 9 Lee B.C....Ham B.J. (amp 2008)
    287. Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study. (PubMed id 15547048)7, 9 Obach R.S....Tremaine L.M. (Drug Metab. Dispos. 2005)
    288. Inhibitors alter the spectrum and redox properties of monoamine oxidase A. (PubMed id 12445480)1, 9 Ramsay R.R. and Hunter D.J. (Biochim. Biophys. Acta 2002)
    289. Association between bipolar disorder and monoamine oxidase A gene polymorphisms: results of a multicenter study. (PubMed id 10831475)4, 9 Preisig M....Malafosse A. (Am J Psychiatry 2000)
    290. Association of a regulatory polymorphism in the promoter region of the monoamine oxidase A gene with antisocial alcoholism. (PubMed id 10359483)4, 9 Samochowiec J....Sander T. (Psychiatry Res 1999)
    291. Is phentermine an inhibitor of monoamine oxidase? A critical appraisal. (PubMed id 10231134)7, 9 Rothman R.B. (Synapse 1999)
    292. No evidence for allelic association between bipolar disorder and monoamine oxidase A gene polymorphisms. (PubMed id 7485269)4, 9 Craddock N....Owen M.J. (Am. J. Med. Genet. 1995)
    293. Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects. (PubMed id 1705137)7, 9 Berlin I....Puech A.J. (Br J Clin Pharmacol 1990)
    294. Early life stress, MAOA, and gene-environment interactions predict behavioral disinhibition in children. (PubMed id 19804559)4, 9 Enoch M.A....Goldman D. (Genes Brain Behav. 2010)
    295. Subcutaneous sumatriptan pharmacokinetics: delimiting the monoamine oxidase inhibitor effect. (PubMed id 19925626)7, 9 Fox A.W. (Headache 2010)
    296. The effect of smoking on MAOA promoter methylation in DNA prepared from lymphoblasts and whole blood. (PubMed id 19777560)1, 9 Philibert R.A....Gerrard M. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010)
    297. Aggressive behavior, related conduct problems, and variation in genes affecting dopamine turnover. (PubMed id 20127808)1, 9 Grigorenko E.L....Yrigollen C.M. (Aggress Behav 2010)
    298. Serotonin, genetic variability, behaviour, and psychiatric disorders--a review. (PubMed id 20187845)1, 9 Nordquist N. and Oreland L. (Ups. J. Med. Sci. 2010)
    299. Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients. (PubMed id 20206656)1, 9 ZumA!rraga M....GuimA^n J. (Neurochem. Int. 2010)
    300. Morphological correlates of MAO A VNTR polymorphism: new evidence from cortical thickness measurement. (PubMed id 20303364)1, 9 Cerasa A....Spalletta G. (Behav. Brain Res. 2010)
    301. MAOA methylation is associated with nicotine and alcohol dependence in women. (PubMed id 18454435)1, 9 Philibert R.A....Madan A. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008)
    302. Ventro-lateral prefrontal activity during working memory is modulated by MAO A genetic variation. (PubMed id 18294618)1, 9 Cerasa A....Quattrone A. (Brain Res. 2008)
    303. Monoamine oxidase A variant influences antidepressant treatment response in female patients with Major Depression. (PubMed id 17884271)1, 9 Domschke K....Baune B.T. (amp 2008)
    304. Genetic variation in MAOA modulates ventromedial prefrontal circuitry mediating individual differences in human personality. (PubMed id 17519928)1, 9 Buckholtz J.W....Meyer-Lindenberg A. (Mol. Psychiatry 2008)
    305. The importance of stress and genetic variation in human aggression. (PubMed id 17295220)1, 9 Craig I.W. (Bioessays 2007)
    306. [Genetic basis of time perception in athletes]. (PubMed id 17944104)1, 9 Portnova G.V....IvanitskiA- A.M. (Zh Vyssh Nerv Deiat Im I P Pavlova 2007)
    307. Amine oxidases and monooxygenases in the in vivo metabolism of xenobiotic amines in humans: has the involvement of amine oxidases been neglected? (PubMed id 17868200)7, 9 Strolin Benedetti M....Whomsley R. (amp 2007)
    308. Association study of monoamine oxidase and catechol-O-methyltransferase genes with smoking behavior. (PubMed id 17885625)1, 9 Tochigi M....Sasaki T. (Pharmacogenet. Genomics 2007)
    309. Adipogenesis-related increase of semicarbazide-sensitive amine oxidase and monoamine oxidase in human adipocytes. (PubMed id 17400359)1, 9 Bour S.... Carpene C. (Biochimie 2007)
    310. Transdermal selegiline for the treatment of major depressive disorder. (PubMed id 19300583)7, 9 Lee K.C. and Chen J.J. (Neuropsychiatr Dis Treat 2007)
    311. [Genetic polymorphism of COMT in mental disorders]. (PubMed id 18046978)1, 9 Tylec A....Kucharska-Pietura K. (Psychiatr. Pol. 2007)
    312. Transdermal selegiline: the new generation of monoamine oxidase inhibitors. (PubMed id 16641841)7, 9 Patkar A.A....Masand P.S. (CNS Spectr 2006)
    313. Clinical pharmacokinetics of almotriptan, a serotonin 5-HT(1B/1D) receptor agonist for the treatment of migraine. (PubMed id 15762767)7, 9 McEnroe J.D. and Fleishaker J.C. (Clin Pharmacokinet 2005)
    314. Catecholamines and aggression: the role of COMT and MAO polymorphisms. (PubMed id 15817751)7, 9 Volavka J....Nolan K. (Ann. N. Y. Acad. Sci. 2004)
    315. The FAD binding sites of human monoamine oxidases A and B. (PubMed id 14697881)1, 9 Edmondson D.E....Mattevi A. (Neurotoxicology 2004)
    316. Mapping the genetic variation of executive attention onto brain activity. (PubMed id 12773616)1, 9 Fan J....Posner M.I. (Proc. Natl. Acad. Sci. U.S.A. 2003)
    317. Identification of the human liver enzymes involved in the metabolism of the antimigraine agent almotriptan. (PubMed id 12642466)7, 9 Salva M....Palacios J.M. (Drug Metab. Dispos. 2003)
    318. Moclobemide response in depressed patients: association study with a functional polymorphism in the monoamine oxidase A promoter. (PubMed id 12163988)1, 9 MA1ller D.J....Rietschel M. (Pharmacopsychiatry 2002)
    319. Migraine pharmacotherapy with oral triptans: a rational approach to clinical management. (PubMed id 11249525)7, 9 Millson D.S....Rapoport A.M. (Expert Opin Pharmacother 2000)
    320. The EcoRV genetic polymorphism of human monoamine oxidase type A is not associated with Parkinson's disease and does not modify the effect of smoking on Parkinson's disease. (PubMed id 10643794)4, 9 Costa-Mallen P....Costa L.G. (Neurosci. Lett. 2000)
    321. A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity. (PubMed id 10904119)4, 9 Manuck S.B....Muldoon M.F. (Psychiatry Res 2000)
    322. Association analysis between mood disorder and monoamine oxidase gene. (PubMed id 10686545)4, 9 Lin S....Gu N. (Am. J. Med. Genet. 2000)
    323. The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers. (PubMed id 10417495)7, 9 Van Haarst A.D....Musson D.G. (Br J Clin Pharmacol 1999)
    324. Determination of the human cytochrome P450 isoforms involved in the metabolism of zolmitriptan. (PubMed id 10553725)7, 9 Wild M.J....Butters C.J. ( the fate of foreign compounds in biological systems 1999)
    325. Monoamine oxidase inhibitors. A perspective on their use in the elderly. (PubMed id 9829163)7, 9 Volz H.P. and Gleiter C.H. (amp 1998)
    326. Genetic association between monoamine oxidase and manic-depressive illness: comparison of relative risk and haplotype relative risk data. (PubMed id 9342194)4, 9 Parsian A. and Todd R.D. (Am. J. Med. Genet. 1997)
    327. Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig, 311C90). (PubMed id 9399014)7, 9 Rolan P. (Cephalalgia 1997)
    328. Association study between schizophrenia and monoamine oxidase A and B DNA polymorphisms. (PubMed id 8804132)4, 9 Coron B....Frebourg T. (Psychiatry Res 1996)
    329. Mutational analysis of the human MAOA gene. (PubMed id 8678123)1, 9 Tivol E.A....Breakefield X.O. (Am. J. Med. Genet. 1996)
    330. Kinetic mechanism of monoamine oxidase A. (PubMed id 2021654)1, 9 Ramsay R.R. (Biochemistry 1991)
    331. Association study of DRD2 and MAOA genes with subtyped alcoholism comorbid with bipolar disorder in Han Chinese. (PubMed id 23044341)1 Hu M.C....Lu R.B. (amp 2013)
    332. MAOA-uVNTR genotype predicts interindividual differences in experimental aggressiveness as a function of the degree of provocation. (PubMed id 23499704)1 Kuepper Y....Hennig J. (Behav. Brain Res. 2013)
    333. MAOA and MAOB polymorphisms and anger-related traits in suicidal participants and controls. (PubMed id 23111930)1 Antypa N....Rujescu D. (Eur Arch Psychiatry Clin Neurosci 2013)
    334. [Functional polymorphism of genes inactivating biogenic amines and cognitive deficits in paranoid schizophrenia]. (PubMed id 23888755)1 Tylec A....Czernikiewicz A. (Psychiatr. Pol. 2013)
    335. Genetic and epigenetic associations of MAOA and NR3C1 with depression and childhood adversities. (PubMed id 23449091)1 Melas P.A....Lavebratt C. (Int. J. Neuropsychopharmacol. 2013)
    336. The relationship between MAOA gene polymorphism and test anxiety. (PubMed id 24229476)1 Liu Y. and Lu Z. (Twin Res Hum Genet 2013)
    337. Plasticity genes do not modify associations between physical activity and depressive symptoms. (PubMed id 23088179)1 Stavrakakis N....de Jonge P. (Health Psychol 2013)
    338. The 5HTT and MAO-A polymorphisms associate with depressive mood and climacteric symptoms in postmenopausal women. (PubMed id 23707423)1 Grochans E....Samochowiec J. (amp 2013)
    339. [Association between MAOA-u VNTR polymorphism and its interaction with stressful life events and major depressive disorder in adolescents]. (PubMed id 23866280)1 Ma J....Su L.Y. (Zhongguo Dang Dai Er Ke Za Zhi 2013)
    340. Two functional serotonin polymorphisms moderate the effect of food reinforcement on BMI. (PubMed id 23544600)1 Carr K.A....Epstein L.H. (Behav. Neurosci. 2013)
    341. Genetic risk factors for depression in Alzheimer`s disease patients. (PubMed id 23157339)1 Arlt S....Jahn H. (Curr Alzheimer Res 2013)
    342. Analysis of monoaminergic genes, childhood abuse, and dimensions of psychopathy. (PubMed id 22985017)1 Sadeh N....Verona E. (J Abnorm Psychol 2013)
    343. MAOA genotype, social exclusion and aggression: an experimental test of a gene-environment interaction. (PubMed id 23067570)1 Gallardo-Pujol D....Maydeu-Olivares A. (Genes Brain Behav. 2013)
    344. Gene A9 environment effects of serotonin transporter, dopamine receptor D4, and monoamine oxidase A genes with contextual and parenting risk factors on symptoms of oppositional defiant disorder, anxiety, and depression in a community sample of 4-year-old children. (PubMed id 23627963)1 Lavigne J.V....Bryant F.B. (Dev. Psychopathol. 2013)
    345. Genetic variation in MAOA modulates prefrontal cortical regulation of approach-avoidance reactions. (PubMed id 23548774)1 Ernst L.H....Plichta M.M. (Neuropsychobiology 2013)
    346. Evidence for interplay between genes and maternal stress in utero: monoamine oxidase A polymorphism moderates effects of life events during pregnancy on infant negative emotionality at 5a88weeks. (PubMed id 23480342)1 Hill J....Pickles A. (Genes Brain Behav. 2013)
    347. Monoamine oxidase A gene polymorphism and the pathogenesis of sudden infant death syndrome. (PubMed id 23391042)1 Courts C....Madea B. (J. Pediatr. 2013)
    348. The effects of DBH, MAOA, and MAOB on attentional biases for facial expressions. (PubMed id 23054588)1 Gong P....Ma H. (J. Mol. Neurosci. 2013)
    349. Gene-environment interaction in externalizing problems among adolescents: evidence from the Pelotas 1993 Birth Cohort Study. (PubMed id 23215821)1 Kieling C....Rohde L.A. (J Child Psychol Psychiatry 2013)
    350. Comparison of expression pattern of monoamine oxidase A with histopathologic subtypes and tumour grade of renal cell carcinoma. (PubMed id 23197227)1 HodorovA! I....Mihalik J. (Med. Sci. Monit. 2012)
    351. MAOA promoter methylation and susceptibility to carotid atherosclerosis: role of familial factors in a monozygotic twin sample. (PubMed id 23116433)1 Zhao J....Vaccarino V. (BMC Med. Genet. 2012)
    352. Monoamine oxidase inhibitory activity in tobacco smoke varies with tobacco type. (PubMed id 21636610)7 Lewis A.J....Miller J.H. (Tob Control 2012)
    353. Working memory brain activity and capacity link MAOA polymorphism to aggressive behavior during development. (PubMed id 22832821)1 Ziermans T....Klingberg T. (Transl Psychiatry 2012)
    354. Association of MAOA and COMT gene polymorphisms with palatable food intake in children. (PubMed id 21530215)1 GalvALo A.C....Almeida S. (J. Nutr. Biochem. 2012)
    355. Monoamine oxidase A gene polymorphism and suicide: an association study and meta-analysis. (PubMed id 22041522)1 Hung C.F....Lin P.Y. (J Affect Disord 2012)
    356. Association of monoamine oxidase A and serotonin transporter gene functional variants with intellectual disability related behavioral problems. (PubMed id 21934643)1 Bhowmik A.D....Mukhopadhyay K. (Psychiatr. Genet. 2012)
    357. Monoamine oxidase A down-regulation contributes to high metanephrine concentration in pheochromocytoma. (PubMed id 22569243)1 Grouzmann E....Abid K. (J. Clin. Endocrinol. Metab. 2012)
    358. Genetically based reduced MAOA and COMT functioning is associated with the cortisol stress response: a replication study. (PubMed id 21912392)1 Bouma E.M....Oldehinkel A.J. (Mol. Psychiatry 2012)
    359. The c.1460C&gt;T polymorphism of MAO-A is associated with the risk of depression in postmenopausal women. (PubMed id 22619623)1 SA8opieA8 R....JagodziA8ski P.P. (ScientificWorldJournal 2012)
    360. Associations of MAOA-VNTR or 5HTT-LPR alleles with attention-deficit hyperactivity disorder symptoms are moderated by platelet monoamine oxidase B activity. (PubMed id 21610556)1 Wargelius H.L....Oreland L. (Psychiatr. Genet. 2012)
    361. Effects of MAOA promoter methylation on susceptibility to paranoid schizophrenia. (PubMed id 22198720)1 Chen Y....Xu Q. (Hum. Genet. 2012)
    362. Meta-analysis argues for a female-specific role of MAOA-uVNTR in panic disorder in four European populations. (PubMed id 22911667)1 Reif A....Deckert J. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2012)
    363. Developmental changes in human dopamine neurotransmission: cortical receptors and terminators. (PubMed id 22336227)1 Rothmond D.A....Webster M.J. (BMC Neurosci 2012)
    364. Combination of polymorphic variants in serotonin transporter and monoamine oxidase-A genes may influence the risk for early-onset alcoholism. (PubMed id 22627167)1 Bordukalo-Niksic T....Cicin-Sain L. (Psychiatry Res 2012)
    365. Child abuse and neglect, MAOA, and mental health outcomes: a prospective examination. (PubMed id 22030358)1 Nikulina V....Brzustowicz L.M. (Biol. Psychiatry 2012)
    366. Study of a possible role of the monoamine oxidase A (MAOA) gene in paranoid schizophrenia among a Chinese population. (PubMed id 22162429)1 Sun Y....Xu Q. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2012)
    367. Monoamine oxidase A gene DNA hypomethylation - a risk factor for panic disorder? (PubMed id 22436428)1 Domschke K....Deckert J. (Int. J. Neuropsychopharmacol. 2012)
    368. Monoamine oxidase A variants are associated with heavy betel quid use. (PubMed id 21521428)1 Chen P.H....Ko Y.C. (Addict Biol 2012)
    369. The effects of child maltreatment on early signs of antisocial behavior: genetic moderation by tryptophan hydroxylase, serotonin transporter, and monoamine oxidase A genes. (PubMed id 22781862)1 Cicchetti D....Thibodeau E.L. (Dev. Psychopathol. 2012)
    370. Association study between the dopamine-related candidate gene polymorphisms and ADHD among Saudi Arabia population via PCR technique. (PubMed id 23076524)1 El-Tarras A.E....Sabry A.M. (Mol. Biol. Rep. 2012)
    371. Evidence that the methylation state of the monoamine oxidase A (MAOA) gene predicts brain activity of MAO A enzyme in healthy men. (PubMed id 22948232)1 Shumay E....Fowler J.S. (Epigenetics 2012)
    372. Association between a functional polymorphism in the MAOA gene and sudden infant death syndrome. (PubMed id 22351881)1 Klintschar M. and Heimbold C. (Pediatrics 2012)
    373. Monoamine oxidase A expression is suppressed in human cholangiocarcinoma via coordinated epigenetic and IL-6-driven events. (PubMed id 22906985)1 Huang L....DeMorrow S. ( a journal of technical methods and pathology 2012)
    374. Serotonin transporter role in identifying similarities between SIDS and idiopathic ALTE. (PubMed id 22711722)1 Filonzi L....Nonnis Marzano F. (Pediatrics 2012)
    375. MAOA, MTHFR, and TNF-I^ genes polymorphisms and personality traits in the pathogenesis of migraine. (PubMed id 22193458)1 Ishii M....Kiuchi Y. (Mol. Cell. Biochem. 2012)
    376. The monoamine oxidase A gene promoter repeat and prostate cancer risk. (PubMed id 22473857)1 White T.A....Nelson P.S. (Prostate 2012)
    377. A^H kinetic isotope effects and pH dependence of catalysis as mechanistic probes of rat monoamine oxidase A: comparisons with the human enzyme. (PubMed id 21819071)1 Wang J. and Edmondson D.E. (Biochemistry 2011)
    378. Aggression, digit ratio and variation in androgen receptor and monoamine oxidase a genes in men. (PubMed id 20967566)1 Hurd P.L....Dinsdale N.L. (Behav. Genet. 2011)
    379. Monoamine oxidase A regulates antisocial personality in whites with no history of physical abuse. (PubMed id 21295226)1 Reti I.M....Nestadt G. (Compr Psychiatry 2011)
    380. Serotonergic modulation in executive functioning: linking genetic variations to working memory performance. (PubMed id 21983350)1 Enge S....Strobel A. (Neuropsychologia 2011)
    381. Molecular-genetic correlates of self-harming behaviors in eating-disordered women: findings from a combined Canadian-German sample. (PubMed id 20869421)1 Steiger H....Bachetzky N. (amp 2011)
    382. MAOA genotype, family relations and sexual abuse in relation to adolescent alcohol consumption. (PubMed id 20731636)1 Nilsson K.W....Oreland L. (Addict Biol 2011)
    383. Parkin degrades estrogen-related receptors to limit the expression of monoamine oxidases. (PubMed id 21177257)1 Ren Y....Feng J. (Hum. Mol. Genet. 2011)
    384. A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. (PubMed id 21890473)1 Wagner S.A....Choudhary C. (amp 2011)
    385. Association of polymorphisms of the serotonergic pathways with clinical traits of impulsive-aggression and suicidality in adolescents: a multi-center study. (PubMed id 20873971)1 Zalsman G....Tyano S. (World J. Biol. Psychiatry 2011)
    386. The effects of serotonin transporter promoter and monoamine oxidase A gene polymorphisms on trait emotional intelligence. (PubMed id 21912191)1 Kim S.J....Song D.H. (Neuropsychobiology 2011)
    387. The association between infants' self-regulatory behavior and MAOA gene polymorphism. (PubMed id 21884321)1 Zhang M....Lu Z. (Dev Sci 2011)
    388. Autism severity is associated with child and maternal MAOA genotypes. (PubMed id 20573161)1 Cohen I.L....Holden J.J. (Clin. Genet. 2011)
    389. Poor replication of candidate genes for major depressive disorder using genome-wide association data. (PubMed id 20351714)1 Bosker F.J....Nolen W.A. (Mol. Psychiatry 2011)
    390. Cumulative-genetic plasticity, parenting and adolescent self-regulation. (PubMed id 21039487)1 Belsky J. and Beaver K.M. (J Child Psychol Psychiatry 2011)
    391. Postpartum depression symptoms: a case-control study on monoaminergic functional polymorphisms and environmental stressors. (PubMed id 21099450)1 Comasco E....Skalkidou A. (Psychiatr. Genet. 2011)
    392. Confirmed association between monoamine oxidase A molecular polymorphisms and Sudden Infant Death Syndrome. (PubMed id 20820831)1 Filonzi L....Marzano F.N. (Neurogenetics 2011)
    393. Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence. (PubMed id 21971001)1 Bortolato M. and Shih J.C. (Int. Rev. Neurobiol. 2011)
    394. Association analyses of MAOA in Chinese Han subjects with attention-deficit/hyperactivity disorder: family-based association test, case-control study, and quantitative traits of impulsivity. (PubMed id 21761555)1 Liu L....Wang Y.F. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2011)
    395. Valproic acid induces monoamine oxidase A via Akt/forkhead box O1 activation. (PubMed id 21775495)1 Wu J.B. and Shih J.C. (Mol. Pharmacol. 2011)
    396. Psychopathy, PCL-R, and MAOA genotype as predictors of violent reconvictions. (PubMed id 20850185)1 Tikkanen R....Virkkunen M. (Psychiatry Res 2011)
    397. Prefrontal cortex lesions and MAO-A modulate aggression in penetrating traumatic brain injury. (PubMed id 21422455)1 Pardini M....Grafman J. (Neurology 2011)
    398. Type A monoamine oxidase regulates life and death of neurons in neurodegeneration and neuroprotection. (PubMed id 21971004)1 Naoi M....Akao Y. (Int. Rev. Neurobiol. 2011)
    399. Association of the MAOA promoter uVNTR polymorphism with suicide attempts in patients with major depressive disorder. (PubMed id 21605465)1 Lung F.W....Lee M.B. (BMC Med. Genet. 2011)
    400. Gene x disease interaction on orbitofrontal gray matter in cocaine addiction. (PubMed id 21383264)1 Alia-Klein N....Goldstein R.Z. (Arch. Gen. Psychiatry 2011)
    401. Transcriptional regulation and multiple functions of MAO genes. (PubMed id 21359973)1 Shih J.C....Chen K. (J Neural Transm 2011)
    402. Deviant peer affiliation and antisocial behavior: interaction with Monoamine Oxidase A (MAOA) genotype. (PubMed id 21152968)1 Lee S.S. (J Abnorm Child Psychol 2011)
    403. Monoamine oxidase and semicarbazide-sensitive amine oxidase kinetic analysis in mesenteric arteries of patients with type 2 diabetes. (PubMed id 21114364)1 Nunes S.F....Caramona M.M. (Physiol Res 2011)
    404. Bimodal distribution of RNA expression levels in human skeletal muscle tissue. (PubMed id 21299892)1 Mason C.C....Bogardus C. (BMC Genomics 2011)
    405. Up-regulation of the isoenzymes MAO-A and MAO-B in the human basal ganglia and pons in Huntington's disease revealed by quantitative enzyme radioautography. (PubMed id 21075085)1 Richards G....Saura J. (Brain Res. 2011)
    406. Maltreatment, MAOA, and delinquency: sex differences in gene-environment interaction in a large population-based cohort of adolescents. (PubMed id 20734127)1 Aslund C....Nilsson K.W. (Behav. Genet. 2011)
    407. Genetic susceptibility for individual cooperation preferences: the role of monoamine oxidase A gene (MAOA) in the voluntary provision of public goods. (PubMed id 21698196)1 Mertins V....Meyer J. (PLoS ONE 2011)
    408. Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury. (PubMed id 20869994)7 Kaludercic N....Paolocci N. (Biochim. Biophys. Acta 2011)
    409. Association study of monoamine oxidase A/B genes and schizophrenia in Han Chinese. (PubMed id 21978760)1 Wei Y.L....Hu L. (Behav Brain Funct 2011)
    410. Structural properties of human monoamine oxidases A and B. (PubMed id 21971000)1 Binda C....Edmondson D.E. (Int. Rev. Neurobiol. 2011)
    411. MAO A VNTR polymorphism and amygdala volume in healthy subjects. (PubMed id 21236646)1 Cerasa A....Spalletta G. (Psychiatry Res 2011)
    412. MAOA-L carriers are better at making optimal financial decisions under risk. (PubMed id 21147794)1 Frydman C....Rangel A. (Proc. Biol. Sci. 2011)
    413. MAOA, DBH, and SLC6A4 variants in CHARGE: a case-control study of autism spectrum disorders. (PubMed id 21538940)1 Tassone F....Hertz-Picciotto I. (Autism Res 2011)
    414. Cognitive effects of genetic variation in monoamine neurotransmitter systems: a population-based study of COMT, MAOA, and 5HTTLPR. (PubMed id 21302344)1 Barnett J.H....Jones P.B. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2011)
    415. Systematic and quantitative assessment of the ubiquitin-modified proteome. (PubMed id 21906983)1 Kim W....Gygi S.P. (Mol. Cell 2011)
    416. Association analysis between 12 genetic variants of ten genes and personality traits in a young chinese Han population. (PubMed id 20464528)1 Gong P....Zhang F. (J. Mol. Neurosci. 2010)
    417. Search for association between suicide and 5-HTT, MAOA and DAT polymorphism in Polish males. (PubMed id 21516943)1 Linkowska K....Grzybowski T. (Arch Med Sadowej Kryminol 2010)
    418. Targeting monoamine oxidase A in advanced prostate cancer. (PubMed id 20204405)1 Flamand V....Peehl D.M. (J. Cancer Res. Clin. Oncol. 2010)
    419. Effects of age and MAOA genotype on the neural processing of social rejection. (PubMed id 20497231)1 Sebastian C.L....Blakemore S.J. (Genes Brain Behav. 2010)
    420. Deletion of MAOA and MAOB in a male patient causes severe developmental delay, intermittent hypotonia and stereotypical hand movements. (PubMed id 20485326)1 Whibley A....Raymond F.L. (Eur. J. Hum. Genet. 2010)
    421. MAO-A promoter polymorphism and idiopathic pulmonary arterial hypertension. (PubMed id 21273708)1 Vadapalli S....Nallari P. (J. Genet. 2010)
    422. Genetic determinants of time perception mediated by the serotonergic system. (PubMed id 20862259)1 Sysoeva O.V....Wackermann J. (PLoS ONE 2010)
    423. Mirtazapine abolishes hyperthermia in an animal model of serotonin syndrome. (PubMed id 20655983)7 Shioda K....Kato S. (Neurosci. Lett. 2010)
    424. MAOA interacts with the ALDH2 gene in anxiety-depression alcohol dependence. (PubMed id 20477771)1 Lee S.Y....Lu R.B. (Alcohol. Clin. Exp. Res. 2010)
    425. A population-specific HTR2B stop codon predisposes to severe impulsivity. (PubMed id 21179162)2 Bevilacqua L.... Goldman D. (Nature 2010)
    426. Harsh discipline, childhood sexual assault, and MAOA genotype: an investigation of main and interactive effects on diverse clinical externalizing outcomes. (PubMed id 20364435)1 Derringer J....Iacono W.G. (Behav. Genet. 2010)
    427. Identification and characterization of putative methylation targets in the MAOA locus using bioinformatic approaches. (PubMed id 20421737)1 Shumay E. and Fowler J.S. (Epigenetics 2010)
    428. Zonisamide: a new drug for Parkinson's disease. (PubMed id 20502722)7 Murata M. (Drugs Today 2010)
    429. MAOA T941G polymorphism and the time course of emotional recovery following unpleasant pictures. (PubMed id 20374544)1 Larson C.L....Robinson J.S. (Psychophysiology 2010)
    430. Long-term administration of monoamine oxidase inhibitors alters the firing rate and pattern of dopamine neurons in the ventral tegmental area. (PubMed id 18700056)7 Chenu F....Blier P. (Int. J. Neuropsychopharmacol. 2009)
    431. Antidepressant phenelzine alters differentiation of cultured human and mouse preadipocytes. (PubMed id 19201819)7 Chiche F....FA"ve B. (Mol. Pharmacol. 2009)
    432. Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. (PubMed id 19913121)1 Talmud P.J.... . (Am. J. Hum. Genet. 2009)
    433. Neighborhoods and genes and everything in between: understanding adolescent aggression in social and biological contexts. (PubMed id 19583892)1 Hart D. and Marmorstein N.R. (Dev. Psychopathol. 2009)
    434. A Bayesian approach to gene-gene and gene-environment interactions in chronic fatigue syndrome. (PubMed id 19102713)4 Lin E. and Hsu S.Y. (Pharmacogenomics 2009)
    435. Serotonin produces monoamine oxidase-dependent oxidative stress in human heart valves. (PubMed id 19666839)1 PeA+a-Silva R.A....Heistad D.D. (Am. J. Physiol. Heart Circ. Physiol. 2009)
    436. Monoamine oxidase A gene (MAOA) associated with attitude towards longshot risks. (PubMed id 20046877)1 Zhong S....Chew S.H. (PLoS ONE 2009)
    437. Biosocial influences on fraudulent behaviors. (PubMed id 19492728)1 Beaver K.M. and Holtfreter K. (J Genet Psychol 2009)
    438. Cerebral monoamine oxidase A inhibition in tobacco smokers confirmed with PET and [11C]befloxatone. (PubMed id 19142115)7 Leroy C....Trichard C. (J Clin Psychopharmacol 2009)
    439. Association between monoamine oxidase A (MAOA) and personality traits in Japanese individuals. (PubMed id 18845200)1 Tsuchimine S....Kaneko S. (amp 2008)
    440. MAOA and the neurogenetic architecture of human aggression. (PubMed id 18258310)1 Buckholtz J.W. and Meyer-Lindenberg A. (Trends Neurosci. 2008)
    441. Which genotype of MAO gene that the patients have are likely to be most susceptible to the symptoms of fibromyalgia? (PubMed id 17885758)1 GA1rsoy S....Sahin G. (Rheumatol. Int. 2008)
    442. Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition. (PubMed id 17768678)7 MacKenzie E.M....Wood P.L. (Neurochem. Res. 2008)
    443. Reduced activity of monoamine oxidase in the rat brain following repeated nandrolone decanoate administration. (PubMed id 18539264)7 Birgner C....BergstrAPm L. (Brain Res. 2008)
    444. Monoamine oxidase inactivation: from pathophysiology to therapeutics. (PubMed id 18652859)7 Bortolato M....Shih J.C. (Adv. Drug Deliv. Rev. 2008)
    445. Comparison of the structural properties of the active site cavities of human and rat monoamine oxidase A and B in their soluble and membrane-bound forms. (PubMed id 18092818)1 Upadhyay A.K....Edmondson D.E. (Biochemistry 2008)
    446. Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells. (PubMed id 17220478)1 Tu L.C....Lin B. (amp 2007)
    447. [Genetic polymorphism of a MAO in mental disorders]. (PubMed id 18046979)1 Tylec A....Kucharska-Pietura K. (Psychiatr. Pol. 2007)
    448. The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats. (PubMed id 17912044)7 Wooters T.E. and Bardo M.T. (Behav Pharmacol 2007)
    449. Pharmacokinetics and absolute bioavailability of selegiline following treatment of healthy subjects with the selegiline transdermal system (6 mg/24 h): a comparison with oral selegiline capsules. (PubMed id 17715422)7 Azzaro A.J....VanDenBerg C. (J Clin Pharmacol 2007)
    450. A link between monoamine oxidase-A and apoptosis in serum deprived human SH-SY5Y neuroblastoma cells. (PubMed id 17393061)1 Fitzgerald J.C....Billett E.E. (J Neural Transm 2007)
    451. Calcium-sensitive regulation of monoamine oxidase-A contributes to the production of peroxyradicals in hippocampal cultures: implications for Alzheimer disease-related pathology. (PubMed id 17868476)1 Cao X....Mousseau D.D. (BMC Neurosci 2007)
    452. Analysis of monoamine oxidase A promoter polymorphism in mentally retarded individuals. (PubMed id 17167335)1 Das Bhowmik A....Mukhopadhyay K. (Psychiatr. Genet. 2007)
    453. Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders? (PubMed id 17823646)7 Baker G.B....Todd K.G. (amp 2007)
    454. Association between monoamine oxidase A polymorphisms and anger-related personality traits in Korean women. (PubMed id 17943028)1 Yang J.W....Ham B.J. (Neuropsychobiology 2007)
    455. The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. (PubMed id 16370964)7 McIntyre R.S....Kennedy S.H. (Expert Opin Drug Saf 2006)
    456. The consensus coding sequences of human breast and colorectal cancers. (PubMed id 16959974)2 Sjoeblom T.... Velculescu V.E. (Science 2006)
    457. Linezolid and serotonergic drug interactions: a retrospective survey. (PubMed id 16779744)7 Taylor J.J....Estes L.L. (Clin. Infect. Dis. 2006)
    458. How many drug targets are there? (PubMed id 17139284)7 Overington J.P....Hopkins A.L. (Nat Rev Drug Discov 2006)
    459. Drugs, their targets and the nature and number of drug targets. (PubMed id 17016423)7 Imming P....Meyer A. (Nat Rev Drug Discov 2006)
    460. Monoallelic expression of MAOA in skin fibroblasts. (PubMed id 16890910)1 Nordquist N. and Oreland L. (Biochem. Biophys. Res. Commun. 2006)
    461. Effects of monoamine oxidase inhibitors on cocaine discrimination in rats. (PubMed id 16495723)7 Gatch M.B....Forster M.J. (Behav Pharmacol 2006)
    462. Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway. (PubMed id 16829576)1 Ou X.-M.... Shih J.C. (Proc. Natl. Acad. Sci. U.S.A. 2006)
    463. Allelic mRNA expression of X-linked monoamine oxidase a (MAOA) in human brain: dissection of epigenetic and genetic factors. (PubMed id 16893905)1 Pinsonneault J.K....SadAce W. (Hum. Mol. Genet. 2006)
    464. Parkin suppresses the expression of monoamine oxidases. (PubMed id 16455660)1 Jiang H....Feng J. (J. Biol. Chem. 2006)
    465. Mechanisms of neurotransmitter release by amphetamines: a review. (PubMed id 15955613)7 Sulzer D....Galli A. (Prog. Neurobiol. 2005)
    466. A stable tyrosyl radical in monoamine oxidase A. (PubMed id 15556933)1 Rigby S.E....Scrutton N.S. (J. Biol. Chem. 2005)
    467. The DNA sequence of the human X chromosome. (PubMed id 15772651)2 Ross M.T.... Bentley D.R. (Nature 2005)
    468. A review of linezolid: the first oxazolidinone antibiotic. (PubMed id 15482171)7 Stevens D.L....Madaras-Kelly K. (Expert Rev Anti Infect Ther 2004)
    469. Extracellular serotonin, dopamine and glutamate levels are elevated in the hypothalamus in a serotonin syndrome animal model induced by tranylcypromine and fluoxetine. (PubMed id 15276688)7 Shioda K....Kato S. (amp 2004)
    470. Complete sequencing and characterization of 21,243 full-length human cDNAs. (PubMed id 14702039)2 Ota T.... Sugano S. (Nat. Genet. 2004)
    471. Inhibitory effects of the monoamine oxidase inhibitor tranylcypromine on the cytochrome P450 enzymes CYP2C19, CYP2C9, and CYP2D6. (PubMed id 15049511)7 Salsali M....Baker G.B. (Cell. Mol. Neurobiol. 2004)
    472. Positive selection in MAOA gene is human exclusive: determination of the putative amino acid change selected in the human lineage. (PubMed id 15349769)1 Andres A.M....Bertranpetit J. (Hum. Genet. 2004)
    473. Liquid chromatographic and tandem mass spectrometric assay for evaluation of in vivo inhibition of rat brain monoamine oxidases (MAO) A and B following a single dose of MAO inhibitors: application of biomarkers in drug discovery. (PubMed id 15351283)7 Lang W....Rafferty B.M. (Anal. Biochem. 2004)
    474. MAOA and persistent, pervasive childhood aggression. (PubMed id 15024395)1 Beitchman J.H....Kennedy J.L. (Mol. Psychiatry 2004)
    475. Identification of a furazolidone metabolite responsible for the inhibition of amino oxidases. (PubMed id 12623758)7 Timperio A.M....Zolla L. ( the fate of foreign compounds in biological systems 2003)
    476. Elucidating the role of genetic factors in smoking behavior and nicotine dependence. (PubMed id 12627466)4 Lerman C. and Berrettini W. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003)
    477. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression]. (PubMed id 14574774)7 Nolen W.A. (Ned Tijdschr Geneeskd 2003)
    478. An in vitro interethnic comparison of monoamine oxidase activities between Japanese and Caucasian livers using rizatriptan, a serotonin receptor 1B/1D agonist, as a model drug. (PubMed id 14651728)7 Iwasa T....Ishizaki T. (Br J Clin Pharmacol 2003)
    479. The genetic determinants of smoking. (PubMed id 12740294)4 Batra V....Leone F.T. (Chest 2003)
    480. TTD: Therapeutic Target Database. (PubMed id 11752352)7 Chen X....Chen Y.Z. (Nucleic Acids Res. 2002)
    481. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. (PubMed id 12477932)1 Strausberg R.L....Marra M.A. (Proc. Natl. Acad. Sci. U.S.A. 2002)
    482. Clinical pharmacokinetics of intranasal sumatriptan. (PubMed id 12190330)7 Fuseau E....Ibbotson T. (Clin Pharmacokinet 2002)
    483. Evidence for positive selection and population structure at the human MAO-A gene. (PubMed id 11805333)1 Gilad Y....Skorecki K. (Proc. Natl. Acad. Sci. U.S.A. 2002)
    484. Pharmacological properties of the anti-Parkinson drug rasagiline; modification of endogenous brain amines, reserpine reversal, serotonergic and dopaminergic behaviours. (PubMed id 12504917)7 Finberg J.P. and Youdim M.B. (Neuropharmacology 2002)
    485. Pharmacogenetics of antidepressant and mood-stabilizing drugs: a review of candidate-gene studies and future research directions. (PubMed id 12366879)4 Lerer B. and Macciardi F. (Int. J. Neuropsychopharmacol. 2002)
    486. Almotriptan, a new anti-migraine agent: a review. (PubMed id 12353056)7 Gras J....Palacios J.M. (CNS Drug Rev 2002)
    487. Substrates but not inhibitors alter the redox potentials of monoamine oxidases. (PubMed id 11761322)1 Sablin S.O. and Ramsay R.R. (amp 2001)
    488. Monoamine oxidase inhibition is unlikely to be relevant to the risks associated with phentermine and fenfluramine: a comparison with their abilities to evoke monoamine release. (PubMed id 11673765)7 Kilpatrick I.C....Heal D.J. (Int. J. Obes. Relat. Metab. Disord. 2001)
    489. Characterization of phentermine and related compounds as monoamine oxidase (MAO) inhibitors. (PubMed id 10799660)7 Ulus I.H....Wurtman R.J. (Biochem. Pharmacol. 2000)
    490. Association of a functional polymorphism of the monoamine oxidase A gene promoter with personality and psychiatric symptoms. (PubMed id 10994647)4 Jorm A.F....Easteal S. (Psychiatr. Genet. 2000)
    491. No genetic linkage or association between a functional promoter polymorphism in the monoamine oxidase-A gene and panic disorder. (PubMed id 11032378)4 Hamilton S.P....Knowles J.A. (Mol. Psychiatry 2000)
    492. Association analysis between a regulatory-promoter polymorphism of the human monoamine oxidase A gene and idiopathic generalized epilepsy. (PubMed id 10759301)4 Haug K....Heils A. (Epilepsy Res. 2000)
    493. The Protein Data Bank. (PubMed id 10592235)7 Berman H.M....Bourne P.E. (Nucleic Acids Res. 2000)
    494. 3H[2-(2-benzofuranyl)-2-imidazoline] (BFI) binding in human platelets: modulation by tranylcypromine. (PubMed id 10494892)7 Wiest S.A. and Steinberg M.I. (Naunyn Schmiedebergs Arch. Pharmacol. 1999)
    495. The inhibition of monoamine oxidase activity by various antidepressants: differences found in various mammalian species. (PubMed id 10580379)7 Egashira T....Yamanaka Y. (Jpn. J. Pharmacol. 1999)
    496. Sensitivity of [11C]phenylephrine kinetics to monoamine oxidase activity in normal human heart. (PubMed id 10025828)7 Raffel D.M....Wieland D.M. (J. Nucl. Med. 1999)
    497. [Genetic association between mood disorder and monoamine oxidase gene]. (PubMed id 11715502)4 Lin S....Jiang K. (Zhonghua Yi Xue Za Zhi 1999)
    498. Reduction of oral ethanol self-administration in rats by monoamine oxidase inhibitors. (PubMed id 10548268)7 Cohen C....Sanger D.J. (Pharmacol. Biochem. Behav. 1999)
    499. Pharmacological, therapeutic and toxicological properties of furazolidone: some recent research. (PubMed id 10543364)7 Ali B.H. (Vet. Res. Commun. 1999)
    500. Effects of long-term treatment with dicyclic, tricyclic, tetracyclic, and noncyclic antidepressant drugs on monoamine oxidase activity in mouse brain. (PubMed id 8842678)7 Egashira T....Yamanaka Y. (Gen. Pharmacol. 1996)
    501. Clinical evaluation of carbon-11-phenylephrine: MAO-sensitive marker of cardiac sympathetic neurons. (PubMed id 8970507)7 Raffel D.M....Wieland D.M. (J. Nucl. Med. 1996)
    502. Moclobemide. An update of its pharmacological properties and therapeutic use. (PubMed id 8875133)7 Fulton B. and Benfield P. (Drugs 1996)
    503. Normalization and subtraction: two approaches to facilitate gene discovery. (PubMed id 8889548)1 Bonaldo M.F.... Soares M.B. (Genome Res. 1996)
    504. GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline. (PubMed id 8749840)7 Todd K.G. and Baker G.B. (J Affect Disord 1995)
    505. Effects of zonisamide on dopaminergic system. (PubMed id 8991786)7 Okada M....Fukushima Y. (Epilepsy Res. 1995)
    506. MAOIs in the contemporary treatment of depression. (PubMed id 7612154)7 Thase M.E....Rush A.J. (Neuropsychopharmacology 1995)
    507. Association analysis of the monoamine oxidase A gene in bipolar affective disorder by using family-based internal controls. (PubMed id 7573065)4 NAPthen M.M....Franzek E. (Am. J. Hum. Genet. 1995)
    508. Possible association between monoamine oxidase A gene and bipolar affective disorder. (PubMed id 7880306)4 Kawada Y....Nanko S. (Am. J. Hum. Genet. 1995)
    509. Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. (PubMed id 8125298)1 Maruyama K. and Sugano S. (Gene 1994)
    510. X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. (PubMed id 8503438)1 Brunner H.G....van Oost B.A. (Am. J. Hum. Genet. 1993)
    511. Association of monoamine oxidase (MAO) activity with alcoholism and alcoholic subtypes. (PubMed id 8135303)4 Devor E.J....Tabakoff B. (Am. J. Med. Genet. 1993)
    512. Use of pig hepatocytes to study the inhibition of monoamine oxidase by furazolidone. (PubMed id 2032659)7 Hoogenboom L.A....Kuiper H.A. (Food Chem. Toxicol. 1991)
    513. Genetic and physical mapping around the properdin P gene. (PubMed id 1783405)1 Coleman M.P....Davies K.E. (Genomics 1991)
    514. Comparison of monoamine oxidase-A inhibition by moclobemide in vitro and ex vivo in rats. (PubMed id 2248058)7 Kettler R....Burkard W.P. (Acta Psychiatr Scand Suppl 1990)
    515. Human monoamine oxidase A and B genes map to Xp 11.23 and are deleted in a patient with Norrie disease. (PubMed id 2744764)1 Lan N.C....Shih J.C. (Genomics 1989)
    516. Monoamine oxidase deficiency in males with an X chromosome deletion. (PubMed id 2483108)1 Sims K.B....Bruns G. (Neuron 1989)
    517. Effects of monoamine oxidase inhibitors on levels of catechols and homovanillic acid in striatum and plasma. (PubMed id 2506486)7 Hovevey-Sion D....Goldstein D.S. (Neuropharmacology 1989)
    518. Localization of human monoamine oxidase-A gene to Xp11.23-11.4 by in situ hybridization: implications for Norrie disease. (PubMed id 2793188)1 Levy E.R....Craig I.W. (Genomics 1989)
    519. Human monoamine oxidase gene (MAOA): chromosome position (Xp21-p11) and DNA polymorphism. (PubMed id 2906043)1 Ozelius L....Trofatter J.A. (Genomics 1988)
    520. Effect of the antidepressant minaprine on both forms of monoamine oxidase in the rat. (PubMed id 3954800)7 Kan J.P....Biziere K. (Biochem. Pharmacol. 1986)
    521. Assignment of genes for human monoamine oxidases A and B to the X chromosome. (PubMed id 3540317)1 Kochersperger L.M....Denney R.M. (J. Neurosci. Res. 1986)
    522. Inhibition of monoamine oxidase activity by phenylpropanolamine, an anorectic agent. (PubMed id 3961266)7 Yu P.H. (Res. Commun. Chem. Pathol. Pharmacol. 1986)
    523. Immunological uniqueness of human monoamine oxidases A and B: new evidence from studies with monoclonal antibodies to human monoamine oxidase A. (PubMed id 2414414)1 Kochersperger L.M....Denney R.M. (J. Neurosci. 1985)
    524. Selective inhibition of monoamine oxidase in monoaminergic neurons in the rat brain. (PubMed id 6646243)7 Ask A.L....Ross S.B. (Naunyn Schmiedebergs Arch. Pharmacol. 1983)
    525. The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions. (PubMed id 6408492)1 O'Carroll A.M....Tipton K.F. (Naunyn Schmiedebergs Arch. Pharmacol. 1983)
    526. Human liver MAO-A and MAO-B separated by immunoaffinity chromatography with MAO-B-specific monoclonal antibody. (PubMed id 7063850)1 Denney R.M....Abell C.W. (Science 1982)
    527. Selective and nonselective monoamine oxidase inhibitors: behavioral disturbances during their administration to depressed patients. (PubMed id 7092487)7 Pickar D....Lipper S. (Arch. Gen. Psychiatry 1982)
    528. Studies on beta-phenylethylamine deamination by human placental monoamine oxidase. (PubMed id 6788990)1 Oguchi K....Kamijo K. (Jpn. J. Pharmacol. 1981)
    529. p-Methoxyamphetamine, a potent reversible inhibitor of type-A monoamine oxidase in vitro and in vivo. (PubMed id 6103055)7 Green A.L. and El Hait M.A. (J. Pharm. Pharmacol. 1980)
    530. Central mediation of the antihypertensive effect of pargyline in spontaneously hypertensive rats. (PubMed id 477738)7 Fuentes J.A....Neff N.H. (Eur. J. Pharmacol. 1979)
    531. Interaction of testosterone with monoamineoxidase in mouse brain maturation. (PubMed id 590724)7 Hoff K.M. (Gen. Pharmacol. 1977)
    532. High-level expression and purification of rat monoamine oxidase A (MAO A) in Pichia pastoris: comparison with human MAO A. (PubMed id 19883764)9 Wang J. and Edmondson D.E. (Protein Expr. Purif. 2010)
    533. Problems with the measurement of monoamine oxidase A protein concentration in mitochondrial preparations. Revised molecular activities and implications for estimating ratios of MAO A:MAO B molecules from radiochemical assay data. (PubMed id 1741773)9 Riley L.A. and Denney R.M. (Biochem. Pharmacol. 1991)
    534. Relationship between monoamine oxidase (MAO) A specific activity and proportion of human skin fibroblasts which express the enzyme in culture. (PubMed id 9564604)9 Denney R.M. (J. Neural Transm. Suppl. 1998)
    535. Reversible inhibitors of monoamine oxidase-A (RIMAs): robust, reversible inhibition of human brain MAO-A by CX157. (PubMed id 19890267)9 Fowler J.S....Apelskog-Torres K. (Neuropsychopharmacology 2010)
    536. Progress in monoamine oxidase (MAO) research in relation to genetic engineering. (PubMed id 14697876)9 Nagatsu T. (Neurotoxicology 2004)
    537. Reduced monoamine oxidase A activity in pregnant smokers and in their newborns. (PubMed id 19615672)9 Berlin I....Spreux-Varoquaux O. (Biol. Psychiatry 2009)
    538. The significance of monoamine oxidase-A expression in high grade prostate cancer. (PubMed id 18804811)9 Peehl D.M....Zhao H. (J. Urol. 2008)
    539. Forebrain-specific expression of monoamine oxidase A reduces neurotransmitter levels, restores the brain structure, and rescues aggressive behavior in monoamine oxidase A-deficient mice. (PubMed id 17090537)9 Chen K....Shih J.C. (J. Biol. Chem. 2007)
    540. [Discovery of monoamine oxidase forms A and B]. (PubMed id 9503561)9 Squires R.F. (Vopr. Med. Khim. 1997)
    541. Monoamine oxidase A is highly expressed by the human corpus luteum of pregnancy. (PubMed id 18499710)9 Takao Y....Ueda M. (Reproduction 2008)
    542. Expression regulation of MAO isoforms in monocytic cells in response to Th2 cytokines. (PubMed id 16049371)9 Chaitidis P....Kuhn H. (Med. Sci. Monit. 2005)
    543. Early and persistent alterations in prefrontal cortex MAO A and B in Alzheimer's disease. (PubMed id 12811639)9 Kennedy B.P....Masliah E. (J Neural Transm 2003)
    544. Elevated brain monoamine oxidase A binding in the early postpartum period. (PubMed id 20439828)9 Sacher J....Meyer J.H. (Arch. Gen. Psychiatry 2010)
    545. MAOA genotype, maltreatment, and aggressive behavior: the changing impact of genotype at varying levels of trauma. (PubMed id 18996506)9 Weder N....Kaufman J. (Biol. Psychiatry 2009)
    546. Understanding genetic risk for aggression: clues from the brain's response to social exclusion. (PubMed id 17137563)9 Eisenberger N.I....Lieberman M.D. (Biol. Psychiatry 2007)
    547. Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction. (PubMed id 17721552)9 Ramsay R.R....Gillman P.K. (Br. J. Pharmacol. 2007)
    548. Positron emission tomography quantification of [11C]-harmine binding to monoamine oxidase-A in the human brain. (PubMed id 16079787)9 Ginovart N....Wilson A.A. (J. Cereb. Blood Flow Metab. 2006)
    549. Inactivation of purified human recombinant monoamine oxidases A and B by rasagiline and its analogues. (PubMed id 15027867)9 HubA!lek F....Edmondson D.E. (J. Med. Chem. 2004)
    550. Evidence that L-deprenyl treatment for one week does not inhibit MAO A or the dopamine transporter in the human brain. (PubMed id 11400918)9 Fowler J.S....Hitzemann R. (Life Sci. 2001)
    551. Bidirectional promoter of human monoamine oxidase A (MAO A) controlled by transcription factor Sp1. (PubMed id 7996184)9 Zhu Q.S....Shih J.C. (J. Neurosci. 1994)
    552. Plasma 5-hydroxyindoleacetic acid as an indicator of monoamine oxidase-A inhibition in rat brain and peripheral tissues. (PubMed id 7504085)9 Celada P. and Artigas F. (J. Neurochem. 1993)
    553. Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence. (PubMed id 19996035)9 Meyer J.H....Houle S. (Arch. Gen. Psychiatry 2009)
    554. Regulation of monoamine oxidase A by the SRY gene on the Y chromosome. (PubMed id 19661285)9 Wu J.B....Shih J.C. (FASEB J. 2009)
    555. High-throughput screening for monoamine oxidase-A and monoamine oxidase-B inhibitors using one-step fluorescence assay. (PubMed id 16723097)9 Guang H.M. and Du G.H. (Acta Pharmacol. Sin. 2006)
    556. Structure of rat monoamine oxidase A and its specific recognitions for substrates and inhibitors. (PubMed id 15050826)9 Ma J....Tsukihara T. (J. Mol. Biol. 2004)
    557. Organization of MAO A and MAO B promoters and regulation of gene expression. (PubMed id 14697878)9 Chen K. (Neurotoxicology 2004)
    558. Th2 response of human peripheral monocytes involves isoform-specific induction of monoamine oxidase-A. (PubMed id 15470022)9 Chaitidis P....KA1hn H. (J. Immunol. 2004)
    559. Altered regulation of the 5-HT system in the brain of MAO-A knock-out mice. (PubMed id 11906526)9 Evrard A....Adrien J. (Eur. J. Neurosci. 2002)
    560. Loss of serotonin oxidation as a component of the altered substrate specificity in the Y444F mutant of recombinant human liver MAO A. (PubMed id 11732903)9 Nandigama R.K....Edmondson D.E. (Biochemistry 2001)
    561. The expression and activity of monoamine oxidase A, but not of the serotonin transporter, is decreased in human placenta from pre-eclamptic pregnancies. (PubMed id 11133008)9 Carrasco G....GonzA!lez C. (Life Sci. 2000)
    562. Phe(208) and Ile(199) in human monoamine oxidase A and B do not determine substrate and inhibitor specificities as in rat. (PubMed id 10936214)9 Geha R.M....Shih J.C. (J. Neurochem. 2000)
    563. Screen for MAOA mutations in target human groups. (PubMed id 10050962)9 Schuback D.E....Hsu Y.P. (Am. J. Med. Genet. 1999)
    564. MAOA deficiency and abnormal behaviour: perspectives on an association. (PubMed id 8862875)9 Brunner H.G. (Ciba Found. Symp. 1996)
    565. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. I. Biochemical profile. (PubMed id 8613928)9 Curet O....Jarreau F.X. (J. Pharmacol. Exp. Ther. 1996)
    566. The insertion of monoamine oxidase A into the outer membrane of rat liver mitochondria. (PubMed id 1309756)9 Zhuang Z.P....McCauley R.B. (J. Biol. Chem. 1992)
    567. Serine 209 resides within a putative p38(MAPK) consensus motif and regulates monoamine oxidase-A activity. (PubMed id 19650872)9 Cao X....Mousseau D.D. (J. Neurochem. 2009)
    568. Kinetic properties of recombinant MAO-A on incorporation into phospholipid nanodisks. (PubMed id 17393065)9 Cruz F. and Edmondson D.E. (J Neural Transm 2007)
    569. MAO-A-induced mitogenic signaling is mediated by reactive oxygen species, MMP-2, and the sphingolipid pathway. (PubMed id 17561096)9 Coatrieux C....Auge N. (amp 2007)
    570. Type A monoamine oxidase is the target of an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol, leading to apoptosis in SH-SY5Y cells. (PubMed id 16336631)9 Yi H....Naoi M. (J. Neurochem. 2006)
    571. Substrate selectivity of monoamine oxidase A, monoamine oxidase B, diamine oxidase, and semicarbazide-sensitive amine oxidase in COS-1 expression systems. (PubMed id 17142964)9 Ochiai Y....Tanaka Y. (amp 2006)
    572. Monoamine oxidase-A is a major target gene for glucocorticoids in human skeletal muscle cells. (PubMed id 15946989)9 Manoli I....Blackman M.R. (FASEB J. 2005)
    573. R1, a novel repressor of the human monoamine oxidase A. (PubMed id 15654081)9 Chen K.... Shih J.C. (J. Biol. Chem. 2005)
    574. Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling. (PubMed id 15801832)9 Gallardo-Godoy A....Nichols D.E. (J. Med. Chem. 2005)
    575. Immobilized enzyme reactors based upon the flavoenzymes monoamine oxidase A and B. (PubMed id 15081923)9 Markoglou N....Wainer I.W. (J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2004)
    576. Regulation of MAO-A and MAO-B gene expression. (PubMed id 15279563)9 Shih J.C. and Chen K. (Curr. Med. Chem. 2004)
    577. Haplotypes of the monoamine oxidase genes and the risk for substance use disorders. (PubMed id 14755456)9 Vanyukov M.M....Ferrell R.E. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004)
    578. Fluorinated phenylcyclopropylamines. Part 3: Inhibition of monoamine oxidase A and B. (PubMed id 15110846)9 Yoshida S....Kirk K.L. (amp 2004)
    579. Monoamine oxidase A inhibitory potency and flavin perturbation are influenced by different aspects of pirlindole inhibitor structure. (PubMed id 12781338)9 Hynson R.M....Ramsay R.R. (Biochem. Pharmacol. 2003)
    580. Nonselective inhibition of monoamine oxidases A and B by activators of soluble guanylate cyclase. (PubMed id 14606950)9 Severina I.S....Medvedev A.E. (Biochemistry Mosc. 2003)
    581. Daily transdermal administration of selegiline to guinea-pigs preferentially inhibits monoamine oxidase activity in brain when compared with intestinal and hepatic tissues. (PubMed id 12625864)9 Mawhinney M....Azzaro A.J. (J. Pharm. Pharmacol. 2003)
    582. Investigation of the functional effect of monoamine oxidase polymorphisms in human brain. (PubMed id 11810289)9 Balciuniene J....Jazin E. (Hum. Genet. 2002)
    583. Structure-activity relations in the oxidation of phenethylamine analogues by recombinant human liver monoamine oxidase A. (PubMed id 11106506)9 Nandigama R.K. and Edmondson D.E. (Biochemistry 2000)
    584. Pathological gambling and DNA polymorphic markers at MAO-A and MAO-B genes. (PubMed id 10673777)9 IbaA+ez A....Saiz-Ruiz J. (Mol. Psychiatry 2000)
    585. Quantitative distribution of monoamine oxidase A in brainstem monoamine nuclei is normal in major depression. (PubMed id 10564737)9 Ordway G.A....Klimek V. (Brain Res. 1999)
    586. Role of MAO A and B in neurotransmitter metabolism and behavior. (PubMed id 10389141)9 Shih J.C....Ridd M.J. (Pol J Pharmacol 1999)
    587. MAOA: association and linkage studies with lithium responsive bipolar disorder. (PubMed id 10335547)9 Turecki G....Alda M. (Psychiatr. Genet. 1999)
    588. Monoamine oxidase A deficiency: biogenic amine metabolites in random urine samples. (PubMed id 9564603)9 Abeling N.G....Brunner H.G. (J. Neural Transm. Suppl. 1998)
    589. Tissue-specific effects of estrogen on monoamine oxidase A and B in the rat. (PubMed id 9698044)9 Holschneider D.P....Shih J.C. (Life Sci. 1998)
    590. Simultaneous inhibition of catechol-O-methyltransferase and monoamine oxidase A: effects on hemodynamics and catecholamine metabolism in healthy volunteers. (PubMed id 8612391)9 Illi A....Gordin A. (Clin. Pharmacol. Ther. 1996)
    591. Interaction of indole derivatives with monoamine oxidase A and B. Studies on the structure-inhibitory activity relationship. (PubMed id 7663405)9 Medvedev A.E....Marshakov VYu . (Biochem. Mol. Biol. Int. 1995)
    592. The therapeutic potential of moclobemide, a reversible selective monoamine oxidase A inhibitor in Parkinson's disease. (PubMed id 7593732)9 Sieradzan K....Youdim M.B. (J Clin Psychopharmacol 1995)
    593. Studies on the monoamine oxidase (MAO)-catalyzed oxidation of phenyl-substituted 1-methyl-4-phenoxy-1,2,3,6-tetrahydropyridine derivatives: factors contributing to MAO-A and MAO-B selectivity. (PubMed id 7783122)9 Wang Y.X. and Castagnoli N. (J. Med. Chem. 1995)
    594. Radioautographic evidence that the GABAA receptor antagonist SR 95531 is a substrate inhibitor of MAO-A in the rat and human locus coeruleus. (PubMed id 7952273)9 Luque J.M....Richards J.G. (Eur. J. Neurosci. 1994)
    595. Molecular size and flexibility as determinants of selectivity in the oxidation of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs by monoamine oxidase A and B. (PubMed id 8487265)9 Efange S.M....Singer T.P. (J. Med. Chem. 1993)
    596. Structure and promoter organization of the human monoamine oxidase A and B genes. (PubMed id 8461277)9 Shih J.C....Zhu Q.S. (amp 1993)
    597. Synthesis, biological evaluation and quantitative structure activity relationship analysis of nuclear-substituted pargylines as competitive inhibitors of MAO-A and MAO-B. (PubMed id 1686901)9 Ali A. and Robinson J.B. (J. Pharm. Pharmacol. 1991)
    598. Inhibition of monoamine oxidases A and B by simple isoquinoline alkaloids: racemic and optically active 1,2,3,4-tetrahydro-, 3,4-dihydro-, and fully aromatic isoquinolines. (PubMed id 2296014)9 Bembenek M.E....Brossi A. (J. Med. Chem. 1990)
    599. Upregulation of serotonin transporter by alcohol in human dendritic cells: possible implication in neuroimmune deregulation. (PubMed id 19572987)9 Babu D.K....Nair M.P. (Alcohol. Clin. Exp. Res. 2009)
    600. Attention Deficit Hyperactivity Disorder comorbid oppositional defiant disorder and its predominately inattentive type: evidence for an association with COMT but not MAOA in a Chinese sample. (PubMed id 19228412)9 Qian Q.J....Faraone S.V. (Behav Brain Funct 2009)
    601. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors. (PubMed id 19682910)9 GAPkhan-KelekAsi N....Bilgin A.A. (amp 2009)
    602. Fluorinated phenylcyclopropylamines. Part 5: Effects of electron-withdrawing or -donating aryl substituents on the inhibition of monoamine oxidases A and B by 2-aryl-2-fluoro-cyclopropylamines. (PubMed id 18640844)9 Hruschka S....Haufe G. (amp 2008)
    603. An indicator of cancer: downregulation of monoamine oxidase-A in multiple organs and species. (PubMed id 18366702)9 Rybaczyk L.A....Huang K. (BMC Genomics 2008)
    604. Genetic pathway of major depressive disorder in shortening telomeric length. (PubMed id 17417064)9 Lung F.W....Shu B.C. (Psychiatr. Genet. 2007)
    605. CHF3381, a N-methyl-D-aspartate receptor antagonist and monoamine oxidase-A inhibitor, attenuates secondary hyperalgesia in a human pain model. (PubMed id 16885013)9 Mathiesen O....Dahl J.B. (J Pain 2006)
    606. Structural variation of the monoamine oxidase A gene promoter repeat polymorphism in nonhuman primates. (PubMed id 16436187)9 Wendland J.R....Lesch K.P. (Genes Brain Behav. 2006)
    607. The role of monoamine oxidase A, MAOA, in the aetiology of antisocial behaviour: the importance of gene-environment interactions. (PubMed id 16206884)9 Craig I.W. (Novartis Found. Symp. 2005)
    608. Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)- pyrazole derivatives. (PubMed id 16279769)9 Chimenti F....Distinto S. (J. Med. Chem. 2005)
    609. Monoamine oxidase a and tryptophan hydroxylase gene polymorphisms: are they associated with bipolar disorder? (PubMed id 15727488)9 Preisig M....Malafosse A. (Am J Pharmacogenomics 2005)
    610. Modifier effects in autism at the MAO-A and DBH loci. (PubMed id 15048649)9 Jones M.B....Szatmari P. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004)
    611. Gene-gene interaction between the monoamine oxidase A gene and solute carrier family 6 (neurotransmitter transporter, noradrenalin) member 2 gene in anorexia nervosa (restrictive subtype). (PubMed id 14508509)9 Urwin R.E....Nunn K.P. (Eur. J. Hum. Genet. 2003)
    612. Turner syndrome and Xp deletions: clinical and molecular studies in 47 patients. (PubMed id 11701728)9 Ogata T....Tachibana K. (J. Clin. Endocrinol. Metab. 2001)
    613. Different allele distribution of a regulatory MAOA gene promoter polymorphism in antisocial and anxious-depressive alcoholics. (PubMed id 10943908)9 Schmidt L.G....Lesch K.P. (J Neural Transm 2000)
    614. Relevance of benzyloxy group in 2-indolyl methylamines in the selective MAO-B inhibition. (PubMed id 10433493)9 PAcrez V....Unzeta M. (Br. J. Pharmacol. 1999)
    615. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. (PubMed id 10331110)9 Karayiorgou M....Gogos J.A. (Biol. Psychiatry 1999)
    616. A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorders. (PubMed id 10483059)9 Kunugi H....Nanko S. (Mol. Psychiatry 1999)
    617. Inhibition of monoamine oxidase-B by condensed pyridazines and pyrimidines: effects of lipophilicity and structure-activity relationships. (PubMed id 9748356)9 Altomare C....Stoeckli-Evans H. (J. Med. Chem. 1998)
    618. Correlation of length of VNTR alleles at the X-linked MAOA gene and phenotypic effect in Tourette syndrome and drug abuse. (PubMed id 9491813)9 Gade R....Comings D.E. (Mol. Psychiatry 1998)
    619. MAO-A inhibition in brain after dosing with esuprone, moclobemide and placebo in healthy volunteers: in vivo studies with positron emission tomography. (PubMed id 9174681)9 BergstrAPm M....LAYngstrAPm B. (Eur. J. Clin. Pharmacol. 1997)
    620. Localization of monoamine oxidases in human peripheral tissues. (PubMed id 8876663)9 Saura J....Mahy N. (Life Sci. 1996)
    621. Detection of MAO-A and MAO-B mRNAs in monkey brainstem by cross-hybridization with human oligonucleotide probes. (PubMed id 8965658)9 Luque J.M....Richards J.G. (Brain Res. Mol. Brain Res. 1996)
    622. Association of monoamine oxidase A alleles with alcoholism among male Chinese in Taiwan. (PubMed id 8780428)9 Hsu Y.P....Cheng A.T. (Am J Psychiatry 1996)
    623. Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes. (PubMed id 8613523)9 Lenders J.W....Brunner H.G. (J. Clin. Invest. 1996)
    624. Estrogenic control of monoamine oxidase A activity in human neuroblastoma cells expressing physiological concentrations of estrogen receptor. (PubMed id 8549621)9 Ma Z.Q....Maggi A. (Eur. J. Pharmacol. 1995)
    625. Monoamine oxidase inhibitors and the cheese effect. (PubMed id 8255365)9 Anderson M.C....Tipton K.F. (Neurochem. Res. 1993)
    626. Characterisation of wild-type and mutant forms of human monoamine oxidase A and B expressed in a mammalian cell line. (PubMed id 8428624)9 Gottowik J....Da Prada M. (FEBS Lett. 1993)
    627. Interaction of flexible analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of N-methyl-4-phenylpyridinium with highly purified monoamine oxidase A and B. (PubMed id 1610807)9 Krueger M.J....Singer T.P. (Biochemistry 1992)
    628. [Brain monoamine oxidase in mink selected for their reaction to man]. (PubMed id 1323180)9 VoA-tenko N.N....Kharlamova A.A. (Zh Vyssh Nerv Deiat Im I P Pavlova 1992)
    629. Characterization of a YAC containing part or all of the Norrie disease locus. (PubMed id 1303171)9 Chen Z.Y....Craig I.W. (Hum. Mol. Genet. 1992)
    630. Molecular neuroanatomy of monoamine oxidases in human brainstem. (PubMed id 1546134)9 Richards J.G....Da Prada M. (Psychopharmacology (Berl.) 1992)
    631. Type A and B monoamine oxidase activities in the human and rat kidney. (PubMed id 1529723)9 Fernandes M.H. and Soares-da-Silva P. (Acta Physiol. Scand. 1992)
    632. Synthesis of fluorine and iodine analogues of clorgyline and selective inhibition of monoamine oxidase A. (PubMed id 1893487)9 Ohmomo Y....Yokoyama A. (amp 1991)
    633. (PubMed id 16963982)9 
    634. Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies. (PubMed id 19945874)9 Sahoo A....Jayaprakash V. (amp 2010)
    635. [The development of antisocial behavior: psychobiological and environmental factors and gene-environment interactions]. (PubMed id 19226487)9 Gallardo-Pujol D....AndrAcs-Pueyo A. (Rev Neurol 2009)
    636. Further investigation into the mechanism of tachykinin NK(2) receptor-triggered serotonin release from guinea-pig proximal colon. (PubMed id 19423952)9 Kojima S....Kamikawa Y. (J. Pharmacol. Sci. 2009)
    637. Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells. (PubMed id 19691856)9 Zhao H....Peehl D.M. (BMC Med Genomics 2009)
    638. New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity. (PubMed id 19091581)9 GAPkhan-KelekAsi N....YeA9ilada A. (amp 2009)
    639. Elucidating the mechanism of action and potential interactions of MAO-B inhibitors. (PubMed id 18774444)9 Bainbridge J.L....Ruscin J.M. (Neurol Clin 2008)
    640. Contiguous deletion of the NDP, MAOA, MAOB, and EFHC2 genes in a patient with Norrie disease, severe psychomotor retardation and myoclonic epilepsy. (PubMed id 17431911)9 Rodriguez-Revenga L....MilA M. (Am. J. Med. Genet. A 2007)
    641. New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity. (PubMed id 17256833)9 La Regina G....Agostinelli E. (J. Med. Chem. 2007)
    642. [The genetics of child temperament]. (PubMed id 17918108)9 Ivorra-MartA-nez J....SanjuA!n J. (Rev Neurol 2007)
    643. Optical bio-sniffer for methyl mercaptan in halitosis. (PubMed id 17723508)9 Mitsubayashi K....Saito H. (Anal. Chim. Acta 2006)
    644. From genes to aggressive behavior: the role of serotonergic system. (PubMed id 16615082)9 Popova N.K. (Bioessays 2006)
    645. The antioxidant anethole dithiolethione inhibits monoamine oxidase-B but not monoamine oxidase A activity in extracts of cultured astrocytes. (PubMed id 16252076)9 Drukarch B....Schoffelmeer A.N. (J Neural Transm 2006)
    646. Evidence for reduced arterial plasma input, prolonged lung retention and reduced lung monoamine oxidase in smokers. (PubMed id 15982583)9 Logan J. and Fowler J.S. (Nucl. Med. Biol. 2005)
    647. Binding of rasagiline-related inhibitors to human monoamine oxidases: a kinetic and crystallographic analysis. (PubMed id 16366596)9 Binda C....Mattevi A. (J. Med. Chem. 2005)
    648. Childhood adversity, monoamine oxidase a genotype, and risk for conduct disorder. (PubMed id 15237086)9 Foley D.L....Riley B. (Arch. Gen. Psychiatry 2004)
    649. Crystallization and preliminary crystallographic analysis of rat monoamine oxidase A complexed with clorgyline. (PubMed id 14747710)9 Ma J....Tsukihara T. (Acta Crystallogr. D Biol. Crystallogr. 2004)
    650. Effects of ovarian steroids and raloxifene on proteins that synthesize, transport, and degrade serotonin in the raphe region of macaques. (PubMed id 15199371)9 Smith L.J....Bethea C.L. (Neuropsychopharmacology 2004)
    651. [Specifics of monoaminergic regulation of the central nervous system of hibernating animals (Citellus undulatus)]. (PubMed id 15174262)9 Semenova T.P. (Zh Vyssh Nerv Deiat Im I P Pavlova 2004)
    652. Localization of monoamine oxidase A and B and semicarbazide-sensitive amine oxidase in human peripheral tissues. (PubMed id 15035812)9 Ramonet D....Mahy N. (Inflammopharmacology 2003)
    653. A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition. (PubMed id 14628189)9 Clarke A....Corn T.H. (J Neural Transm 2003)
    654. Fatal combination of moclobemide overdose and whisky. (PubMed id 12765230)9 Bleumink G.S....Stricker B.H. (Neth J Med 2003)
    655. Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid. (PubMed id 11134050)9 Geha R.M....Shih J.C. (J. Biol. Chem. 2001)
    656. Effects of long-term cigarette smoking on the human locus coeruleus. (PubMed id 11545664)9 Klimek V....Ordway G.A. (Arch. Gen. Psychiatry 2001)
    657. Paradoxical effects of copper and manganese on brain mitochondrial function. (PubMed id 11263670)9 Heron P....Daya S. (Life Sci. 2001)
    658. Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans. (PubMed id 11422001)9 Fleishaker J.C....Azie N.E. (Br J Clin Pharmacol 2001)
    659. Selective inhibitors and computer modelling of the active site of monoamine oxidase. (PubMed id 11061215)9 Medvedev A.E....Veselovsky A.V. (Neurobiology (Bp) 2000)
    660. MAO-A and MAO-B activities in rat striatum, frontal cortex and liver are unaltered after long-term treatment with fluvoxamine and desipramine. (PubMed id 10706994)9 Silver H. and Youdim M.B. (Eur Neuropsychopharmacol 2000)
    661. Age-related changes of MAO-A and -B distribution in human and mouse brain. (PubMed id 11008877)9 Mahy N....Saura J. (Neurobiology (Bp) 2000)
    662. Accumulation of 3,4-dihydroxyphenylglycolaldehyde, the neurotoxic monoamine oxidase A metabolite of norepinephrine, in locus ceruleus cell bodies in Alzheimer's disease: mechanism of neuron death. (PubMed id 9878889)9 Burke W.J....Gillespie K.N. (Brain Res. 1999)
    663. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. (PubMed id 10072430)9 Deckert J....Lesch K.P. (Hum. Mol. Genet. 1999)
    664. Relationship between I2 imidazoline binding sites and monoamine oxidase B in liver. (PubMed id 10415894)9 Remaury A....Parini A. (Ann. N. Y. Acad. Sci. 1999)
    665. Influence of flavin analogue structure on the catalytic activities and flavinylation reactions of recombinant human liver monoamine oxidases A and B. (PubMed id 10438531)9 Miller J.R. and Edmondson D.E. (J. Biol. Chem. 1999)
    666. Sequence analysis of exon 8 of MAO-A gene in alcoholics with antisocial personality and normal controls. (PubMed id 10049583)9 Parsian A. (Genomics 1999)
    667. Localization of monoamine oxidase mRNA in human placenta. (PubMed id 9815281)9 Auda G.R....Billett E.E. (J. Histochem. Cytochem. 1998)
    668. The therapeutic effect of moclobemide, a reversible selective monoamine oxidase A inhibitor, in Parkinson's disease. (PubMed id 9579294)9 Sternic N....Kostic V.S. (Clin Neuropharmacol 1998)
    669. Substrate regulation of monoamine oxidases. (PubMed id 9564616)9 Ramsay R.R. (J. Neural Transm. Suppl. 1998)
    670. Cognitive performance in elderly subjects after a single dose of befloxatone, a new reversible selective monoamine oxidase A inhibitor. (PubMed id 9728902)9 Rosenzweig P....Gandon J.M. (Clin. Pharmacol. Ther. 1998)
    671. Is one amino acid responsible for substrate specificity of monoamine oxidase A and B? (PubMed id 9916164)9 Veselovsky A.V....Medvedev A.E. (Biochemistry Mosc. 1998)
    672. Double-blind randomized controlled study of the efficacy and tolerability of two reversible monoamine oxidase A inhibitors, pirlindole and moclobemide, in the treatment of depression. (PubMed id 9272198)9 Tanghe A....GAcczy J. (Acta Psychiatr Scand 1997)
    673. Potential latent nitrogen mustard derivatives designed to target monoamine oxidase rich cells. (PubMed id 9377092)9 Wang Y.X. and Castagnoli N. (amp 1997)
    674. QSAR analysis of indole analogues as monoamine oxidase inhibitors. (PubMed id 8768761)9 Medvedev A.E....Archakov A.I. (J Chem Inf Comput Sci 1996)
    675. Effects of befloxatone, a reversible selective monoamine oxidase-A inhibitor, on psychomotor function and memory in healthy subjects. (PubMed id 8930782)9 Warot D....Puech A.J. (J Clin Pharmacol 1996)
    676. The monoamine regulon including syntheses of arylsulfatase and monoamine oxidase in bacteria. (PubMed id 8695909)9 Murooka Y....Yamashita M. (Biosci. Biotechnol. Biochem. 1996)
    677. Effects of the antidepressant pirlindole and its dehydro-derivative on the activity of monoamine oxidase-A and on GABAA receptors. (PubMed id 8953568)9 Medvedev A.E....Squires R.F. (Neurochem. Res. 1996)
    678. Pharmacokinetic-pharmacodynamic interactions between two selective monoamine oxidase inhibitors: moclobemide and selegiline. (PubMed id 8889283)9 Dingemanse J....Korn A. (Clin Neuropharmacol 1996)
    679. Initial monoamine oxidase-A inhibition by moclobemide does not predict the therapeutic response in patients with major depression. A double blind, randomized study. (PubMed id 8923574)9 Radat F....Puech A.J. (Psychopharmacology (Berl.) 1996)
    680. Influence of C terminus on monoamine oxidase A and B catalytic activity. (PubMed id 8592154)9 Chen K....Shih J.C. (J. Neurochem. 1996)
    681. A dinucleotide repeat polymorphism at the gene for monoamine oxidase A and measures of aggressiveness. (PubMed id 8771218)9 Vanyukov M.M....Deka R. (Psychiatry Res 1995)
    682. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. (PubMed id 7792602)9 Cases O....Shih J.C. (Science 1995)
    683. Inhibition of monoamine oxidase by isoquinoline derivatives. Qualitative and 3D-quantitative structure-activity relationships. (PubMed id 7575650)9 Thull U....McNaught K.S. (Biochem. Pharmacol. 1995)
    684. Pressor effect of oral tyramine during treatment with befloxatone, a new reversible monoamine oxidase-A inhibitor, in healthy subjects. (PubMed id 7665725)9 Patat A....Caille P. (J Clin Pharmacol 1995)
    685. Monoamine oxidase-A: pharmacodynamics in humans of moclobemide, a reversible and selective inhibitor. (PubMed id 7519866)9 Holford N.H....Banken L. (Br J Clin Pharmacol 1994)
    686. Monoamine oxidases and alcoholism: studies in unrelated alcoholics, normal controls and alcoholic families. (PubMed id 8974315)9 Parsian A....Cloninger C.R. (Alcohol Alcohol Suppl 1994)
    687. Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. (PubMed id 7816197)9 Saura J....Richards J.G. (Neuroscience 1994)
    688. Neurochemical and histopathologic alterations characteristic of Pick's disease in a non-demented individual. (PubMed id 8301318)9 Sparks D.L....Coyne C.M. (J. Neuropathol. Exp. Neurol. 1994)
    689. The MAO-B inhibitor deprenyl, but not the MAO-A inhibitor clorgyline, potentiates the neurotoxicity of p-chloroamphetamine. (PubMed id 7953696)9 Benmansour S. and Brunswick D.J. (Brain Res. 1994)
    690. Effects of chronic brofaromine administration on biogenic amines including sulphatoxymelatonin and acid metabolites in patients with bulimia nervosa. (PubMed id 7505890)9 Kennedy S.H....d'Souza J. (Neurochem. Res. 1993)
    691. Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide. (PubMed id 7905288)9 Nair N.P....Kin N.M. (amp 1993)
    692. Brofaromine: a monoamine oxidase-A and serotonin uptake inhibitor. (PubMed id 8313393)9 Waldmeier P.C....Bittiger H. (Clin Neuropharmacol 1993)
    693. Reversible monoamine oxidase-A inhibitors in social phobia. (PubMed id 8313403)9 Liebowitz M.R....Feerick J. (Clin Neuropharmacol 1993)
    694. Calbindin D-28k and monoamine oxidase A immunoreactive neurons in the nucleus basalis of Meynert in senile dementia of the Alzheimer type and Parkinson's disease. (PubMed id 8358501)9 Chan-Palay V....Hungerecker G. (Dementia 1993)
    695. Moclobemide: a reversible inhibitor of monoamine oxidase type A. (PubMed id 8490690)9 Baldwin D. and Rudge S. (Br J Hosp Med 1993)
    696. L-deprenyl confers specific protection against MPTP-induced Parkinson's disease-like movement disorder in the goldfish. (PubMed id 8243537)9 Adeyemo O.M....Pollard H.B. (Eur. J. Pharmacol. 1993)
    697. Comparative investigation of the effect of moclobemide and toloxatone on monoamine oxidase activity and psychometric performance in healthy subjects. (PubMed id 1546145)9 Dingemanse J....Puech A.J. (Psychopharmacology (Berl.) 1992)
    698. Clinical, biochemical, and neuropsychiatric evaluation of a patient with a contiguous gene syndrome due to a microdeletion Xp11.3 including the Norrie disease locus and monoamine oxidase (MAOA and MAOB) genes. (PubMed id 1308352)9 Collins F.A....Antonarakis S.E. (Am. J. Med. Genet. 1992)
    699. Inhibitory potency of some isatin analogues on human monoamine oxidase A and B. (PubMed id 1510706)9 Medvedev A.E....Sandler M. (Biochem. Pharmacol. 1992)
    700. Pharmacokinetic and pharmacodynamic interaction between toloxatone, a new reversible monoamine oxidase-A inhibitor, and oral tyramine in healthy subjects. (PubMed id 1424410)9 Provost J.C....Jaillon P. (Clin. Pharmacol. Ther. 1992)
    701. The Norrie disease gene maps to a 150 kb region on chromosome Xp11.3. (PubMed id 1301161)9 Sims K.B....Breakefield X.O. (Hum. Mol. Genet. 1992)
    702. PC12 cells as a window for the differentiation of neural crest into adrenergic nerve ending and adrenal medulla. (PubMed id 1817165)9 Youdim M.B. (J. Neural Transm. Suppl. 1991)
    703. Adrenergic-cholinergic imbalances: the physostigmine-syndrome is not antagonized by the MAO-A inhibitor brofaromine. (PubMed id 1967018)9 Fritze J....Riederer P. (Eur Neuropsychopharmacol 1990)
    704. Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo. (PubMed id 2123366)9 Versiani M....Stabl M. (Acta Psychiatr Scand Suppl 1990)
    705. Relationship between tyramine potentiation and monoamine oxidase (MAO) inhibition: comparison between moclobemide and other MAO inhibitors. (PubMed id 2248084)9 Zimmer R. (Acta Psychiatr Scand Suppl 1990)
    706. Behavioral genetics in antisocial spectrum disorders and psychopathy: a review of the recent literature. (PubMed id 20422643)9 Gunter T.D....Philibert R.A. (amp 2010)
    707. Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson's disease. (PubMed id 19879939)9 Samoylenko V....Muhammad I. (J Ethnopharmacol 2010)
    708. Expression of zebrafish (Danio rerio) monoamine oxidase (MAO) in Pichia pastoris: purification and comparison with human MAO A and MAO B. (PubMed id 20079438)9 Arslan B.K. and Edmondson D.E. (Protein Expr. Purif. 2010)
    709. Serotonin pathway gene-gene and gene-environment interactions influence behavioral stress response in infant rhesus macaques. (PubMed id 20102645)9 Kinnally E.L....Capitanio J.P. (Dev. Psychopathol. 2010)
    710. Molecular genetics of attention deficit hyperactivity disorder. (PubMed id 20159345)9 Faraone S.V. and Mick E. (Psychiatr. Clin. North Am. 2010)
    711. beta-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO). (PubMed id 20036304)9 Herraiz T....GuillAcn H. (Food Chem. Toxicol. 2010)
    712. Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson's disease. (PubMed id 20219660)9 Wang Y.H....Muhammad I. (J Ethnopharmacol 2010)
    713. Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins. (PubMed id 19267475)9 Chimenti F....Alcaro S. (J. Med. Chem. 2009)
    714. Investigation of 17 candidate genes for personality traits confirms effects of the HTR2A gene on novelty seeking. (PubMed id 19566713)9 Heck A....Ising M. (Genes Brain Behav. 2009)
    715. Genetics of human aggressive behaviour. (PubMed id 19506905)9 Craig I.W. and Halton K.E. (Hum. Genet. 2009)
    716. Transcription factor AP2 beta involved in severe female alcoholism. (PubMed id 19778525)9 Nordquist N....Hallman J. (Brain Res. 2009)
    717. Circadian polymorphisms associated with affective disorders. (PubMed id 19166596)9 Kripke D.F....Kelsoe J.R. (J Circadian Rhythms 2009)
    718. In vivo brain imaging of human exposure to nicotine and tobacco. (PubMed id 19184649)9 Sharma A. and Brody A.L. (Handb Exp Pharmacol 2009)
    719. ARVCF single marker and haplotypic association with schizophrenia. (PubMed id 19508883)9 Mas S....Lafuente A. (amp 2009)
    720. Single nucleotide polymorphisms related to HPA axis reactivity. (PubMed id 19571595)9 Derijk R.H. (Neuroimmunomodulation 2009)
    721. Monoamine oxidase and semicarbazide sensitive amine oxidase activities in normal and inflamed human dental pulp. (PubMed id 19789505)9 Vavilova T....Medvedev A. (Med. Sci. Monit. 2009)
    722. Inhibition of monoamine oxidase by (E)-styrylisatin analogues. (PubMed id 19342233)9 Van der Walt E.M....Petzer J.P. (amp 2009)
    723. Development of spin-labeled pargyline analogues as specific inhibitors of human monoamine oxidases A and B. (PubMed id 19296688)9 Upadhyay A.K. and Edmondson D.E. (Biochemistry 2009)
    724. [The genetics of suicidal behavior]. (PubMed id 19306130)9 Ozalp E. (Turk Psikiyatri Derg 2009)
    725. Candidate genes and neuropsychological phenotypes in children with ADHD: review of association studies. (PubMed id 19270759)9 Kebir O....Joober R. (amp 2009)
    726. Genetic and non-genetic influences on the development of co-occurring alcohol problem use and internalizing symptomatology in adolescence: a review. (PubMed id 19438423)9 Saraceno L....van den Bree M.B. (Addiction 2009)
    727. Selegiline transdermal system: a novel treatment option for major depressive disorder. (PubMed id 19527191)9 Nandagopal J.J. and DelBello M.P. (Expert Opin Pharmacother 2009)
    728. The role of pharmacogenetics in the treatment of depression and anxiety disorders. (PubMed id 19738481)9 Schosser A. and Kasper S. (Int Clin Psychopharmacol 2009)
    729. Mitochondria in neurodegenerative disorders: regulation of the redox state and death signaling leading to neuronal death and survival. (PubMed id 19763773)9 Naoi M....Shamoto-Nagai M. (J Neural Transm 2009)
    730. Influence of serotonergic/noradrenergic gene polymorphisms on nausea and sweating induced by milnacipran in the treatment of depression. (PubMed id 19649213)9 Higuchi H....Yoshida K. (Neuropsychiatr Dis Treat 2009)
    731. Vulnerability genes or plasticity genes? (PubMed id 19455150)9 Belsky J....Williams R. (Mol. Psychiatry 2009)
    732. The neuroprotective mechanism of action of the multimodal drug ladostigil. (PubMed id 18508575)9 Weinreb O....Youdim M.B. (Front. Biosci. 2008)
    733. The pH dependence of kinetic isotope effects in monoamine oxidase A indicates stabilization of the neutral amine in the enzyme-substrate complex. (PubMed id 18573102)9 Dunn R.V....Scrutton N.S. (FEBS J. 2008)
    734. Novel monoamine oxidase A knock out mice with human-like spontaneous mutation. (PubMed id 18418249)9 Scott A.L....Shih J.C. (Neuroreport 2008)
    735. X-LRT: a likelihood approach to estimate genetic risks and test association with X-linked markers using a case-parents design. (PubMed id 18278816)9 Zhang L....Morris R.W. (Genet. Epidemiol. 2008)
    736. Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. (PubMed id 18834112)9 Santana L....Orallo F. (J. Med. Chem. 2008)
    737. Inhibition of vascular adhesion protein-1 suppresses endotoxin-induced uveitis. (PubMed id 18032635)9 Noda K....Hafezi-Moghadam A. (FASEB J. 2008)
    738. [Potential genetic predictors for individual vulnerability to substance dependence]. (PubMed id 18411704)9 Ujike H. (Nihon Shinkei Seishin Yakurigaku Zasshi 2008)
    739. Epigenetic alterations of the dopaminergic system in major psychiatric disorders. (PubMed id 18370235)9 Abdolmaleky H.M....Thiagalingam S. (Methods Mol. Biol. 2008)
    740. Structural and mechanistic studies of arylalkylhydrazine inhibition of human monoamine oxidases A and B. (PubMed id 18426226)9 Binda C....Edmondson D.E. (Biochemistry 2008)
    741. Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth. (PubMed id 19010890)9 Alpini G....DeMorrow S. (Cancer Res. 2008)
    742. Synthesis, structure-activity relationships and molecular modeling studies of new indole inhibitors of monoamine oxidases A and B. (PubMed id 18951803)9 La Regina G....Agostinelli E. (amp 2008)
    743. Is fetal brain monoamine oxidase inhibition the missing link between maternal smoking and conduct disorders? (PubMed id 18592036)9 Baler R.D....Benveniste H. (amp 2008)
    744. Desistance from delinquency: the marriage effect revisited and extended. (PubMed id 19086113)9 Beaver K.M....Vaughn M.G. (Soc Sci Res 2008)
    745. Synthesis and monoamine oxidase inhibitory activities of 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-1H-pyrazole derivatives. (PubMed id 18266289)9 Palaska E....Erol D. (Arch. Pharm. (Weinheim) 2008)
    746. Mutations in human monoamine-related neurotransmitter pathway genes. (PubMed id 18444257)9 Haavik J....ThAPny B. (Hum. Mutat. 2008)
    747. Modification of L-DOPA pharmacological activity by MAO inhibitors. (PubMed id 17417741)9 Finberg J.P. and Sader-Mazbar O. (J Neural Transm 2007)
    748. Identification of genes with correlated patterns of variations in DNA copy number and gene expression level in gastric cancer. (PubMed id 17229543)9 Yang S....Chung H.C. (Genomics 2007)
    749. Identification and occurrence of beta-carboline alkaloids in raisins and inhibition of monoamine oxidase (MAO). (PubMed id 17883257)9 Herraiz T. (J. Agric. Food Chem. 2007)
    750. Selegiline transdermal system: in the treatment of major depressive disorder. (PubMed id 17284087)9 Frampton J.E. and Plosker G.L. (Drugs 2007)
    751. Monoamine oxidase A and B inhibitors in Parkinson's disease. (PubMed id 18808943)9 Youdim M.B. and Riederer P.F. (Handb Clin Neurol 2007)
    752. [Advances on comprehensive research on attention deficit hyperactivity disorder (review)]. (PubMed id 17572793)9 Qian Q.J....Wang Y.F. (Beijing Da Xue Xue Bao 2007)
    753. In vitro metabolism of the analgesic bicifadine in the mouse, rat, monkey, and human. (PubMed id 17881661)9 Erickson D.A....Krieter P.A. (Drug Metab. Dispos. 2007)
    754. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis. (PubMed id 17681180)9 Nocito A....Clavien P.A. (Gastroenterology 2007)
    755. Meta-analysis of gene-environment interactions in developmental psychopathology. (PubMed id 17931432)9 Taylor A. and Kim-Cohen J. (Dev. Psychopathol. 2007)
    756. Factors affecting the relative importance of amine oxidases and monooxygenases in the in vivo metabolism of xenobiotic amines in humans. (PubMed id 17401530)9 Strolin Benedetti M....Baltes E. (J Neural Transm 2007)
    757. Biogenic amine synthesis and uptake in rodent taste buds. (PubMed id 17879273)9 Dvoryanchikov G....Chaudhari N. (J. Comp. Neurol. 2007)
    758. Interactions of imidazoline ligands with the active site of purified monoamine oxidase A. (PubMed id 17480205)9 Jones T.Z....Ramsay R.R. (FEBS J. 2007)
    759. Characterization of the covalently bound anionic flavin radical in monoamine oxidase a by electron paramagnetic resonance. (PubMed id 18044898)9 Kay C.W....Ramsay R.R. (J. Am. Chem. Soc. 2007)
    760. Renal albumin excretion: twin studies identify influences of heredity, environment, and adrenergic pathway polymorphism. (PubMed id 17353515)9 Rao F....O'Connor D.T. (Hypertension 2007)
    761. Bad nature, bad nurture, and testimony regarding MAOA and SLC6A4 genotyping at murder trials. (PubMed id 17944904)9 Bernet W....Montgomery S.A. (J. Forensic Sci. 2007)
    762. Variations in activity and inhibition with pH: the protonated amine is the substrate for monoamine oxidase, but uncharged inhibitors bind better. (PubMed id 17401535)9 Jones T.Z....Ramsay R.R. (J Neural Transm 2007)
    763. Effects of a tyramine-enriched meal on blood pressure response in healthy male volunteers treated with selegiline transdermal system 6 mg/24 hour. (PubMed id 17192761)9 Blob L.F....Azzaro A.J. (CNS Spectr 2007)
    764. Structural insights into the mechanism of amine oxidation by monoamine oxidases A and B. (PubMed id 17573034)9 Edmondson D.E....Mattevi A. (Arch. Biochem. Biophys. 2007)
    765. Evaluation of the potential for pharmacodynamic and pharmacokinetic drug interactions between selegiline transdermal system and two sympathomimetic agents (pseudoephedrine and phenylpropanolamine) in healthy volunteers. (PubMed id 17554106)9 Azzaro A.J....Campbell B.J. (J Clin Pharmacol 2007)
    766. Nature and nurture predispose to violent behavior: serotonergic genes and adverse childhood environment. (PubMed id 17342170)9 Reif A....Retz W. (Neuropsychopharmacology 2007)
    767. Structural insights into monoamine oxidase inhibitory potency and selectivity of 7-substituted coumarins from ligand- and target-based approaches. (PubMed id 16884303)9 Catto M....Carotti A. (J. Med. Chem. 2006)
    768. Metabolism of nomifensine to a dihydroisoquinolinium ion metabolite by human myeloperoxidase, hemoglobin, monoamine oxidase A, and cytochrome P450 enzymes. (PubMed id 16679384)9 Obach R.S. and Dalvie D.K. (Drug Metab. Dispos. 2006)
    769. Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cells. (PubMed id 17447416)9 Nagatsu T. and Sawada M. (J. Neural Transm. Suppl. 2006)
    770. Estrogen-related receptors-stimulated monoamine oxidase B promoter activity is down-regulated by estrogen receptors. (PubMed id 16484337)9 Zhang Z....Teng C.T. (Mol. Endocrinol. 2006)
    771. Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness. (PubMed id 16402116)9 Youdim M.B. and Bakhle Y.S. (Br. J. Pharmacol. 2006)
    772. Human monoamine oxidase enzyme inhibition by coffee and beta-carbolines norharman and harman isolated from coffee. (PubMed id 16139309)9 Herraiz T. and Chaparro C. (Life Sci. 2006)
    773. [Genetic background of ADHD: population studies, genes of the catecholamine system]. (PubMed id 16756025)9 SA8opiAcn A....Hauser J. (Psychiatr. Pol. 2006)
    774. Synthesis, biological evaluation and 3D-QSAR of 1,3,5-trisubstituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase A inhibitors. (PubMed id 16719786)9 Chimenti F....Langer T. (Curr. Med. Chem. 2006)
    775. A molecular correlate to the Gleason grading system for prostate adenocarcinoma. (PubMed id 16829574)9 True L....Nelson P.S. (Proc. Natl. Acad. Sci. U.S.A. 2006)
    776. Functional role of the &quot;aromatic cage&quot; in human monoamine oxidase B: structures and catalytic properties of Tyr435 mutant proteins. (PubMed id 16605246)9 Li M....Edmondson D.E. (Biochemistry 2006)
    777. Involvement of type A monoamine oxidase in neurodegeneration: regulation of mitochondrial signaling leading to cell death or neuroprotection. (PubMed id 17447417)9 Naoi M....Yamaoka Y. (J. Neural Transm. Suppl. 2006)
    778. Design, synthesis, and biological evaluation of semicarbazide-sensitive amine oxidase (SSAO) inhibitors with anti-inflammatory activity. (PubMed id 16570912)9 Wang E.Y....Linnik M.D. (J. Med. Chem. 2006)
    779. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. (PubMed id 17088501)9 Meyer J.H....Houle S. (Arch. Gen. Psychiatry 2006)
    780. Molecular genetics of bipolar disorder. (PubMed id 16436192)9 Hayden E.P. and Nurnberger J.I. (Genes Brain Behav. 2006)
    781. Genetic and environmental influences on the development of alcoholism: resilience vs. risk. (PubMed id 17347351)9 Enoch M.A. (Ann. N. Y. Acad. Sci. 2006)
    782. Moclobemide upregulated Bcl-2 expression and induced neural stem cell differentiation into serotoninergic neuron via extracellular-regulated kinase pathway. (PubMed id 16702990)9 Chiou S.H....Chang Y.L. (Br. J. Pharmacol. 2006)
    783. The imidazoline I2-site ligands BU 224 and 2-BFI inhibit MAO-A and MAO-B activities, hydrogen peroxide production, and lipolysis in rodent and human adipocytes. (PubMed id 17056035)9 Bour S....CarpAcnAc C. (Eur. J. Pharmacol. 2006)
    784. Pharmacotherapy of social anxiety disorder: what does the evidence tell us? (PubMed id 17092192)9 Davidson J.R. (J Clin Psychiatry 2006)
    785. Translational neuroimaging: positron emission tomography studies of monoamine oxidase. (PubMed id 16265597)9 Fowler J.S....Wang G.J. (Mol Imaging Biol 2005)
    786. Mechanistic pharmacokinetic and pharmacodynamic modeling of CHF3381 (2-[(2,3-dihydro-1H-inden-2-yl)amino]acetamide monohydrochloride), a novel N-methyl-D-aspartate antagonist and monoamine oxidase-A inhibitor in healthy subjects. (PubMed id 15671203)9 Csajka C....Verotta D. (J. Pharmacol. Exp. Ther. 2005)
    787. Orientation of oxazolidinones in the active site of monoamine oxidase. (PubMed id 15950194)9 Jones T.Z....Ramsay R.R. (Biochem. Pharmacol. 2005)
    788. Acute inhibition of cardiac monoamine oxidase A after tobacco smoke inhalation: validation study of [11C]befloxatone in rats followed by a positron emission tomography application in baboons. (PubMed id 15833896)9 Valette H....Syrota A. (J. Pharmacol. Exp. Ther. 2005)
    789. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide. (PubMed id 15804499)9 Freezer A....Irvine R.J. (Brain Res. 2005)
    790. Mutation of surface cysteine 374 to alanine in monoamine oxidase A alters substrate turnover and inactivation by cyclopropylamines. (PubMed id 15848762)9 VintAcm A.P....Ramsay R.R. (amp 2005)
    791. Social anxiety disorder : current treatment recommendations. (PubMed id 15907150)9 Muller J.E....Stein D.J. (CNS Drugs 2005)
    792. Steady-state pharmacokinetics and pharmacodynamics of CHF3381, a novel antineuropathic pain agent, in healthy subjects. (PubMed id 15801935)9 Astruc B....Imbimbo B.P. (Br J Clin Pharmacol 2005)
    793. Interdependent serotonin transporter and receptor pathways regulate S100A4/Mts1, a gene associated with pulmonary vascular disease. (PubMed id 16002749)9 Lawrie A....Rabinovitch M. (Circ. Res. 2005)
    794. Serotonin and aggressive behavior in rodents and nonhuman primates: predispositions and plasticity. (PubMed id 16289029)9 Ferrari P.F....Miczek K.A. (Eur. J. Pharmacol. 2005)
    795. Fast and slow metabolizers of Hoasca. (PubMed id 16149329)9 Callaway J.C. (J Psychoactive Drugs 2005)
    796. Identification of 4-substituted 1,2,3-triazoles as novel oxazolidinone antibacterial agents with reduced activity against monoamine oxidase A. (PubMed id 15658863)9 Reck F....Gravestock M.B. (J. Med. Chem. 2005)
    797. Human monoamine oxidase is inhibited by tobacco smoke: beta-carboline alkaloids act as potent and reversible inhibitors. (PubMed id 15582589)9 Herraiz T. and Chaparro C. (Biochem. Biophys. Res. Commun. 2005)
    798. A genetic analysis of serotonergic biosynthetic and metabolic enzymes in migraine using a DNA pooling approach. (PubMed id 16200390)9 Johnson M.P. and Griffiths L.R. (J. Hum. Genet. 2005)
    799. Molecular characterization of monoamine oxidase in zebrafish (Danio rerio). (PubMed id 15621520)9 Setini A....Nicotra A. (amp 2005)
    800. Fluorinated phenylcyclopropylamines. Part 4: effects of aryl substituents and stereochemistry on the inhibition of monoamine oxidases by 1-aryl-2-fluoro-cyclopropylamines. (PubMed id 15755651)9 Ye S....Kirk K.L. (amp 2005)
    801. Synthesis of novel N-substituted imidazolecarboxylic acid hydrazides as monoamine oxidase inhibitors. (PubMed id 15784243)9 Hadizadeh F. and Ghodsi R. (Farmaco 2005)
    802. Association analysis of the monoamine oxidase A and B genes with attention deficit hyperactivity disorder (ADHD) in an Irish sample: preferential transmission of the MAO-A 941G allele to affected children. (PubMed id 15717295)9 Domschke K....Hawi Z. (Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005)
    803. Demonstration of isoleucine 199 as a structural determinant for the selective inhibition of human monoamine oxidase B by specific reversible inhibitors. (PubMed id 15710600)9 Hubalek F....Edmondson D.E. (J. Biol. Chem. 2005)
    804. Genetic features of antidepressant induced mania and hypo-mania in bipolar disorder. (PubMed id 15248044)9 Serretti A....Catalano M. (Psychopharmacology (Berl.) 2004)
    805. Uptake and metabolism of serotonin by ependymal primary cultures. (PubMed id 15453270)9 Verleysdonk S....Wellard J. (Neurochem. Res. 2004)
    806. Calcitonin gene-related peptide facilitates serotonin release from guinea-pig colonic mucosa via myenteric neurons and tachykinin NK2/NK3 receptors. (PubMed id 14718265)9 Kojima S....Kamikawa Y. (Br. J. Pharmacol. 2004)
    807. Dopamine toxicity involves mitochondrial complex I inhibition: implications to dopamine-related neuropsychiatric disorders. (PubMed id 15130772)9 Ben-Shachar D....Ljubuncic P. (Biochem. Pharmacol. 2004)
    808. Gender in obsessive-compulsive disorder: clinical and genetic findings. (PubMed id 15013025)9 Lochner C....Stein D.J. (Eur Neuropsychopharmacol 2004)
    809. Clinical pharmacology of MAO inhibitors: safety and future. (PubMed id 14697896)9 Yamada M. and Yasuhara H. (Neurotoxicology 2004)
    810. Effect of oral linezolid on the pressor response to intravenous tyramine. (PubMed id 15521893)9 Cantarini M.V....Hughes A.M. (Br J Clin Pharmacol 2004)
    811. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation. (PubMed id 14697899)9 Youdim M.B. and Weinstock M. (Neurotoxicology 2004)
    812. Conserved elements of the cytochrome P-450 superfamily found in monoamine oxidase B. (PubMed id 14697882)9 Lewis D.A....Abell C.W. (Neurotoxicology 2004)
    813. HPLC-based bioactivity profiling of plant extracts: a kinetic assay for the identification of monoamine oxidase-A inhibitors using human recombinant monoamine oxidase-A. (PubMed id 15501256)9 Dittmann K....Hamburger M. (Phytochemistry 2004)
    814. Tribulin and endogenous MAO-inhibitory regulation in vivo. (PubMed id 14697893)9 Medvedev A.E. and Glover V. (Neurotoxicology 2004)
    815. Structure and mechanism of monoamine oxidase. (PubMed id 15279562)9 Edmondson D.E....HubA!lek F. (Curr. Med. Chem. 2004)
    816. [A search for psychobiological determinants of anxiety disorders]. (PubMed id 16529167)9 Hajduk A. (Ann Acad Med Stetin 2004)
    817. Corrigendum to &quot;gender in obsessive-compulsive disorder: clinical and genetic findings&quot; [Eur. Neuropsychopharmacol. 14 (2004) 105-113]. (PubMed id 15468463)9 Lochner C....Stein D.J. (Eur Neuropsychopharmacol 2004)
    818. Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women. (PubMed id 15009906)9 Domschke K....Deckert J. (Int. J. Neuropsychopharmacol. 2004)
    819. [Molecular pharmacogenetic studies of drug responses to obsessive-compulsive disorder and six functional genes]. (PubMed id 15476175)9 Zhang L....Collier D. (Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2004)
    820. Synthesis of 4-methyl-thio-phenyl-propylamine and the evaluation of its interaction with different amine oxidases. (PubMed id 14697793)9 Gallardo-Godoy A....Unzeta M. (amp 2004)
    821. Computer visualisation of the active site of monoamine oxidase-A by means of selective inhibitors. (PubMed id 15035815)9 Medvedev A.E....Veselovsky A.V. (Inflammopharmacology 2003)
    822. Simple, potent, and selective pyrrole inhibitors of monoamine oxidase types A and B. (PubMed id 12620068)9 Silvestri R....Turini P. (J. Med. Chem. 2003)
    823. Experimental gene interaction studies with SERT mutant mice as models for human polygenic and epistatic traits and disorders. (PubMed id 14653307)9 Murphy D.L....Lesch K.P. (Genes Brain Behav. 2003)
    824. Effects of human growth hormone (hrGH) treatment on amine metabolism in rats subjected to extensive small bowel resection. (PubMed id 12624735)9 Fogel W.A....Andrzejewski W. (Amino Acids 2003)
    825. Molecular genetics in the analysis of suicide. (PubMed id 12822741)9 Souery D....Mendlewicz J. (Ann. Med. 2003)
    826. Demonstration of high monoaminoxidase-A levels in neuroendocrine gastroenteropancreatic tumors in vitro and in vivo-tumor visualization using positron emission tomography with 11C-harmine. (PubMed id 12900293)9 Orlefors H....BergstrAPm M. (Nucl. Med. Biol. 2003)
    827. 1-methyl-2-undecyl-4(1H)-quinolone as an irreversible and selective inhibitor of type B monoamine oxidase. (PubMed id 12672993)9 Lee M.K....Ro J.S. (amp 2003)
    828. Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism. (PubMed id 12895680)9 Schwarz M.J....Lees A.D. (Pharmacol. Biochem. Behav. 2003)
    829. Dosage-sensitive X-linked locus influences the development of amygdala and orbitofrontal cortex, and fear recognition in humans. (PubMed id 12958079)9 Good C.D....Skuse D.H. (Brain 2003)
    830. Moclobemide: therapeutic use and clinical studies. (PubMed id 12595913)9 Bonnet U. (CNS Drug Rev 2003)
    831. Interactions of D-amphetamine with the active site of monoamine oxidase-A. (PubMed id 15035814)9 Ramsay R.R. and Hunter D.J. (Inflammopharmacology 2003)
    832. Synthesis and in vivo imaging properties of [11C]befloxatone: a novel highly potent positron emission tomography ligand for mono-amine oxidase-A. (PubMed id 12729662)9 Dolle F....Bottlaender M. (amp 2003)
    833. Mapping the cerebral monoamine oxidase type A: positron emission tomography characterization of the reversible selective inhibitor [11C]befloxatone. (PubMed id 12606609)9 Bottlaender M....Valette H. (J. Pharmacol. Exp. Ther. 2003)
    834. Decreased methylation and transcription repressor Sp3 up-regulated human monoamine oxidase (MAO) B expression during Caco-2 differentiation. (PubMed id 12855685)9 Wong W.K....Shih J.C. (J. Biol. Chem. 2003)
    835. Pathogenesis of hepatic encephalopathy: update on molecular mechanisms. (PubMed id 15025246)9 Butterworth R.F. (Indian J Gastroenterol 2003)
    836. Expression profiling of osteosarcoma cells transfected with MDR1 and NEO genes: regulation of cell adhesion, apoptosis, and tumor suppression-related genes. (PubMed id 12695554)9 Sanchez-Carbayo M....Cordon-Cardo C. ( a journal of technical methods and pathology 2003)
    837. Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial. (PubMed id 14531724)9 Stalker D.J. and Jungbluth G.L. (Clin Pharmacokinet 2003)
    838. [Molecular genetics of mood disorders]. (PubMed id 12451683)9 Ikeda M....Ozaki N. (Nihon Shinkei Seishin Yakurigaku Zasshi 2002)
    839. Ovarian steroid regulation of monoamine oxidase-A and -B mRNAs in the macaque dorsal raphe and hypothalamic nuclei. (PubMed id 11889496)9 Gundlah C....Bethea C.L. (Psychopharmacology (Berl.) 2002)
    840. Assessing the molecular genetics of attention networks. (PubMed id 12366871)9 Fossella J....Posner M.I. (BMC Neurosci 2002)
    841. Treatment of comorbid opiate addiction and attention-deficit hyperactivity disorder (residual type) with moclobemide: a case report. (PubMed id 11999916)9 Vaiva G....Bailly D. (amp 2002)
    842. Monoamine oxidase: radiotracer development and human studies. (PubMed id 12183115)9 Fowler J.S....Ding Y.S. (Methods 2002)
    843. Monoamine oxidase inhibitors: a new generation. (PubMed id 12473970)9 Robinson D.S. (Psychopharmacol Bull 2002)
    844. Antisocial alcoholism and serotonin-related polymorphisms: association tests. (PubMed id 12218658)9 Hill E.M....Burmeister M. (Psychiatr. Genet. 2002)
    845. In vitro biotransformation of the selective serotonin reuptake inhibitor citalopram, its enantiomers and demethylated metabolites by monoamine oxidase in rat and human brain preparations. (PubMed id 11840311)9 Kosel M....Baumann P. (Mol. Psychiatry 2002)
    846. Pharmacotherapy of social anxiety disorder. (PubMed id 11801236)9 Blanco C....Liebowitz M.R. (Biol. Psychiatry 2002)
    847. Effect of TV3326, a novel monoamine-oxidase cholinesterase inhibitor, in rat models of anxiety and depression. (PubMed id 11889501)9 Weinstock M....Youdim M.B. (Psychopharmacology (Berl.) 2002)
    848. Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease. (PubMed id 12431053)9 Sterling J....Weinstock M. (J. Med. Chem. 2002)
    849. The pharmacokinetics of sumatriptan when administered with clarithromycin in healthy volunteers. (PubMed id 12017403)9 Moore K.H....Sale M. (Clin Ther 2002)
    850. Moclobemide in the treatment of hot flashes in postmenopausal women. (PubMed id 12665046)9 Tarim E....Kuscu E. (Adv Ther 2002)
    851. Analysis of ten candidate genes in autism by association and linkage. (PubMed id 11857571)9 Philippe A....Leboyer M. (Am. J. Med. Genet. 2002)
    852. Monoamine oxidase A and B activities in embryonic chick hepatocytes: differential regulation by retinoic acid. (PubMed id 11979502)9 Nicotra A....Conti Devirgiliis L. (Cell Biochem. Funct. 2002)
    853. Serotonergic pathway genes and subtypes of alcoholism: association studies. (PubMed id 11525423)9 Parsian A. and Cloninger C.R. (Psychiatr. Genet. 2001)
    854. Molecular genetics of bipolar disorder. (PubMed id 11377748)9 Kato T. (Neurosci. Res. 2001)
    855. Efficacy and tolerability of moclobemide in bulimia nervosa: a placebo-controlled trial. (PubMed id 11195257)9 Carruba M.O....Nisoli E. (Int Clin Psychopharmacol 2001)
    856. Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase. (PubMed id 11543689)9 BrA1hlmann C....Carotti A. (J. Med. Chem. 2001)
    857. Inhibition of MAO-A fails to alter cocaine-induced increases in extracellular dopamine and norepinephrine in rat nucleus accumbens. (PubMed id 11245920)9 Pepper J.P....Rothman R.B. (Brain Res. Mol. Brain Res. 2001)
    858. Effects of histamine H3-receptor ligands on brain monoamine oxidase in various mammalian species. (PubMed id 11430877)9 Sakurai E....Oreland L. (Brain Res. 2001)
    859. Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study. (PubMed id 11449400)9 Payton A....Thapar A. (Am. J. Med. Genet. 2001)
    860. Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized, double blind trial. (PubMed id 11297592)9 Then Bergh F....Trenkwalder C. (J. Clin. Endocrinol. Metab. 2001)
    861. Candidate gene studies of bipolar disorder. (PubMed id 11405546)9 Jones I. and Craddock N. (Ann. Med. 2001)
    862. Neurotransmitter dysfunction in hepatic encephalopathy: new approaches and new findings. (PubMed id 11726089)9 Butterworth R.F. (Metab Brain Dis 2001)
    863. Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease. (PubMed id 11326308)9 MAPssner R....Lesch K.P. (Mol. Psychiatry 2001)
    864. Cardiovascular sympathomimetic amine interactions in rats treated with monoamine oxidase inhibitors and the novel oxazolidinone antibiotic linezolid. (PubMed id 11336106)9 Humphrey S.J....Stryd R.P. (J. Cardiovasc. Pharmacol. 2001)
    865. Catecholamine monoamine oxidase a metabolite in adrenergic neurons is cytotoxic in vivo. (PubMed id 11164826)9 Burke W.J....Ruggiero D.A. (Brain Res. 2001)
    866. [A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors]. (PubMed id 11481866)9 Maki Y. (Hokkaido Igaku Zasshi 2001)
    867. Spectrometric evidence for the flavin-1-phenylcyclopropylamine inactivator adduct with monoamine oxidase N. (PubMed id 11331009)9 Mitchell D.J....Silverman R.B. (Biochemistry 2001)
    868. Analysis of 4-methylthioamphetamine in clinical specimens. (PubMed id 11471875)9 Elliott S.P. (Ann. Clin. Biochem. 2001)
    869. Production and metabolism of serotonin (5-HT) by the human adrenal cortex: paracrine stimulation of aldosterone secretion by 5-HT. (PubMed id 11600577)9 Lefebvre H....Kuhn J.M. (J. Clin. Endocrinol. Metab. 2001)
    870. Association studies of bipolar disorder. (PubMed id 11843779)9 Craddock N....Greening J. (Bipolar Disord 2001)
    871. Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19. (PubMed id 11309556)9 Yu K.S....Shin S.G. (Clin. Pharmacol. Ther. 2001)
    872. Predictors of treatment response in patients with posttraumatic stress disorder. (PubMed id 11294480)9 Connor K.M....Davidson J.R. (amp 2001)
    873. Role of monoamine oxidase inhibition and monoamine depletion in fenfluramine-induced neurotoxicity and serotonin release. (PubMed id 11881977)9 Halladay A.K....Wagner G.C. (amp 2001)
    874. Non-MAO A binding of clorgyline in white matter in human brain. (PubMed id 11739617)9 Fowler J.S....Zhu W. (J. Neurochem. 2001)
    875. Clinically significant drug interactions with agents specific for migraine attacks. (PubMed id 11460889)9 Eadie M.J. (CNS Drugs 2001)
    876. Mild learning difficulties and offending behaviour--is there a link with monoamine oxidase A deficiency? (PubMed id 11702062)9 Stamps V.R....Gurling H.M. (Psychiatr. Genet. 2001)
    877. Characterization of a major form of human isatin reductase and the reduced metabolite. (PubMed id 11722560)9 Usami N....Hara A. (Eur. J. Biochem. 2001)
    878. The covalent FAD of monoamine oxidase: structural and functional role and mechanism of the flavinylation reaction. (PubMed id 11761328)9 Edmondson D.E. and Newton-Vinson P. (amp 2001)
    879. Molecular determinants of MAO selectivity in a series of indolylmethylamine derivatives: biological activities, 3D-QSAR/CoMFA analysis, and computational simulation of ligand recognition. (PubMed id 10794685)9 MorA^n J.A....Pardo L. (J. Med. Chem. 2000)
    880. A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers. (PubMed id 10867119)9 JAPnsson E.G....Sedvall G.C. (J Psychiatr Res 2000)
    881. Inhibition of monoamine oxidases by functionalized coumarin derivatives: biological activities, QSARs, and 3D-QSARs. (PubMed id 11123983)9 Gnerre C....Testa B. (J. Med. Chem. 2000)
    882. Adrenergic and noradrenergic plasma levels in Lesch-Nyhan disease. (PubMed id 10693160)9 Ernst M....Cohen R.M. (Neuropsychopharmacology 2000)
    883. Use of PET in neuroendocrine tumors. In vivo applications and in vitro studies. (PubMed id 10932603)9 Eriksson B....LAYngstrAPm B. (Q J Nucl Med 2000)
    884. Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults. The Australian and German Study Groups. (PubMed id 10974600)9 Philipp M....Kohnen R. (Eur Neuropsychopharmacol 2000)
    885. A randomized, double-blind placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome. (PubMed id 11030484)9 Hickie I.B....Lloyd A.R. (J Clin Psychiatry 2000)
    886. The FAD binding sites of human liver monoamine oxidases A and B: investigation of the role of flavin ribityl side chain hydroxyl groups in the covalent flavinylation reaction and catalytic activities. (PubMed id 10606764)9 Miller J.R....Edmondson D.E. (Biochim. Biophys. Acta 2000)
    887. [The influence of genes on the development of personality]. (PubMed id 10853361)9 Samochowiec J....Horodnicki J. (Psychiatr. Pol. 2000)
    888. An association between a polymorphism of the tryptophan hydroxylase gene and aggression in schizophrenia and schizoaffective disorder. (PubMed id 11204346)9 Nolan K.A....Saito T. (Psychiatr. Genet. 2000)
    889. Transport and metabolism of serotonin in the human placenta from normal and severely pre-eclamptic pregnancies. (PubMed id 10729753)9 Carrasco G....GonzA!lez C. (Gynecol. Obstet. Invest. 2000)
    890. [Seasonal characteristics of the monoaminergic regulation of the behavior of hibernating animals]. (PubMed id 11081224)9 Semenova T.P....Kolaeva S.G. (Ross Fiziol Zh Im I M Sechenova 2000)
    891. [Study on molecular mechanism of ganyang shangkang syndrome in hypertension]. (PubMed id 11783321)9 Jin Y....Yan D. (Zhongguo Zhong Xi Yi Jie He Za Zhi 2000)
    892. Variability and validity of polymorphism association studies in Parkinson's disease. (PubMed id 10953187)9 Tan E.K....Ashizawa T. (Neurology 2000)
    893. Genetic associations with clinical characteristics in bipolar affective disorder and recurrent unipolar depressive disorder. (PubMed id 10686549)9 Ho L.W....Rubinsztein D.C. (Am. J. Med. Genet. 2000)
    894. Complications of cirrhosis III. Hepatic encephalopathy. (PubMed id 10728803)9 Butterworth R.F. (J. Hepatol. 2000)
    895. Rasagiline, a monoamine oxidase-B inhibitor, protects NGF-differentiated PC12 cells against oxygen-glucose deprivation. (PubMed id 10518120)9 Abu-Raya S....Lazarovici P. (J. Neurosci. Res. 1999)
    896. Moclobemide treatment in multiple sclerosis patients with comorbid depression: an open-label safety trial. (PubMed id 10334000)9 Barak Y....Achiron A. (J Neuropsychiatry Clin Neurosci 1999)
    897. Monoamine oxidase: from genes to behavior. (PubMed id 10202537)9 Shih J.C....Ridd M.J. (Annu. Rev. Neurosci. 1999)
    898. Sixth World Congress of Psychiatric Genetics X Chromosome Workshop. (PubMed id 10374746)9 Paterson A.D. (Am. J. Med. Genet. 1999)
    899. Social anxiety disorder: designing a pharmacologic treatment strategy. (PubMed id 10335676)9 Pollack M.H. (J Clin Psychiatry 1999)
    900. Regulation of heme oxygenase-1 expression by dopamine in cultured C6 glioma and primary astrocytes. (PubMed id 10581397)9 Schmidt J....Morgan J.I. (Brain Res. Mol. Brain Res. 1999)
    901. Benzylamine analog binding studies as probes of the substrate sites of monoamine oxidases A and B. (PubMed id 10065374)9 Edmondson D.E. (Drug Metab. Rev. 1999)
    902. Structure-activity relationships in the oxidation of para-substituted benzylamine analogues by recombinant human liver monoamine oxidase A. (PubMed id 10521274)9 Miller J.R. and Edmondson D.E. (Biochemistry 1999)
    903. Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives. (PubMed id 10525109)9 Inoue H....Castagnoli N. (J. Pharmacol. Exp. Ther. 1999)
    904. Social phobia: diagnosis, severity and implications for treatment. (PubMed id 10361959)9 Montgomery S.A. (Eur Arch Psychiatry Clin Neurosci 1999)
    905. Pharmacokinetics of Hoasca alkaloids in healthy humans. (PubMed id 10404423)9 Callaway J.C....Mash D.C. (J Ethnopharmacol 1999)
    906. Befloxatone (Synthelabo). (PubMed id 16160936)9 Emilien G. (IDrugs 1999)
    907. Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression. (PubMed id 9987207)9 Ramasubbu R. (amp 1999)
    908. Moclobemide in patients with dementia and depression. (PubMed id 10410765)9 Amrein R....Cameron A.M. (Adv Neurol 1999)
    909. Inversion of selectivity of N-substituted propargylamine monoamine oxidase inhibitors following structural modifications to quaternary salts. (PubMed id 10641793)9 Yu P.H. and Davis B.A. (amp 1999)
    910. Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistas. (PubMed id 10357046)9 Brunello N....Wessely S. (J Affect Disord 1999)
    911. Imaging the neurochemistry of nicotine actions: studies with positron emission tomography. (PubMed id 11768169)9 Volkow N.D....Gatley S.J. (amp 1999)
    912. Hepatic encephalopathy: An update of pathophysiologic mechanisms. (PubMed id 10564534)9 Hazell A.S. and Butterworth R.F. (Proc. Soc. Exp. Biol. Med. 1999)
    913. A reversible monoamine oxidase A inhibitor, befloxatone: structural approach of its mechanism of action. (PubMed id 10482460)9 Wouters J....Durant F. (amp 1999)
    914. Unified approach to the analysis of genetic variation in serotonergic pathways. (PubMed id 10581480)9 Marshall S.E.... Welsh K.I. (Am. J. Med. Genet. 1999)
    915. MAO-A and -B gene knock-out mice exhibit distinctly different behavior. (PubMed id 10591056)9 Shih J.C. and Chen K. (Neurobiology (Bp) 1999)
    916. Inhibition of monoamine oxidase by pirlindole analogues: 3D-QSAR analysis. (PubMed id 10591049)9 Medvedev A.E....Axenova L.N. (Neurobiology (Bp) 1999)
    917. In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. (PubMed id 10537016)9 Schallreuter K.U....Hibberts N.A. (J. Investig. Dermatol. Symp. Proc. 1999)
    918. Effects of aging and glucocorticoid treatment on monoamine oxidase subtypes in rat cerebral cortex: therapeutic implications. (PubMed id 9886786)9 Slotkin T.A....Ritchie J.C. (Brain Res. Bull. 1998)
    919. The monoamine oxidase-A gene and major psychosis in Japanese subjects. (PubMed id 9807650)9 Sasaki T....Nanko S. (Biol. Psychiatry 1998)
    920. Allelic association between dinucleotide repeats at the monoamine oxidase loci and schizophrenia. (PubMed id 19698656)9 Wei J. and Hammings G. (Eur. Psychiatry 1998)
    921. Serotonin syndrome: history and risk. (PubMed id 9794145)9 Gillman P.K. (amp 1998)
    922. Monoamine oxidase activities in human cystic and colonic arteries--influence of age. (PubMed id 9564621)9 Figueiredo I.V....Callingham B.A. (J. Neural Transm. Suppl. 1998)
    923. A higher frequency of a low activity-related allele of the MAO-A gene in females with obsessive-compulsive disorder. (PubMed id 9861646)9 Camarena B....Nicolini H. (Psychiatr. Genet. 1998)
    924. Experience with tranylcypromine in early Parkinson's disease. (PubMed id 9564607)9 Fahn S. and Chouinard S. (J. Neural Transm. Suppl. 1998)
    925. Comparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man. (PubMed id 9663810)9 Bitsios P....Bradshaw C.M. (Br J Clin Pharmacol 1998)
    926. Norepinephrine transmitter metabolite generates free radicals and activates mitochondrial permeability transition: a mechanism for DOPEGAL-induced apoptosis. (PubMed id 9518674)9 Burke W.J....Lin T.S. (Brain Res. 1998)
    927. Detection and analysis of four polymorphic markers at the human monoamine oxidase (MAO) gene in Japanese controls and patients with Parkinson's disease. (PubMed id 9642149)9 Nakatome M....Honda K. (Biochem. Biophys. Res. Commun. 1998)
    928. Placebo-controlled trial of moclobemide in social phobia. (PubMed id 9534836)9 Schneier F.R....Liebowitz M.R. (Br J Psychiatry 1998)
    929. Clinical pharmacology of befloxatone: a brief review. (PubMed id 10333984)9 Rosenzweig P....Legangneux E. (J Affect Disord 1998)
    930. Selective inhibitors of monoamine oxidase (MAO). 5. 1-Substituted phenoxathiin inhibitors containing no nitrogen that inhibit MAO A by binding it to a hydrophobic site. (PubMed id 9622553)9 Harfenist M....White H.L. (J. Med. Chem. 1998)
    931. Type B monoamine oxidase activity in human brain malignant tumors. (PubMed id 10072212)9 Marcozzi G....MondovA- B. (Cancer Biochem. Biophys. 1998)
    932. [Change of tryptophan hydroxylase and monoamine oxidase A activities in experimental depression induced by social confrontation]. (PubMed id 9891212)9 Avgustinovich D.F....Kudriavtseva N.N. (Dokl. Akad. Nauk. 1998)
    933. The influence of the antidepressant pirlindole and its dehydro-derivative on the activity of monoamine oxidase A and GABAA receptor binding. (PubMed id 9564636)9 Medvedev A.E....Squires R.F. (J. Neural Transm. Suppl. 1998)
    934. Evaluation of efficacies of different classes of antidepressants in the forced swimming test in mice at different ages. (PubMed id 9608606)9 Bourin M....Baker G.B. (amp 1998)
    935. Regional and molecular separation of the four bioactivities of 'tribulin'. (PubMed id 9488167)9 Hucklebridge F....Clow A. (Neurosci. Lett. 1998)
    936. Alterations of neurotransmitter-related gene expression in human and experimental portal-systemic encephalopathy. (PubMed id 10206825)9 Butterworth R.F. (Metab Brain Dis 1998)
    937. Inhibition of monoamine oxidase by pirlindole analogues: 3D-QSAR and CoMFA analysis. (PubMed id 9845968)9 Medvedev A.E....Ivanov A.S. (J Chem Inf Comput Sci 1998)
    938. Role of monoamine oxidase type A and B on the dopamine metabolism in discrete regions of the primate brain. (PubMed id 9704592)9 Lakshmana M.K....Raju T.R. (Neurochem. Res. 1998)
    939. An open trial of moclobemide in the treatment of post-traumatic stress disorder. (PubMed id 9347385)9 Neal L.A....Fox C. (Int Clin Psychopharmacol 1997)
    940. [Poisoning with a reversible and selective monoaminooxidase inhibitor]. (PubMed id 9273760)9 Pall M....Eriksen N.D. (Ugeskr. Laeg. 1997)
    941. Increased stress response and beta-phenylethylamine in MAOB-deficient mice. (PubMed id 9326944)9 Grimsby J....Shih J.C. (Nat. Genet. 1997)
    942. The olfactory bulbectomized rat as a model of depression: an update. (PubMed id 9352586)9 Kelly J.P....Leonard B.E. (amp 1997)
    943. Quantitation of low abundance mRNAs in glial cells using different polymerase chain reaction (PCR)-based methods. (PubMed id 9385056)9 Santagati S....Maggi A. (Brain Res. Brain Res. Protoc. 1997)
    944. Serotonin syndrome and drug combinations: focus on MAOI and RIMA. (PubMed id 9224903)9 Hilton S.E....MAPller H.J. (Eur Arch Psychiatry Clin Neurosci 1997)
    945. Brofaromine versus imipramine in in-patients with major depression--a controlled trial. (PubMed id 9241569)9 Volz H.P....MAPller H.J. (J Affect Disord 1997)
    946. Pressor response to tyramine after single 24-hour application of a selegiline transdermal system in healthy males. (PubMed id 9089426)9 Barrett J.S....DiSanto A.R. (J Clin Pharmacol 1997)
    947. Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group. (PubMed id 9347378)9 Versiani M....Stabl M. (Int Clin Psychopharmacol 1997)
    948. Moclobemide for anxiety disorders: a focus on moclobemide for panic disorder. (PubMed id 9466172)9 Tiller J.W....Behnke K. (Int Clin Psychopharmacol 1997)
    949. [Inhibitory monoamine oxidases of the new generation]. (PubMed id 9432289)9 Nowakowska E. and Chodera A. (Pol. Merkur. Lekarski 1997)
    950. [Preventive treatment of migraine and chronic tension headache with moclobemide]. (PubMed id 9324719)9 Meienberg O. and Amsler F. (Praxis (Bern 1994) 1997)
    951. Inhibition of monoamine oxidase A by beta-carboline derivatives. (PubMed id 8990278)9 Kim H....Ramsay R.R. (Arch. Biochem. Biophys. 1997)
    952. Clonality analysis in tumours of women by PCR amplification of X-linked genes. (PubMed id 9120730)9 Peng H....Pan L. (J. Pathol. 1997)
    953. A fatality due to moclobemide. (PubMed id 9304853)9 Camaris C. and Little D. (J. Forensic Sci. 1997)
    954. Synthesis, conformational analysis and antidepressant activity of moclobemide new analogues. (PubMed id 9112832)9 Ghanbarpour A....Rashidi-Ranjbar P. (Pharm Acta Helv 1997)
    955. Increased density of catalytic sites and expression of brain monoamine oxidase A in humans with hepatic encephalopathy. (PubMed id 9048767)9 Mousseau D.D....Butterworth R.F. (J. Neurochem. 1997)
    956. Antidepressant use in the elderly. Current status of nefazodone, venlafaxine and moclobemide. (PubMed id 9259175)9 Goldberg R.J. (amp 1997)
    957. Monoamine oxidase genes polymorphisms and mood disorder. (PubMed id 9342198)9 Muramatsu T....Asai M. (Am. J. Med. Genet. 1997)
    958. [Monoamine oxidase inhibitors and pressor response to dietary amines]. (PubMed id 9503566)9 Tipton K.F. (Vopr. Med. Khim. 1997)
    959. Altered catecholamine synthesis and degradation in the epidermis of patients with atopic eczema. (PubMed id 9452885)9 Schallreuter K.U....BA1ttner G. (Arch. Dermatol. Res. 1997)
    960. Treatment of depression in Parkinson's disease with moclobemide: A pilot open-label study. (PubMed id 18591080)9 GimAcnez-RoldA!n S....Mateo D. (amp 1997)
    961. Formation of formaldehyde from adrenaline in vivo; a potential risk factor for stress-related angiopathy. (PubMed id 9131641)9 Yu P.H....Zuo D.M. (Neurochem. Res. 1997)
    962. Effects of past history of major depression on smoking characteristics, monoamine oxidase-A and -B activities and withdrawal symptoms in dependent smokers. (PubMed id 9179504)9 Berlin I....Launay J.M. (Drug Alcohol Depend 1997)
    963. Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease: evidence for association of a DRD2 allele. (PubMed id 9191771)9 PlantAc-Bordeneuve V....Harding A.E. (Neurology 1997)
    964. Increased monoamine oxidase A activity in the epidermis of patients with vitiligo. (PubMed id 8750929)9 Schallreuter K.U....Ehrke C. (Arch. Dermatol. Res. 1996)
    965. Epidural anaesthesia, ephedrine and phenylephrine in a patient taking moclobemide, a new monoamine oxidase inhibitor. (PubMed id 9038453)9 Martyr J.W. and Orlikowski C.E. (Anaesthesia 1996)
    966. Pharmacodynamics and pharmacokinetics of two dose regimens of befloxatone, a new reversible and selective monoamine oxidase inhibitor, at steady state in healthy volunteers. (PubMed id 8690815)9 Patat A....Rosenzweig P. (J Clin Pharmacol 1996)
    967. [Tribulin--a novel endogenous monoaminoxidase inhibitor (dedicated to the memory of Merton Sandler)]. (PubMed id 9148606)9 Medvedev A.R. (Vopr. Med. Khim. 1996)
    968. Human anti-mitochondria autoantibodies appearing in iproniazid-induced immunoallergic hepatitis recognize human liver monoamine oxidase B. (PubMed id 8573115)9 Pons C....Mansuy D. (Biochem. Biophys. Res. Commun. 1996)
    969. Direct analysis of candidate genes in impulsive behaviours. (PubMed id 8862874)9 Goldman D....Ozaki N. (Ciba Found. Symp. 1996)
    970. Functional characterization of 5-HT1D autoreceptors on the modulation of 5-HT release in guinea-pig mesencephalic raphe, hippocampus and frontal cortex. (PubMed id 8762094)9 el Mansari M. and Blier P. (Br. J. Pharmacol. 1996)
    971. Monoamine oxidase inhibitors. An update on drug interactions. (PubMed id 8713690)9 Livingston M.G. and Livingston H.M. (Drug Saf 1996)
    972. A double-blind randomized placebo-controlled study of the efficacy and safety of pirlindole, a reversible monoamine oxidase A inhibitor, in the treatment of depression. (PubMed id 9020990)9 De Wilde J.E....GAcczy J. (Acta Psychiatr Scand 1996)
    973. Moclobemide versus fluoxetine for double depression: a randomized double-blind study. (PubMed id 9023788)9 Duarte A....Delini-Stula A. (J Psychiatr Res 1996)
    974. The pharmacotherapy of social phobia. (PubMed id 8923113)9 Pollack M.H. and Gould R.A. (Int Clin Psychopharmacol 1996)
    975. Drug treatment of depression in the 1990s. An overview of achievements and future possibilities. (PubMed id 9118813)9 MAPller H.J. and Volz H.P. (Drugs 1996)
    976. Influence of age, frailty and liver function on the pharmacokinetics of brofaromine. (PubMed id 8866634)9 Zeeh J....Platt D. (Eur. J. Clin. Pharmacol. 1996)
    977. No evidence of linkage between schizophrenia and D2 dopamine receptor gene locus in Italian pedigrees. (PubMed id 8710185)9 Grassi E....Sorbi S. (Neurosci. Lett. 1996)
    978. Tyramine pharmacodynamics during combined administration of lazabemide and moclobemide. (PubMed id 8861736)9 Dingemanse J....Korn A. (Int J Clin Pharmacol Ther 1996)
    979. The role of cytochrome P450 2D6 in the metabolism of moclobemide. (PubMed id 8880082)9 HAortter S....Hiemke C. (Eur Neuropsychopharmacol 1996)
    980. Genetic elevation of monoamine oxidase levels in dopaminergic PC12 cells results in increased free radical damage and sensitivity to MPTP. (PubMed id 8978500)9 Wei Q....Andersen J.K. (J. Neurosci. Res. 1996)
    981. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys. (PubMed id 8949927)9 Di Monte D.A....Langston J.W. (Brain Res. 1996)
    982. [Serotonin syndrome in acute poisoning with antidepressive agents]. (PubMed id 9033760)9 Robert P....Cathala B. (Ann Fr Anesth Reanim 1996)
    983. A study of monoamine oxidase activity in fetal membranes. (PubMed id 8677764)9 Sekizawa A....Oguchi K. (Acta Obstet Gynecol Scand 1996)
    984. Brofaromine--a review of its pharmacological properties and therapeutic use. (PubMed id 9026374)9 Volz H.P....MAPller H.J. (J Neural Transm 1996)
    985. Different modes of data processing and statistical testing applied to the same set of pharmaco-EEG recordings: effects on the evaluation of a selective and reversible MAO A inhibitor (brofaromine). (PubMed id 8776746)9 Reimann I.W....Herrmann W.M. (Neuropsychobiology 1996)
    986. Moclobemide in the treatment of social phobia. (PubMed id 8923114)9 Nutt D. and Montgomery S.A. (Int Clin Psychopharmacol 1996)
    987. Species differences in the interactions of the anticonvulsant milacemide and some analogues with monoamine oxidase-B. (PubMed id 7646533)9 O'Brien E.M....Tipton K.F. (Biochem. Pharmacol. 1995)
    988. Serotonin receptors. Genetic insights into serotonin function. (PubMed id 8542294)9 Heath M.J. and Hen R. (Curr. Biol. 1995)
    989. Effect of aging on lazabemide binding, monoamine oxidase activity and monoamine metabolites in human frontal cortex. (PubMed id 8695059)9 Galva M.D....Picotti G.B. (J. Neural Transm. Gen. Sect. 1995)
    990. A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers. (PubMed id 7586937)9 Berlin I....Puech A.J. (Clin. Pharmacol. Ther. 1995)
    991. Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders. (PubMed id 7717094)9 Priest R.G....Steinert J. (Acta Psychiatr Scand Suppl 1995)
    992. A risk-benefit assessment of moclobemide in the treatment of depressive disorders. (PubMed id 7741983)9 Norman T.R. and Burrows G.D. (Drug Saf 1995)
    993. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression. (PubMed id 7570133)9 Kok L.P. and Tsoi W.F. (Singapore Med J 1995)
    994. Dopaminergic and serotonergic neurotransmitters in bone marrow transplant patients. (PubMed id 7544403)9 Davis D.G. and Sparks D.L. (J. Neurol. Sci. 1995)
    995. Recent advances in geriatric psychopharmacology. (PubMed id 8535049)9 Naranjo C.A....Bremner K.E. (amp 1995)
    996. Moclobemide safety: monitoring a newly developed product in the 1990s. (PubMed id 7593735)9 Hilton S....Ruch R. (J Clin Psychopharmacol 1995)
    997. Social phobia: the clinical efficacy and tolerability of the monoamine oxidase -A and serotonin uptake inhibitor brofaromine. A double-blind placebo-controlled study. (PubMed id 8619339)9 FahlAcn T....Pauli U. (Acta Psychiatr Scand 1995)
    998. Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine. (PubMed id 7796873)9 Glinka Y.Y. and Youdim M.B. (Eur. J. Pharmacol. 1995)
    999. Moclobemide versus clomipramine in nonmelancholic, nonpsychotic major depression. A Study group. (PubMed id 8848950)9 Lecrubier Y....Stabl M. (Acta Psychiatr Scand 1995)
    1000. Redox properties of the flavin cofactor of monoamine oxidases A and B and their relationship to the kinetic mechanism. (PubMed id 8584669)9 Ramsay R.R....Singer T.P. (Prog. Brain Res. 1995)
    1001. Studies of reversible and selective inhibitors of monoamine oxidase A in dysthymia. (PubMed id 7717093)9 PActursson H. (Acta Psychiatr Scand Suppl 1995)
    1002. Relevance of reversible inhibitors of monoamine oxidase type A and of reuptake inhibition for noradrenaline turnover. (PubMed id 7717090)9 Hartmann D....Amrein R. (Acta Psychiatr Scand Suppl 1995)
    1003. Effect of initial treatment with antidepressants as a predictor of outcome after 8 weeks. (PubMed id 8570762)9 Volz H.P....MAPller H.J. (Psychiatry Res 1995)
    1004. Moclobemide in chronic neuropathic pain: preliminary case reports. (PubMed id 7549169)9 Menkes D.B....Jones D. (Clin J Pain 1995)
    1005. L-dopa cytotoxicity to PC12 cells in culture is via its autoxidation. (PubMed id 7830076)9 Basma A.N....Geller H.M. (J. Neurochem. 1995)
    1006. Platelet and brain GABA-transaminase and monoamine oxidase activities in patients with complex partial seizures. (PubMed id 7750512)9 Kumlien E....Oreland L. (Epilepsy Res. 1995)
    1007. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. (PubMed id 7599386)9 Schallreuter K.U....Levenig C. (Dermatology (Basel) 1995)
    1008. Monoamine oxidase A and B activities in heavy smokers. (PubMed id 8580230)9 Berlin I....Puech A.J. (Biol. Psychiatry 1995)
    1009. Clinical efficacy of reversible and selective inhibitors of monoamine oxidase A in major depression. (PubMed id 7717091)9 Paykel E.S. (Acta Psychiatr Scand Suppl 1995)
    1010. Norrie disease and MAO genes: nearest neighbors. (PubMed id 8541872)9 Chen Z.Y....Breakefield X.O. (Hum. Mol. Genet. 1995)
    1011. [The effect of pyrazidole on monoamine level in hypobaric hypoxia]. (PubMed id 8122400)9 Goroshinskaia I.A....Sorokina I.V. (Vopr. Med. Khim. 1994)
    1012. Characterization of the enzyme responsible for the metabolism of sumatriptan in human liver. (PubMed id 8161354)9 Dixon C.M....Tarbit M.H. (Biochem. Pharmacol. 1994)
    1013. Multicenter double-blind study of moclobemide and maprotiline. (PubMed id 7954483)9 Vaz-Serra A....Pestana L.C. (Clin Neuropharmacol 1994)
    1014. A cross-study comparison of the effects of moclobemide and brofaromine on actual driving performance and estimated sleep. (PubMed id 7954488)9 Ramaekers J.G....O'Hanlon J.F. (Clin Neuropharmacol 1994)
    1015. In vivo effects of the monoamine oxidase inhibitors Ro 41-1049 and Ro 19-6327 on the production and fate of renal dopamine. (PubMed id 7931252)9 Vieira-Coelho M.A....Soares-da-Silva P. (J. Neural Transm. Suppl. 1994)
    1016. Selective MAO-A and B inhibitors, radical scavengers and nitric oxide synthase inhibitors in Parkinson's disease. (PubMed id 7527888)9 Youdim M.B. and Lavie L. (Life Sci. 1994)
    1017. Brofaromine in non-endogenous major depressed inpatients--results of a preliminary dose-finding trial versus tranylcypromine. (PubMed id 7972347)9 Volz H.P....MAPller H.J. (Pharmacopsychiatry 1994)
    1018. Correlations of plasma and urinary phenylacetic acid and phenylethylamine concentrations with eating behavior and mood rating scores in brofaromine-treated women with bulimia nervosa. (PubMed id 7918350)9 Davis B.A....Boulton A.A. (amp 1994)
    1019. Experimental and theoretical study of reversible monoamine oxidase inhibitors: structural approach of the active site of the enzyme. (PubMed id 7931244)9 Wouters J....Jarreau F.X. (J. Neural Transm. Suppl. 1994)
    1020. Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs. (PubMed id 7834200)9 Blier P. and Bouchard C. (Br. J. Pharmacol. 1994)
    1021. Biogenic amine metabolite patterns in the urine of monoamine oxidase A-deficient patients. A possible tool for diagnosis. (PubMed id 7807947)9 Abeling N.G....Brunner H.G. (J. Inherit. Metab. Dis. 1994)
    1022. Moclobemide for depression. (PubMed id 7635005)9 (Drug Ther Bull 1994)
    1023. Effects of monoamine oxidase A inhibition on plasma biogenic amine metabolites in depressed patients. (PubMed id 7527564)9 Markianos M....Stefanis C. (Psychiatry Res 1994)
    1024. Interaction of tetrahydrostilbazoles with monoamine oxidase A and B. (PubMed id 8289189)9 Sablin S.O....Tkachenko S.E. (J. Med. Chem. 1994)
    1025. Monoamine oxidase inhibitors, cognitive functions and neurodegenerative diseases. (PubMed id 7931235)9 Delumeau J.C....Allain H. (J. Neural Transm. Suppl. 1994)
    1026. Novel 4-(aryloxy)tetrahydropyridine analogs of MPTP as monoamine oxidase A and B substrates. (PubMed id 8151621)9 Kalgutkar A.S....Castagnoli N. (J. Med. Chem. 1994)
    1027. Inhibition of monoamine oxidase by clorgyline analogues. (PubMed id 7931241)9 O'Brien E.M....Dostert P. (J. Neural Transm. Suppl. 1994)
    1028. Comparison of the efficacy and tolerability of moclobemide and maprotiline in depressed patients treated by general practitioners. (PubMed id 7954482)9 Gachoud J.P....KAPhler M. (Clin Neuropharmacol 1994)
    1029. Identification of human monoamine oxidase (MAO) A and B gene promoters. (PubMed id 7931237)9 Shih J.C....Chen K. (J. Neural Transm. Suppl. 1994)
    1030. Moclobemide (Aurorix) in primary major depression. (PubMed id 8208985)9 Rihmer Z....GA!bor A. (amp 1994)
    1031. (-)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis. (PubMed id 7931312)9 Tatton W.G....Kwan M. (J. Neurochem. 1994)
    1032. Modulation of capsaicin induced airway reflexes in humans: effect of monoamine oxidase inhibition. (PubMed id 8443037)9 Choudry N.B....Fuller R.W. (Br J Clin Pharmacol 1993)
    1033. Is there a role for selective monoamine oxidase inhibitor therapy in bulimia nervosa? A placebo-controlled trial of brofaromine. (PubMed id 8120155)9 Kennedy S.H....Lofchy J. (J Clin Psychopharmacol 1993)
    1034. [An increase in the radioprotective effect of O-methyltyramine and mezaton by monoamine oxidase inhibitors]. (PubMed id 8469735)9 KulinskiA- V.I....Rumiantseva N.P. (Radiobiologiia 1993)
    1035. Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons. (PubMed id 8100196)9 Gu X.F. and Azmitia E.C. (Eur. J. Pharmacol. 1993)
    1036. Double-blind comparison of moclobemide and tranylcypromine in depression. (PubMed id 8127928)9 Heinze G....Allen S.R. (Pharmacopsychiatry 1993)
    1037. Drug interactions with reversible monoamine oxidase-A inhibitors. (PubMed id 8313396)9 Callingham B.A. (Clin Neuropharmacol 1993)
    1038. Reversible monoamine oxidase-A inhibitors in resistant major depression. (PubMed id 8313400)9 Nolen W.A....Haffmans P.M. (Clin Neuropharmacol 1993)
    1039. Increased activities of MAOA and MAOB in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. (PubMed id 8242348)9 Rao V.L....Butterworth R.F. (Brain Res. 1993)
    1040. The effect of side chain substitution at positions 2 and 3 of the heterocyclic ring of N-acetylenic analogues of tryptamine as monoamine oxidase inhibitors. (PubMed id 8517863)9 Avila M....Unzeta M. (Biochem. Pharmacol. 1993)
    1041. Substrate-specific enhancement of the oxidative half-reaction of monoamine oxidase. (PubMed id 8443155)9 Tan A.K. and Ramsay R.R. (Biochemistry 1993)
    1042. Serotonin uptake inhibition by the monoamine oxidase inhibitor brofaromine. (PubMed id 8471696)9 Waldmeier P.C....Howald H. (Biol. Psychiatry 1993)
    1043. Reversible monoamine oxidase-A inhibitors in panic disorder. (PubMed id 8313401)9 Bakish D....D'Souza J. (Clin Neuropharmacol 1993)
    1044. In vitro hepatic biotransformation of moclobemide (Ro 11-1163) in man and rat. (PubMed id 8259692)9 VallA"s B....Rahmani R. ( the fate of foreign compounds in biological systems 1993)
    1045. Differential increases in catecholamine metabolizing enzymes in amyotrophic lateral sclerosis. (PubMed id 8405291)9 Ekblom J....Jossan S.S. (Exp. Neurol. 1993)
    1046. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies. (PubMed id 8313397)9 Chouinard G....Kukha-Mohamad S.A. (Clin Neuropharmacol 1993)
    1047. An update of recent moclobemide interaction data. (PubMed id 8468439)9 Dingemanse J. (Int Clin Psychopharmacol 1993)
    1048. Synthesis and characterization of 11C-labeled fluoroclorgyline: a monoamine oxidase A specific inhibitor for positron emission tomography. (PubMed id 8293522)9 Ohmomo Y....Yokoyama A. (amp 1993)
    1049. Estrogen modulation of catecholamine synthesis and monoamine oxidase A activity in the human neuroblastoma cell line SK-ER3. (PubMed id 7903862)9 Ma Z.Q....Maggi A. (J. Steroid Biochem. Mol. Biol. 1993)
    1050. [Brain monoamine oxidase in aging wild Norway rats, chosen for lack of aggressive behavior toward humans]. (PubMed id 8511882)9 VoA-tenko N.N. (Vopr. Med. Khim. 1993)
    1051. Cytotoxicity of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines. (PubMed id 8093579)9 Maruyama W....Naoi M. (Adv Neurol 1993)
    1052. Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition. (PubMed id 8390270)9 Youdim M.B. and Riederer P. (J. Neural Transm. Gen. Sect. 1993)
    1053. Clinical overview on moclobemide. (PubMed id 8255982)9 Tiller J.W. (amp 1993)
    1054. Newer aspects of the reversible inhibitor of MAO-A and serotonin reuptake, brofaromine. (PubMed id 8430214)9 Waldmeier P.C. (amp 1993)
    1055. Safety of moclobemide in clinical use. (PubMed id 8313399)9 Chen D.T. and Ruch R. (Clin Neuropharmacol 1993)
    1056. Reversible monoamine oxidase-A inhibitors in resistant major depression. (PubMed id 1498903)9 Nolen W.A....Haffmans P.M. (Clin Neuropharmacol 1992)
    1057. The new generation of monoamine oxidase inhibitors. (PubMed id 1609114)9 Cesura A.M. and Pletscher A. (Prog Drug Res 1992)
    1058. Biochemistry and pharmacology of moclobemide, a prototype RIMA. (PubMed id 1546143)9 Haefely W....Da Prada M. (Psychopharmacology (Berl.) 1992)
    1059. Brofaromine in panic disorder: a pilot study with a new reversible inhibitor of monoamine oxidase-A. (PubMed id 1494591)9 Garcia-Borreguero D....Krieg J.C. (Pharmacopsychiatry 1992)
    1060. RIMA: a safe concept in the treatment of depression with moclobemide. (PubMed id 1394030)9 Amrein R....Schmid-Burgk W. (Can J Psychiatry 1992)
    1061. Biochemical effects of high single doses of moclobemide in man: correlation with plasma concentrations. (PubMed id 1347659)9 Dingemanse J....GA1ntert T.W. (Psychopharmacology (Berl.) 1992)
    1062. Safety of moclobemide taken in overdose for attempted suicide. (PubMed id 1546127)9 Hetzel W. (Psychopharmacology (Berl.) 1992)
    1063. Deprenyl alters behavior and caudate dopamine through an amphetamine-like action. (PubMed id 1475291)9 Okuda C....Kuczenski R. (Pharmacol. Biochem. Behav. 1992)
    1064. Efficacy of moclobemide in different patient groups: a meta-analysis of studies. (PubMed id 1347658)9 Angst J. and Stabl M. (Psychopharmacology (Berl.) 1992)
    1065. New pharmacological approaches to the management of depression: from theory to clinical practice. (PubMed id 1580888)9 Norman T.R....Burrows G.D. (Aust N Z J Psychiatry 1992)
    1066. An Australian multicentre study of moclobemide versus amitriptyline in the treatment of depression. (PubMed id 1417632)9 Evans L....Adena M. (Aust N Z J Psychiatry 1992)
    1067. Brain gamma-aminobutyrate aminotransferase (GABA-T) and monoamine oxidase (MAO) in patients with Alzheimer's disease. (PubMed id 1627256)9 Sherif F....Oreland L. (J Neural Transm Park Dis Dement Sect 1992)
    1068. Antidepressants and cognition: comparative effects of moclobemide, viloxazine and maprotiline. (PubMed id 1546142)9 Allain H....Gandon J.M. (Psychopharmacology (Berl.) 1992)
    1069. Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement. (PubMed id 1282522)9 Celada P....Artigas F. (J Clin Psychopharmacol 1992)

    (in PubMed, OMIM, and NCBI Bookshelf)
    About This Section

    TryGeneCards Plus
     ANDOR
    Aliases
    Disorders
    Free Text  

      Query String
    PubMed
    OMIM
    NCBI Bookshelf
      (Note: In FireFox, select the above section and copy using Ctrl-C)

    (According to Entrez Gene, HGNC, AceView, euGenes, Ensembl, miRBase, ECgene, Kegg, and/or H-InvDB)
    About This Section

    TryGeneCards Plus
    Entrez Gene: 4128 HGNC: 6833 AceView: MAOA Ensembl:ENSG00000189221 euGenes: HUgn4128
    ECgene: MAOA Kegg: 4128 H-InvDB: MAOA

    (According to HUGE)
    About This Section

    TryGeneCards Plus
      --

    (According to PharmGKB, ATLAS, HORDE, IMGT, LEIDEN, UniProtKB/Swiss-Prot, UniProtKB/TrEMBL, and/or others, e.g. Wikipedia and GeneReviews, via UniProtKB/Swiss-Prot)
    About This Section

    TryGeneCards Plus
    NameDescription
    PharmGKB entry for MAOA Pharmacogenomics, SNPs, Pathways
    GeneReviewshttp://www.ncbi.nlm.nih.gov/books/NBK1116/?term=MAOA[genesymbol]
    Wikipedia http://en.wikipedia.org/wiki/Monoamine_oxidase

    (Patent information from GeneIP,
    Licensable technologies from WIS Yeda, Salk, Tufts,
    IP news from LifeMap Sciences, Inc.)
    About This Section

    TryGeneCards Plus
    Patent Information for MAOA gene:
    Search GeneIP for patents involving MAOA

    GeneCards and IP:
    Japan Patent Office Licenses GeneCards     European Patent Office Licenses GeneCards     Improving the IP Search



    (Antibodies, recombinant proteins, and assays from EMD Millipore, R&D Systems, OriGene, QIAGEN, GenScript, Cell Signaling Technology, Novus Biologicals, Sino Biological, Enzo Life Sciences, Abcam, ProSpec, Cloud-Clone Corp., Thermo Fisher Scientific, LSBio, Gene Editing from DNA2.0. Clones from OriGene, GenScript, Sino Biological, DNA2.0, SwitchGear Genomics, Vector BioLabs, Cell lines from GenScript, and ESI BIO, PCR Arrays from QIAGEN, Drugs and/or compounds from EMD Millipore, Tocris Bioscience, Enzo Life Sciences, and/or ApexBio, In Situ Hybridization Assays from
    Advanced Cell Diagnostics, Animal models from inGenious Targeting Laboratory, genOway)
    About This Section

    TryGeneCards Plus

     EMD Millipore Mono- and Polyclonal Antibodies for the study of MAOA
     Browse Small Molecules at EMD Millipore
     Browse Kits and Assays available from EMD Millipore
     Browse Purified and Recombinant Proteins at EMD Millipore
     
     EMD Millipore genomic analysis products

      
     Browse Antibodies   Browse Cell Culture Products  
     Browse ELISAs   Browse Flow Cytometry Kits  
     Browse Primer Pairs   Browse Enzyme Activity Assays/Reagents  
     Browse ELISpot/FluoroSpot Kits/Development Modules   Browse TFB/Immunoprecipitation Assays  
     Browse Apoptosis Detection Kits/Reagents   Browse Ubiquitin Proteasome Pathway (UPP) Assay Kits/Reagents  
     Browse DNA Damage/Repair Kits/Reagents   Browse Luminex Assays  
     Browse Cell Selection/Detection Kits/Reagents   Browse Secondary Antibodies/Controls/Staining Reagents  
     Browse Recombinant/Natural Proteins   Browse Stem Cell Products  
     Browse cDNA Clones   Browse Proteome Profiler Antibody Arrays  
     OriGene Antibodies for MAOA   OriGene RNAi products in human, mouse, rat for MAOA  
     OriGene qPCR primer pairs and template standards for MAOA   OriGene Protein Over-expression Lysate for MAOA  
     OriGene Custom Mass Spec   OriGene clones in human, mouse for MAOA  
     OriGene qSTAR qPCR primer pairs in human, mouse for MAOA   Browse OriGene full length recombinant human proteins expressed in human HEK293 cells  
     OriGene ORF clones in mouse, rat for MAOA   OriGene custom cloning services - gene synthesis, subcloning, mutagenesis, variant library, vector shuttling  
     OriGene Custom Antibody Services for MAOA   OriGene Custom Protein Services for MAOA  

     
     
     Block miRNA regulation of human, mouse, rat MAOA using miScript Target Protectors SeqTarget long-range PCR primers for resequencing MAOA
     DNA Methylation CpG Assay Predesigned for Pyrosequencing in human, mouse, rat MAOA Predesigned siRNA for gene silencing in human, mouse, rat MAOA
     QuantiFast Probe-based Assays in human, mouse, rat MAOA QuantiTect SYBR Green Assays in human, mouse, rat MAOA
     PCR Arrays including human, mouse, rat MAOA Search Chromatin IP Primers for MAOA
     Pre-validated RT2 qPCR Primer Assay in human, mouse, rat MAOA  GeneGlobe Interaction Network for MAOA
     Regulatory tfbs in MAOA promoter
     GenScript Custom Purified and Recombinant Proteins Services for MAOA GenScript cDNA clones with any tag delivered in your preferred vector for MAOA
     GenScript Custom Assay Services for MAOA GenScript Custom overexpressing Cell Line Services for MAOA
     CloneReady with Over 120,000 Genes  Gene Synthesis: Any Gene in Any Vector
     Vector-based siRNA and miRNA, Ready for Transfection Gene Mutant Library, Variants up to 10^11
     Plasmid Preparation Custom Peptide Services
     Search for Antibodies & Assays

     Tocris compounds for MAOA
     Proteins for MAOA
     Browse Sino Biological Cell Lysates
     cDNA Clones for MAOA
     4000+ Proteins
     Search Sino Biological for antibodies, proteins & pathways
     Protein Production Services
     Transfection Reagents
     Protein A/G/L resins
     Isotyping reagents
     Search www.enzolifesciences.com for proteins, assays, substrates, inhibitors & antibodies

     Novus Tissue Slides
     MAOA antibodies
     MAOA proteins
     MAOA lysates
     Antibodies for MAOA
     See all of Abcam's Antibodies, Kits and Proteins for MAOA
     Custom Antibody / Protein Production Service
     Bulk Purchasing
     Advantages of Rabbit Monoclonal antibodies
     Abcam protocols and scientific support
     Browse ProSpec Recombinant Proteins
     Proteins for MAOA
     Antibodies for MAOA
     ELISAs for MAOA
     CLIAs for MAOA



     Browse ESI BIO Cell Lines and PureStem Progenitors for MAOA
     Gene Synthesis
     Protein Engineering
     Variant Library Synthesis
     Codon Optimization
     Protein Production and Purification
     Advanced Cell Diagnostics RNAscope RNA in situ hybridization assays for MAOA
     SwitchGear 3'UTR luciferase reporter plasmids for MAOA
     SwitchGear Promoter luciferase reporter plasmids for MAOA
     ThermoFisher Antibodies for MAOA
     Vector BioLabs ready-to-use adenovirus/AAV for human, mouse, rat MAOA
     inGenious Targeting Laboratory: Let us create your new Knockout/Knockin mouse model for MAOA
     inGenious Targeting Laboratory: Contact us about creating complex and humanized mouse models for MAOA
     LSBio Antibodies in human, mouse, rat for MAOA
    Customized transgenic rodents for:
     Humanization
     Biomarker expression
     Off-target effect monitoring
     Translational medicine
     Tissue-specific gene expresssion
     Time-controlled gene expresssion
     Browse compounds at ApexBio
           
    GeneCards Homepage - Last full update: 7 May 2014 - Incrementals: 9 May 2014 , 2 Jun 2014 , 26 Jun 2014 , 30 Jun 2014

    View Random Gene

    Category
    (GIFtS: )
    GIFtS Group
    The GeneCards human gene database gene index: 1 3 5 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 


    Developed at the Crown Human Genome Center, Department of Molecular Genetics, the Weizmann Institute of Science

    Hot genes      Disease genes      MAOA gene at Home site.
    Version: 3.12.166 28 Aug 2014
    hostname: 356977-web1.xennexinc.com index build: 126 solr: 1.4